Valentín Fuster | Academic Influence

Valentín Fuster's AcademicInfluence.com Rankings

Valentín Fuster

Medical

#24

World Rank

#49

Historical Rank

Cardiology

#3

World Rank

#3

Historical Rank

medical Degrees

Download Badge

Medical

Valentín Fuster's Degrees

Doctorate Medicine University of Barcelona
PhD Medicine University of Barcelona

Why Is Valentín Fuster Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Valentín Fuster Carulla, 1st Marquess of Fuster is a Spanish cardiologist and aristocrat. He is editor-in-chief of the Journal of the American College of Cardiology , past President of the American Heart Association, past President of the World Heart Federation, and has been a member of the US National Academy of Medicine and Member of the European Horizon 2020 Scientific Panel of Health. In 2016 he co-chaired, with Jendayi Frazer, the Advisory Committee on The Role of the United States on Global Health.

(See a Problem?)

Valentín Fuster's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult—Summary Article (2005) (5001)
A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. (1995) (3817)
Coronary plaque disruption. (1995) (3687)
Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients (1994) (3667)
ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients (2002) (3666)
The pathogenesis of coronary artery disease and the acute coronary syndromes (2). (1992) (3538)
ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography (2006) (3207)
ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. (2002) (2786)
ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association task force on practice guidelines and the European society of cardiology committee for PRAC (2006) (2631)
ACC/AHA 2002 guideline update for exercise testing: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). (2002) (2258)
ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--2002: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients (2002) (2245)
Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel. (1988) (1962)
ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conference (2001) (1865)
ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). (2004) (1807)
The pathogenesis of coronary artery disease and the acute coronary syndromes (1). (1992) (1652)
Strategies for multivessel revascularization in patients with diabetes. (2012) (1569)
ACC/AHA 2002 guideline update for the management of patients with chronic stable angina--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina). (2003) (1549)
ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery---executive summary a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluat (2002) (1523)
Angiographic progression of coronary artery disease and the development of myocardial infarction. (1988) (1493)
ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to update the 2001 Guidelines for Percutaneous Coronary Intervention (2006) (1467)
ACC/AHA/ASE 2003 Guideline Update for the Clinical Application of Echocardiography: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echoca (2003) (1407)
ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Commit (2006) (1406)
ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiov (2007) (1400)
ACC/AHA 2002 guideline update for exercise testing: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). (2002) (1400)
Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. (1999) (1393)
ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). (2002) (1373)
Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease (2017) (1358)
ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionucl (2003) (1224)
Macrophage Infiltration in Acute Coronary Syndromes: Implications for Plaque Rupture (1994) (1201)
ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update 2001 Guidelines for Percutaneous Coronary Intervention). (2006) (1197)
[Guidelines for the management of patients with atrial fibrillation. Executive summary]. (2006) (1171)
ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committ (2006) (1079)
Coronary artery calcification: pathophysiology, epidemiology, imaging methods, and clinical implications. A statement for health professionals from the American Heart Association. Writing Group. (1996) (1076)
ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation (2007) (1064)
Primary pulmonary hypertension: natural history and the importance of thrombosis. (1984) (1062)
Hurst's the Heart (1966) (1056)
ACC/AHA Guidelines for the Management of Patients with Peripheral Arterial Disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Associations for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Intervent (2006) (1040)
Assessment of Cardiovascular Risk by Use of Multiple-Risk-Factor Assessment Equations (1999) (1033)
ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). (2000) (1029)
2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. (2011) (1008)
Platelet-active drugs: the relationships among dose, effectiveness, and side effects. (2004) (1008)
ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Ang (2006) (1006)
The natural history of idiopathic dilated cardiomyopathy. (1981) (939)
Long-term outcome in patients undergoing surgical repair of tetralogy of Fallot. (1993) (930)
Prevention Conference V: Beyond secondary prevention: identifying the high-risk patient for primary prevention: noninvasive tests of atherosclerotic burden: Writing Group III. (2000) (897)
ACC/AHA 2002 guideline update for the management of patients with unstable angina and non–ST-segment elevation myocardial infarction—summary article (2002) (893)
2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (updating the 2006 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. (2011) (888)
2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (Updating the 2006 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. (2011) (880)
2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 Guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in partnership with the Europe (2011) (860)
Genetic Risk, Adherence to a Healthy Lifestyle, and Coronary Disease. (2016) (847)
Lewis A. Conner Memorial Lecture. Mechanisms leading to myocardial infarction: insights from studies of vascular biology. (1994) (844)
American Heart Association/American College of Cardiology Foundation guide to warfarin therapy. (2003) (830)
Association of Treatment Dose Anticoagulation With In-Hospital Survival Among Hospitalized Patients With COVID-19 (2020) (816)
Atherothrombosis and high-risk plaque: part I: evolving concepts. (2005) (796)
Long-term air pollution exposure and acceleration of atherosclerosis and vascular inflammation in an animal model. (2005) (786)
ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Co (2003) (786)
Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Potential role of matrix-degrading metalloproteinases and implications for plaque rupture. (1995) (785)
Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit. (1990) (784)
Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport. (2012) (779)
ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text (2006) (778)
Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell proliferation. (1990) (773)
ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionucl (2003) (769)
ACC/AHA guidelines of percutaneous coronary interventions (revision of the 1993 PTCA guidelines)--executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (committee to revise the 1993 guidelines for percutaneous transluminal coro (2001) (767)
Coronary artery disease: pathogenesis and acute coronary syndromes. (2001) (748)
Angiographie morphology and the pathogenesis of unstable angina pectoris (1985) (733)
ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias--executive summary. a report of the American college of cardiology/American heart association task force on practice guidelines and the European society of cardiology committee for practice guidelines (writing co (2003) (731)
ACC/AHA Guidelines for Percutaneous Coronary Intervention (Revision of the 1993 PTCA Guidelines)—Executive Summary (2001) (728)
AHA/ACC Guidelines for Preventing Heart Attack and Death in Patients With Atherosclerotic Cardiovascular Disease: 2001 update. A statement for healthcare professionals from the American Heart Association and the American College of Cardiology. (2001) (723)
Balloon angioplasty. Natural history of the pathophysiological response to injury in a pig model. (1985) (712)
ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). (2006) (709)
Magnetic resonance images lipid, fibrous, calcified, hemorrhagic, and thrombotic components of human atherosclerosis in vivo. (1996) (690)
Tissue factor modulates the thrombogenicity of human atherosclerotic plaques. (1997) (667)
Promoting Cardiovascular Health in the Developing World: A Critical Challenge to Achieve Global Health (2010) (655)
Management of patients with atrial fibrillation. A Statement for Healthcare Professionals. From the Subcommittee on Electrocardiography and Electrophysiology, American Heart Association. (1996) (643)
Plaque Neovascularization Is Increased in Ruptured Atherosclerotic Lesions of Human Aorta: Implications for Plaque Vulnerability (2004) (633)
AHA/ACC Scientific Statement: AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update: A statement for healthcare professionals from the American Heart Association and the American College of Cardiology. (2001) (628)
ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echoca (2003) (618)
In vivo diagnosis of plaque erosion and calcified nodule in patients with acute coronary syndrome by intravascular optical coherence tomography. (2013) (607)
ACC/AHA guidelines for the management of patients with unstable angina and non‐ST segment elevation myocardial infarction: Executive summary and recommendations (2000) (606)
Coarctation of the aorta. Long-term follow-up and prediction of outcome after surgical correction. (1989) (599)
Characterization of the relative thrombogenicity of atherosclerotic plaque components: implications for consequences of plaque rupture. (1994) (595)
Noninvasive in vivo human coronary artery lumen and wall imaging using black-blood magnetic resonance imaging. (2000) (591)
Terminology for high-risk and vulnerable coronary artery plaques. Report of a meeting on the vulnerable plaque, June 17 and 18, 2003, Santorini, Greece. (2004) (559)
A platelet-inhibitor-drug trial in coronary-artery bypass operations: benefit of perioperative dipyridamole and aspirin therapy on early postoperative vein-graft patency. (1982) (548)
Effect of dipyridamole and aspirin on late vein-graft patency after coronary bypass operations. (1984) (537)
Insights into the pathogenesis of acute ischemic syndromes. (1988) (531)
Clinical Imaging of the High-Risk or Vulnerable Atherosclerotic Plaque (2001) (529)
Inhibition of intimal thickening after balloon angioplasty in porcine coronary arteries by targeting regulators of the cell cycle. (1999) (528)
Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial (2011) (509)
Effects of Lipid-Lowering by Simvastatin on Human Atherosclerotic Lesions: A Longitudinal Study by High-Resolution, Noninvasive Magnetic Resonance Imaging (2001) (507)
Lipid Lowering by Simvastatin Induces Regression of Human Atherosclerotic Lesions: Two Years’ Follow-Up by High-Resolution Noninvasive Magnetic Resonance Imaging (2002) (505)
Atherosclerotic plaque rupture and thrombosis. Evolving concepts. (1990) (500)
Management of patients with atrial fibrillation (compilation of 2006 ACCF/AHA/ESC and 2011 ACCF/AHA/HRS recommendations): a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. (2013) (493)
Angiographic evolution of coronary artery morphology in unstable angina. (1986) (484)
ACC/AHA Guideline Update for Perioperative Cardiovascular Evaluation for Noncardiac Surgery—Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluati (2002) (479)
A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. (1995) (468)
Atherosclerosis Inflammation Imaging with 18F-FDG PET: Carotid, Iliac, and Femoral Uptake Reproducibility, Quantification Methods, and Recommendations (2008) (455)
Coronary Composition and Macrophage Infiltration in Atherectomy Specimens From Patients With Diabetes Mellitus (2000) (452)
Noninvasive detection of macrophages using a nanoparticulate contrast agent for computed tomography (2007) (450)
Histopathologic characteristics of atherosclerotic coronary disease and implications of the findings for the invasive and noninvasive detection of vulnerable plaques. (2013) (445)
Guide to Anticoagulant Therapy: Heparin: A Statement for Healthcare Professionals From the American Heart Association (2001) (441)
ACC/AHA guidelines for the early management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (subcommittee to develop guidelines for the early manag (1990) (439)
Aspirin as a therapeutic agent in cardiovascular disease: a statement for healthcare professionals from the American Heart Association. (1997) (439)
(18)Fluorodeoxyglucose positron emission tomography imaging of atherosclerotic plaque inflammation is highly reproducible: implications for atherosclerosis therapy trials. (2007) (428)
Exome-wide association study of plasma lipids in >300,000 individuals (2017) (428)
2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on Dabigatran): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. (2011) (426)
Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis of individual patient data (2018) (423)
AKI in Hospitalized Patients with COVID-19. (2020) (420)
Atherosclerotic plaque composition: analysis with multicolor CT and targeted gold nanoparticles. (2010) (419)
Coronary angiographic morphology in myocardial infarction: a link between the pathogenesis of unstable angina and myocardial infarction. (1985) (416)
[ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation--excutive summary]. (2006) (412)
Macrophages, smooth muscle cells, and tissue factor in unstable angina. Implications for cell-mediated thrombogenicity in acute coronary syndromes. (1996) (400)
Diagnosing and managing unstable angina. Agency for Health Care Policy and Research. (1994) (396)
The Global Burden of Cardiovascular Diseases and Risk Factors: 2020 and Beyond. (2019) (391)
Platelet-active drugs : the relationships among dose, effectiveness, and side effects. (2004) (390)
Effects of thrombin inhibition on the development of acute platelet-thrombus deposition during angioplasty in pigs. Heparin versus recombinant hirudin, a specific thrombin inhibitor. (1989) (387)
Principles for national and regional guidelines on cardiovascular disease prevention: a scientific statement from the World Heart and Stroke Forum. (2004) (386)
Prevalence and Impact of Myocardial Injury in Patients Hospitalized With COVID-19 Infection (2020) (381)
Angiographic morphology and the pathogenesis of unstable angina pectoris. (1985) (376)
Acute coronary syndromes: unstable angina and non-Q-wave myocardial infarction. (1998) (374)
Viral myocarditis—diagnosis, treatment options, and current controversies (2015) (373)
Preventing heart attack and death in patients with coronary disease. (1995) (371)
Guidelines for the early management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee to Develop Guidelines for the Early Management of (1990) (370)
The myth of the "vulnerable plaque": transitioning from a focus on individual lesions to atherosclerotic disease burden for coronary artery disease risk assessment. (2015) (361)
Prevalence, impact, and predictive value of detecting subclinical coronary and carotid atherosclerosis in asymptomatic adults: the BioImage study. (2015) (349)
Epithelial-to-Mesenchymal and Endothelial-to-Mesenchymal Transition: From Cardiovascular Development to Disease (2012) (348)
A Statin-Loaded Reconstituted High-Density Lipoprotein Nanoparticle Inhibits Atherosclerotic Plaque Inflammation (2014) (344)
Endothelial to mesenchymal transition is common in atherosclerotic lesions and is associated with plaque instability (2016) (341)
Polygenic Risk Score Identifies Subgroup With Higher Burden of Atherosclerosis and Greater Relative Benefit From Statin Therapy in the Primary Prevention Setting (2017) (338)
Influence of Arterial Damage and Wall Shear Rate on Platelet Deposition: Ex Vivo Study in a Swine Model (1986) (338)
New aspects in the pathogenesis of diabetic atherothrombosis. (2004) (338)
Inflammation, Immunity, and Infection in Atherothrombosis: JACC Review Topic of the Week. (2018) (330)
Perspectives and opportunities for nanomedicine in the management of atherosclerosis (2011) (330)
In vivo magnetic resonance evaluation of atherosclerotic plaques in the human thoracic aorta: a comparison with transesophageal echocardiography. (2000) (329)
The diagnostic accuracy of ex vivo MRI for human atherosclerotic plaque characterization. (1999) (324)
Empagliflozin Ameliorates Adverse Left Ventricular Remodeling in Nondiabetic Heart Failure by Enhancing Myocardial Energetics. (2019) (323)
2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (Updating the 2006 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. (2011) (321)
Isolated atrial septal defect with pulmonary vascular obstructive disease--long-term follow-up and prediction of outcome after surgical correction. (1987) (321)
Neovascularization in human atherosclerosis. (2006) (321)
Thrombus Formation on Atherosclerotic Plaques: Pathogenesis and Clinical Consequences (2001) (320)
2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on dabigatran). A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. (2011) (317)
Trial of combined warfarin plus dipyridamole or aspirin therapy in prosthetic heart valve replacement: danger of aspirin compared with dipyridamole. (1983) (316)
ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention (2006) (315)
Role of Risk Factors in the Modulation of Tissue Factor Activity and Blood Thrombogenicity (2003) (313)
Atherothrombosis: a widespread disease with unpredictable and life-threatening consequences. (2004) (309)
Impact of Oxidative Stress on the Heart and Vasculature: Part 2 of a 3-Part Series. (2017) (307)
Tumors of the Heart and Great Vessels (2003) (305)
Prevalence, Vascular Distribution, and Multiterritorial Extent of Subclinical Atherosclerosis in a Middle-Aged Cohort: The PESA (Progression of Early Subclinical Atherosclerosis) Study (2015) (304)
The role of platelets, thrombin and hyperplasia in restenosis after coronary angioplasty. (1991) (299)
Acute coronary syndromes: biology (1999) (298)
Thoracic aortic aneurysm and dissection. (2014) (290)
Neovascularization in Human Atherosclerosis (2006) (288)
Evaluation of pulmonary artery stiffness in pulmonary hypertension with cardiac magnetic resonance. (2009) (288)
Computed Tomography and Magnetic Resonance Imaging for Noninvasive Coronary Angiography and Plaque Imaging: Current and Potential Future Concepts (2002) (287)
High risk of thromboemboli early after bioprosthetic cardiac valve replacement. (1995) (279)
Management of patients with atrial fibrillation (compilation of 2006 ACCF/AHA/ESC and 2011 ACCF/AHA/HRS recommendations): a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. (2013) (277)
Atherosclerotic Vascular Disease Conference: Writing Group III: pathophysiology. (2004) (275)
Effects of aggressive versus conventional lipid-lowering therapy by simvastatin on human atherosclerotic lesions: a prospective, randomized, double-blind trial with high-resolution magnetic resonance imaging. (2005) (267)
Molecular, cellular and functional imaging of atherothrombosis (2004) (265)
Local inhibition of tissue factor reduces the thrombogenicity of disrupted human atherosclerotic plaques: effects of tissue factor pathway inhibitor on plaque thrombogenicity under flow conditions. (1999) (264)
Characterization of Myocardial Injury in Patients With COVID-19 (2020) (260)
Anticoagulation, Bleeding, Mortality, and Pathology in Hospitalized Patients With COVID-19 (2020) (259)
Hirudin, heparin, and placebo during deep arterial injury in the pig. The in vivo role of thrombin in platelet-mediated thrombosis. (1990) (254)
Acute Coronary Events (2012) (252)
Progression and Regression of Atherosclerotic Lesions: Monitoring With Serial Noninvasive Magnetic Resonance Imaging (2002) (249)
Relationships Among Regional Arterial Inflammation, Calcification, Risk Factors, and Biomarkers: A Prospective Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography Imaging Study (2009) (241)
Is vasospasm related to platelet deposition? Relationship in a porcine preparation of arterial injury in vivo. (1987) (240)
Right ventriculo-arterial coupling in pulmonary hypertension: a magnetic resonance study (2011) (240)
Guidelines for management of left-sided prosthetic valve thrombosis: a role for thrombolytic therapy. Consensus Conference on Prosthetic Valve Thrombosis. (1997) (239)
Effect of Early Metoprolol on Infarct Size in ST-Segment–Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention: The Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) Trial (2013) (237)
Aspirin as a therapeutic agent in cardiovascular disease. Special Writing Group. (1993) (234)
Imaging atherosclerotic plaque inflammation by fluorodeoxyglucose with positron emission tomography: ready for prime time? (2010) (233)
A polypill strategy to improve adherence: results from the FOCUS project. (2014) (232)
AHA/ACC Scientific StatementAmerican Heart Association/American College of Cardiology Foundation guide to warfarin therapy1 (2003) (231)
Noninvasive In vivo high-resolution magnetic resonance imaging of atherosclerotic lesions in genetically engineered mice. (1998) (231)
Carotid plaque burden as a measure of subclinical atherosclerosis: comparison with other tests for subclinical arterial disease in the High Risk Plaque BioImage study. (2012) (229)
A near 100% repair rate for mitral valve prolapse is achievable in a reference center: implications for future guidelines. (2012) (228)
T2-weighted contrast for NMR characterization of human atherosclerosis. (1995) (228)
ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention—summary article: A report of the American college of cardiology/American heart association task force on practice guidelines(ACC/AHA/SCAI writing committee to update the 2001 guidelines for percutaneous coronary intervention) (2006) (226)
Intravascular Modalities for Detection of Vulnerable Plaque: Current Status (2003) (225)
Coronary atherosclerosis. A multifactorial disease. (1993) (224)
Intracardiac thrombi and systemic embolization. (1986) (219)
Platelet Survival and the Development of Coronary Artery Disease in the Young Adult: Effects of Cigarette Smoking, Strong Family History and Medical Therapy (1981) (217)
Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial (2020) (217)
Pulmonary arterial hypertension: noninvasive detection with phase-contrast MR imaging. (2007) (217)
Insights into degenerative aortic valve disease. (2007) (216)
Oxidative Stress and Cardiovascular Risk: Obesity, Diabetes, Smoking, and Pollution: Part 3 of a 3-Part Series. (2017) (215)
High density lipoprotein plasma fractions inhibit aortic fatty streaks in cholesterol-fed rabbits. (1989) (215)
Prevalence and Impact of Myocardial Injury in Patients Hospitalized with COVID-19 Infection (2020) (215)
Normal LDL-Cholesterol Levels Are Associated With Subclinical Atherosclerosis in the Absence of Risk Factors. (2017) (213)
Mechanism of action and pharmacology of unfractionated heparin. (2001) (213)
Idiopathic dilated cardiomyopathy. (1994) (212)
Mitral valvuloplasty is superior to valve replacement for preservation of left ventricular function: an intraoperative two-dimensional echocardiographic study. (1987) (211)
Macrophage infiltration predicts restenosis after coronary intervention in patients with unstable angina. (1996) (210)
Guide to anticoagulant therapy. Part 1: Heparin. American Heart Association. (1994) (208)
Intimomedial Interface Damage and Adventitial Inflammation Is Increased Beneath Disrupted Atherosclerosis in the Aorta: Implications for Plaque Vulnerability (2002) (208)
Long-term evaluation (12 to 22 years) of open heart surgery for tetralogy of Fallot. (1980) (207)
The clinical course of idiopathic dilated cardiomyopathy. A population-based study. (1992) (206)
ACC/AHA Guideline Update for Perioperative Cardiovascular Evaluation for Noncardiac Surgery--Executive Summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluat (2002) (204)
ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). (2002) (202)
Lipid-Rich Atherosclerotic Plaques Detected by Gadofluorine-Enhanced In Vivo Magnetic Resonance Imaging (2004) (202)
Guide to anticoagulant therapy. Part 2: Oral anticoagulants. American Heart Association. (1994) (200)
Changes in plaque lipid content after short-term intensive versus standard statin therapy: the YELLOW trial (reduction in yellow plaque by aggressive lipid-lowering therapy). (2013) (199)
Role of platelets and thrombosis in coronary atherosclerotic disease and sudden death. (1985) (198)
Randomized Trial of Empagliflozin in Non-Diabetic Patients with Heart Failure and Reduced Ejection Fraction. (2020) (198)
Bleeding Complications With Dual Antiplatelet Therapy Among Patients With Stable Vascular Disease or Risk Factors for Vascular Disease: Results From the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) Trial (2010) (197)
Aspirin: A Historical and Contemporary Therapeutic Overview (2011) (197)
Cellular Senescence, Vascular Disease, and Aging: Part 2 of a 2-Part Review Clinical Vascular Disease in the Elderly (2011) (196)
27th Bethesda Conference: matching the intensity of risk factor management with the hazard for coronary disease events. Task Force 1. Pathogenesis of coronary disease: the biologic role of risk factors. (1996) (196)
Design of the Future REvascularization Evaluation in patients with Diabetes mellitus: Optimal management of Multivessel disease (FREEDOM) Trial. (2008) (196)
Sudden death in coronary artery disease: acute ischemia versus myocardial substrate. (1997) (195)
Assessing the Impact of Medication Adherence on Long-Term Cardiovascular Outcomes. (2016) (194)
MDGs: chronic diseases are not on the agenda (2005) (193)
Global burden of CVD: focus on secondary prevention of cardiovascular disease. (2015) (192)
Comparison of coronary artery bypass surgery and percutaneous coronary intervention in patients with diabetes: a meta-analysis of randomised controlled trials. (2013) (187)
Pathogenetic concepts of acute coronary syndromes. (2003) (187)
AHA/ACC scientific statement: Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. (1999) (185)
Myocardial edema after ischemia/reperfusion is not stable and follows a bimodal pattern: imaging and histological tissue characterization. (2015) (184)
Characterization of Atherosclerotic Plaques by Magnetic Resonance Imaging (2000) (179)
Normalization of platelet reactivity in clopidogrel‐treated subjects (2007) (178)
Global Perspective on Acute Coronary Syndrome: A Burden on the Young and Poor (2014) (177)
Cellular Senescence, Vascular Disease, and Aging: Part 1 of a 2-Part Review (2011) (177)
Platelet thrombus formation on collagen type I. A model of deep vessel injury. Influence of blood rheology, von Willebrand factor, and blood coagulation. (1988) (176)
Restenosis after arterial angioplasty: a hemorrheologic response to injury. (1987) (175)
OCT-based diagnosis and management of STEMI associated with intact fibrous cap. (2013) (174)
Coronary artery thrombosis in patients with unstable angina. (1981) (173)
Cardiac MRI Endpoints in Myocardial Infarction Experimental and Clinical Trials (2019) (173)
Anatomic-physiologic links between acute coronary syndromes. (1986) (171)
Hurst's the Heart, Arteries and Veins (1998) (170)
Evolving Concepts in the Triad of Atherosclerosis, Inflammation and Thrombosis (2004) (169)
The MOGE(S) classification for a phenotype-genotype nomenclature of cardiomyopathy: endorsed by the World Heart Federation. (2013) (168)
Is There a Vulnerable Plaque? (2003) (168)
Recombinant hirudin for unstable angina pectoris. A multicenter, randomized angiographic trial. (1994) (168)
Blood thrombogenicity in type 2 diabetes mellitus patients is associated with glycemic control. (2001) (168)
Atherothrombosis and high-risk plaque: Part II: approaches by noninvasive computed tomographic/magnetic resonance imaging. (2005) (167)
Circulating and Tissue Endothelin Immunoreactivit in Hypercholesterolemic Pigs (1993) (167)
The MOGE(S) classification of cardiomyopathy for clinicians. (2014) (166)
Targeted Molecular Probes for Imaging Atherosclerotic Lesions With Magnetic Resonance Using Antibodies That Recognize Oxidation-Specific Epitopes (2008) (165)
MRI of carotid atherosclerosis: clinical implications and future directions (2010) (164)
Echocardiographic "smoke" is produced by an interaction of erythrocytes and plasma proteins modulated by shear forces. (1992) (163)
Deep arterial injury during experimental angioplasty: relation to a positive indium-111-labeled platelet scintigram, quantitative platelet deposition and mural thrombosis. (1986) (163)
Anticoagulation, Mortality, Bleeding and Pathology Among Patients Hospitalized with COVID-19: A Single Health System Study (2020) (163)
Platelets, vasoconstriction, and nitroglycerin during arterial wall injury. A new antithrombotic role for an old drug. (1988) (161)
Multimodality imaging of atherosclerotic plaque activity and composition using FDG-PET/CT and MRI in carotid and femoral arteries. (2009) (159)
MRI to detect atherosclerosis with gadolinium‐containing immunomicelles targeting the macrophage scavenger receptor (2006) (157)
Platelet-Active Drugs (1998) (156)
Membranoproliferative glomerulonephritis. A prospective clinical trial of platelet-inhibitor therapy. (1984) (156)
2-deoxy-2-[18F]fluoro-d-mannose positron emission tomography imaging in atherosclerosis (2014) (155)
Effect of an Eccentric Severe Stenosis on Fibrin(ogen) Deposition on Severely Damaged Vessel Wall in Arterial Thrombosis: Relative Contribution of Fibrin(ogen) and Platelets (1994) (155)
Promoting Cardiovascular Health in the Developing World (2010) (154)
Multimodal clinical imaging to longitudinally assess a nanomedical anti-inflammatory treatment in experimental atherosclerosis. (2010) (153)
Ebstein's anomaly: the clinical features and natural history of Ebstein's anomaly of the tricuspid valve. (1979) (152)
Angiographic demonstration of a common link between unstable angina pectoris and non-Q-wave acute myocardial infarction. (1988) (152)
The BioImage Study: novel approaches to risk assessment in the primary prevention of atherosclerotic cardiovascular disease--study design and objectives. (2010) (152)
Long-term benefit of early pre-reperfusion metoprolol administration in patients with acute myocardial infarction: results from the METOCARD-CNIC trial (Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction). (2014) (152)
ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). (2004) (151)
Statins and cardiovascular diseases: the multiple effects of lipid-lowering therapy by statins. (2000) (150)
Chronic Thrombus Detection With In Vivo Magnetic Resonance Imaging and a Fibrin-Targeted Contrast Agent (2005) (149)
Femoral and Carotid Subclinical Atherosclerosis Association With Risk Factors and Coronary Calcium: The AWHS Study. (2016) (148)
MRI and Characterization of Atherosclerotic Plaque: Emerging Applications and Molecular Imaging (2002) (148)
Platelet inhibitor agents in cardiovascular disease: an update. (1989) (148)
Marfan syndrome. Part 1: pathophysiology and diagnosis (2010) (147)
Haptoglobin Genotype Is a Determinant of Iron, Lipid Peroxidation, and Macrophage Accumulation in the Atherosclerotic Plaque (2007) (146)
Low-dose aspirin and stroke. "It ain't necessarily so". (1992) (146)
Basic Biology of Oxidative Stress and the Cardiovascular System: Part 1 of a 3-Part Series. (2017) (145)
Pathophysiology and clinical significance of atherosclerotic plaque rupture. (1999) (144)
Hybrid Magnetic Resonance Imaging and Positron Emission Tomography With Fluorodeoxyglucose to Diagnose Active Cardiac Sarcoidosis. (2018) (144)
Risk factor control for coronary artery disease secondary prevention in large randomized trials. (2013) (144)
Atherosclerosis: imaging techniques and the evolving role of nuclear medicine. (1997) (144)
Serial Magnetic Resonance Imaging to Identify Early Stages of Anthracycline-Induced Cardiotoxicity. (2019) (143)
Value of CMR for the differential diagnosis of cardiac masses. (2014) (142)
Quality of life after PCI vs CABG among patients with diabetes and multivessel coronary artery disease: a randomized clinical trial. (2013) (142)
Serial in vivo MRI documents arterial remodeling in experimental atherosclerosis. (2000) (141)
Detection of Neovessels in Atherosclerotic Plaques of Rabbits Using Dynamic Contrast Enhanced MRI and 18F-FDG PET (2008) (141)
Long-Term Survival Following Multivessel Revascularization in Patients With Diabetes: The FREEDOM Follow-On Study. (2019) (141)
Role of platelets and platelet inhibitors in aortocoronary artery vein-graft disease. (1986) (141)
Long-term outcome of PCI versus CABG in insulin and non-insulin-treated diabetic patients: results from the FREEDOM trial. (2014) (140)
Downregulation of the Hemoglobin Scavenger Receptor in Individuals With Diabetes and the Hp 2-2 Genotype: Implications for the Response to Intraplaque Hemorrhage and Plaque Vulnerability (2007) (140)
Does shear stress modulate both plaque progression and regression in the thoracic aorta? Human study using serial magnetic resonance imaging. (2005) (139)
Epidemic of cardiovascular disease and stroke: the three main challenges. Presented at the 71st scientific sessions of the American Heart Association. Dallas, Texas. (1999) (139)
Coronavirus and Cardiovascular Disease, Myocardial Injury, and Arrhythmia (2020) (138)
Characterization of a tubular flow chamber for studying platelet interaction with biologic and prosthetic materials: deposition of indium 111-labeled platelets on collagen, subendothelium, and expanded polytetrafluoroethylene. (1987) (138)
RV dysfunction in pulmonary hypertension is independently related to pulmonary artery stiffness. (2012) (137)
Initiation of hormone replacement therapy after acute myocardial infarction is associated with more cardiac events during follow-up. (2001) (136)
The use of high-sensitivity assays for C-reactive protein in clinical practice (2008) (135)
Pulmonary hypertension: accuracy of detection with left ventricular septal-to-free wall curvature ratio measured at cardiac MR. (2007) (134)
Caspase-3 and Tissue Factor Expression in Lipid-Rich Plaque Macrophages: Evidence for Apoptosis as Link Between Inflammation and Atherothrombosis (2004) (134)
Management of restenosis after coronary intervention. (1996) (134)
Early Intravenous Beta-Blockers in Patients With ST-Segment Elevation Myocardial Infarction Before Primary Percutaneous Coronary Intervention. (2016) (134)
Imaging of atherosclerosis: magnetic resonance imaging. (2011) (134)
Mechanisms of unstable angina. (1986) (133)
Prevalence and correlates of septal delayed contrast enhancement in patients with pulmonary hypertension. (2007) (133)
Neutrophil stunning by metoprolol reduces infarct size (2017) (133)
Thoughts on the role of the healing professions and the events of September 11, 2001. (2002) (133)
Biological Versus Chronological Aging: JACC Focus Seminar. (2020) (133)
Atrial fibrillation--risk marker for stroke. (1990) (132)
Early Metoprolol Administration Before Coronary Reperfusion Results in Increased Myocardial Salvage: Analysis of Ischemic Myocardium at Risk Using Cardiac Magnetic Resonance (2007) (131)
Histopathologic comparison of human coronary in-stent and post-balloon angioplasty restenotic tissue. (1999) (130)
Aspirin and other platelet-active drugs. The relationship among dose, effectiveness, and side effects. (1989) (129)
Elderly patients receive less aggressive medical and invasive management of unstable angina: potential impact of practice guidelines. (1998) (129)
Pathophysiology Underlying the Bimodal Edema Phenomenon After Myocardial Ischemia/Reperfusion. (2015) (128)
Atherosclerosis and Coronary Artery Disease (1996) (128)
Rapid change in plaque size, composition, and molecular footprint after recombinant apolipoprotein A-I Milano (ETC-216) administration: magnetic resonance imaging study in an experimental model of atherosclerosis. (2008) (128)
Sphingosine-1-Phosphate Receptor Agonist Fingolimod Increases Myocardial Salvage and Decreases Adverse Postinfarction Left Ventricular Remodeling in a Porcine Model of Ischemia/Reperfusion (2016) (127)
Platelets in Thrombotic and Non‐Thrombotic Disorders (2003) (125)
Non-invasive imaging of atherosclerotic plaque macrophage in a rabbit model with F-18 FDG PET: a histopathological correlation (2006) (125)
Water diffusion properties of human atherosclerosis and thrombosis measured by pulse field gradient nuclear magnetic resonance. (1997) (124)
ACC revised recommendations for training in adult cardiovascular medicine. Core Cardiology Training II (COCATS 2). (Revision of the 1995 COCATS training statement). (2002) (124)
Noninvasive in vivo magnetic resonance imaging of experimental coronary artery lesions in a porcine model. (2000) (123)
Antithrombotic effects of factor Xa inhibition with DU-176b: Phase-I study of an oral, direct factor Xa inhibitor using an ex-vivo flow chamber (2007) (123)
The Global Burden of Cardiovascular Diseases and Risks: A Compass for Global Action. (2020) (123)
Prostacyclin (epoprostenol) and heart-lung transplantation as treatments for severe pulmonary hypertension. (1993) (123)
Platelet glycoprotein IIb/IIIa receptor antagonists in cardiovascular disease. (1999) (123)
Role of insulin resistance and hyperglycemia in the development of atherosclerosis. (2007) (123)
Promoting mechanisms of vascular health: circulating progenitor cells, angiogenesis, and reverse cholesterol transport. (2009) (122)
Global burden of cardiovascular disease: time to implement feasible strategies and to monitor results. (2014) (122)
Reduction of intimal thickening in canine coronary bypass vein grafts with dipyridamole and aspirin. (1978) (122)
Prognostic Impact of Prior Heart Failure in Patients Hospitalized With COVID-19 (2020) (122)
In vivo noninvasive detection and age definition of arterial thrombus by MRI. (2002) (121)
Vascular Endothelial Growth Factor Regulates Reendothelialization and Neointima Formation in a Mouse Model of Arterial Injury (2004) (121)
Lymphocytes and the Adventitial Immune Response in Atherosclerosis (2012) (120)
Clinical Significance of Lipid-Rich Plaque Detected by Optical Coherence Tomography: A 4-Year Follow-Up Study. (2017) (119)
Induction of Sustained Hypercholesterolemia by Single Adeno-Associated Virus–Mediated Gene Transfer of Mutant hPCSK9 (2015) (118)
Surgical Repair of Ebstein's Anomaly (1979) (118)
A dilemma for the 1990s. Choosing appropriate experimental animal model for the prevention of restenosis. (1992) (118)
Plaque rupture, thrombosis, and therapeutic implications. (1996) (117)
Association of Sleep Duration and Quality With Subclinical Atherosclerosis. (2019) (117)
The Three Processes Leading to Post PTCA Restenosis: Dependence on the Lesion Substrate (1995) (116)
Bisphosphonate Use and Prevalence of Valvular and Vascular Calcification in Women MESA (The Multi-Ethnic Study of Atherosclerosis). (2010) (115)
Promoting Global Cardiovascular Health: Moving Forward (2011) (115)
Global position paper on cardiovascular regenerative medicine (2017) (115)
Cost-Effectiveness of Percutaneous Coronary Intervention With Drug Eluting Stents Versus Bypass Surgery for Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease: Results From the FREEDOM Trial (2013) (115)
Left ventricular thrombi and cerebral embolism. (1989) (113)
Challenges and opportunities for cardiovascular disease prevention. (2011) (112)
Aspirin and other platelet-active drugs. The relationship between dose, effectiveness, and side effects. (1992) (112)
Cardiovascular outcomes in high risk patients with osteoarthritis treated with ibuprofen, naproxen or lumiracoxib (2007) (112)
Systemic embolism in chronic left ventricular aneurysm: incidence and the role of anticoagulation. (1985) (111)
Antithrombotic therapy in cardiac disease. An emerging approach based on pathogenesis and risk. (1989) (109)
Atherosclerotic aortic component quantification by noninvasive magnetic resonance imaging: an in vivo study in rabbits. (2001) (109)
Optimizing 18F-FDG PET/CT imaging of vessel wall inflammation: the impact of 18F-FDG circulation time, injected dose, uptake parameters, and fasting blood glucose levels (2014) (109)
A Simple Disease-Guided Approach to Personalize ACC/AHA-Recommended Statin Allocation in Elderly People: The BioImage Study. (2016) (109)
Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group III: Risk Assessment in Persons With Diabetes (2002) (108)
Importance of adequate heparin dosage in arterial angioplasty in a porcine model. (1988) (108)
Usefulness of antithrombotic therapy in resting angina pectoris or non-Q-wave myocardial infarction in preventing death and myocardial infarction (a pilot study from the Antithrombotic Therapy in Acute Coronary Syndromes Study Group). (1990) (106)
High resolution ex vivo magnetic resonance imaging of in situ coronary and aortic atherosclerotic plaque in a porcine model. (2000) (106)
American Heart Association/American College of Cardiology Foundation guide to warfarin therapy. (2003) (105)
Arteriosclerosis in Normal and von Willebrand Pigs: Long‐Term Prospective Study and Aortic Transplantation Study (1982) (105)
The Role of Collateral Circulation in the Various Coronary Syndromes (1979) (104)
Frontiers in cardiovascular magnetic resonance. (2005) (103)
MECHANISMS LEADING TO MYOCARDIAL INFARCTION: INSIGHT FROM VASCULAR BIOLOGY (1994) (102)
Noninvasive Radioisotopic Technique for Detection of Platelet Deposition in Coronary Artery Bypass Grafts in Dogs and Its Reduction with Platelet Inhibitors (1979) (102)
Arteriographic patterns early in the onset of the coronary syndromes. (1975) (102)
Quantitation of Left Ventricular Myocardial Fiber Hypertrophy and Interstitial Tissue in Human Hearts with Chronically Increased Volume and Pressure Overload (1977) (102)
A Comprehensive Lifestyle Peer Group-Based Intervention on Cardiovascular Risk Factors: The Randomized Controlled Fifty-Fifty Program. (2016) (102)
Carotid plaque thickness and carotid plaque burden predict future cardiovascular events in asymptomatic adult Americans (2018) (101)
Thrombosis in Cardiovascular Disorders (1992) (101)
Exaggerated serotonin-mediated platelet reactivity as a possible link in depression and acute coronary syndromes. (2002) (101)
The selective peroxisomal proliferator-activated receptor-gamma agonist has an additive effect on plaque regression in combination with simvastatin in experimental atherosclerosis: in vivo study by high-resolution magnetic resonance imaging. (2004) (100)
Thrombin regulation of platelet interaction with damaged vessel wall and isolated collagen type I at arterial flow conditions in a porcine model: effects of hirudins, heparin, and calcium chelation. (1991) (99)
Elucidation off the role of plaque instability and rupture in acute coronary events (1995) (99)
Antithrombotic therapy in patients with valvular heart disease and prosthetic heart valves. (1986) (99)
Atherogenesis and inflammation. (1993) (99)
Role of high density lipoproteins in the regression of atherosclerosis. (1992) (98)
Antithrombotic therapy: role of platelet-inhibitor drugs. I. Current concepts of thrombogenesis: role of platelets. (first of three parts). (1981) (98)
Acute Antithrombotic Effect of a Front-Loaded Regimen of Clopidogrel in Patients With Atherosclerosis on Aspirin (2000) (98)
Randomized comparison of direct thrombin inhibition versus heparin in conjunction with fibrinolytic therapy for acute myocardial infarction: results from the GUSTO-IIb Trial. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO-IIb) Investigators. (1998) (97)
Management of cardiovascular disease in patients with kidney disease (2013) (96)
ACCF 2008 Recommendations for Training in Adult Cardiovascular Medicine Core Cardiology Training (COCATS 3) (revision of the 2002 COCATS Training Statement). (2008) (96)
Amniotic fluid cells are more efficiently reprogrammed to pluripotency than adult cells. (2009) (95)
Recombinant Hirudin in Patients With Chronic, Stable Coronary Artery Disease Safety, Half‐life, and Effect on Coagulation Parameters (1993) (95)
Unstable angina: outcome according to clinical presentation. (1992) (95)
Atherosclerosis regression and TP receptor inhibition: effect of S18886 on plaque size and composition--a magnetic resonance imaging study. (2005) (94)
Considerations for pre-clinical models and clinical trials of pluripotent stem cell-derived cardiomyocytes (2014) (93)
Cardioprotective effect of prior beta-blocker therapy in reducing creatine kinase-MB elevation after coronary intervention: benefit is extended to improvement in intermediate-term survival. (2000) (93)
Antiplatelet drug 'resistance'. Part 1: mechanisms and clinical measurements (2009) (93)
Exercise triggers ARVC phenotype in mice expressing a disease-causing mutated version of human plakophilin-2. (2015) (93)
Clinical Characteristics of Hospitalized Covid-19 Patients in New York City (2020) (93)
Systemic thromboembolism in mitral and aortic Starr-Edwards prostheses: a 10-19 year follow-up. (1982) (92)
Low Priority of Cardiovascular and Chronic Diseases on the Global Health Agenda: A Cause for Concern (2007) (92)
Utilization of and Adherence to Guideline-Recommended Lipid-Lowering Therapy After Acute Coronary Syndrome: Opportunities for Improvement. (2015) (92)
Cardiac Autonomic Dysfunction and Incidence of Atrial Fibrillation: Results From 20 Years Follow-Up. (2017) (92)
Time Course of LDL Cholesterol Exposure and Cardiovascular Disease Event Risk. (2020) (91)
Coronary Artery PET/MR Imaging: Feasibility, Limitations, and Solutions. (2017) (91)
Risk reduction. (2020) (91)
The role of silent ischemia, the arrhythmic substrate and the short-long sequence in the genesis of sudden cardiac death. (1989) (91)
Usefulness of ST-segment changes in ≥2 leads on the emergency room electrocardiogram in either unstable angina pectoris or non-Q-wave myocardial infarction in predicting outcome (1991) (90)
Macrophage-specific lipid-based nanoparticles improve cardiac magnetic resonance detection and characterization of human atherosclerosis. (2009) (90)
Characterization of right ventricular remodeling and failure in a chronic pulmonary hypertension model. (2014) (90)
Fixed-dose combination therapy and secondary cardiovascular prevention: rationale, selection of drugs and target population (2009) (90)
Clinical-pathological correlations of coronary disease progression and regression. (1992) (90)
Vascular Inflammation in Subclinical Atherosclerosis Detected by Hybrid PET/MRI. (2019) (90)
Quantitative and qualitative effects of intracoronary streptokinase in unstable angina and non-Q wave infarction. (1987) (89)
Noninvasive Assessment of Hypoxia in Rabbit Advanced Atherosclerosis Using 18F-fluoromisonidazole Positron Emission Tomographic Imaging (2014) (89)
Anxiety is a better predictor of platelet reactivity in coronary artery disease patients than depression. (2010) (87)
Effect of Computed Tomography Scanning Parameters on Gold Nanoparticle and Iodine Contrast (2012) (87)
Atherosclerosis and coronary artery diseases (1996) (87)
The Importance of Breakfast in Atherosclerosis Disease: Insights From the PESA Study. (2017) (87)
Thrombosis in unstable angina. (1992) (86)
Recombinant HDL(Milano) exerts greater anti-inflammatory and plaque stabilizing properties than HDL(wild-type). (2012) (86)
Brain imaging changes associated with risk factors for cardiovascular and cerebrovascular disease in asymptomatic patients. (2014) (86)
Early intravenous beta-blockers in patients with acute coronary syndrome--a meta-analysis of randomized trials. (2013) (86)
Pioglitazone modulates vascular inflammation in atherosclerotic rabbits noninvasive assessment with FDG-PET-CT and dynamic contrast-enhanced MR imaging. (2011) (86)
Reversal of chronic ischemic myocardial dysfunction after transluminal coronary angioplasty. (1988) (86)
Characterization and clinical significance of right ventricular mechanics in pulmonary hypertension evaluated with cardiovascular magnetic resonance feature tracking (2016) (86)
Empagliflozin Ameliorates Diastolic Dysfunction and Left Ventricular Fibrosis/Stiffness in Nondiabetic Heart Failure: A Multimodality Study. (2020) (85)
Mechanistic Insights of Empagliflozin in Nondiabetic Patients With HFrEF: From the EMPA-TROPISM Study. (2021) (85)
From Detecting the Vulnerable Plaque to Managing the Vulnerable Patient: JACC State-of-the-Art Review. (2019) (85)
Compliance With Guideline-Directed Medical Therapy in Contemporary Coronary Revascularization Trials. (2018) (85)
Quantification of human atherosclerotic plaques using spatially enhanced cluster analysis of multicontrast‐weighted magnetic resonance images (2004) (84)
The Progression and Early detection of Subclinical Atherosclerosis (PESA) study: rationale and design. (2013) (84)
Subclinical Atherosclerosis Burden by 3D Ultrasound in Mid-Life: The PESA Study. (2017) (83)
Percutaneous left atrial appendage closure for stroke prevention in patients with atrial fibrillation: an assessment of net clinical benefit. (2012) (83)
Stroke Rates Following Surgical Versus Percutaneous Coronary Revascularization. (2018) (83)
Soluble CD40 Ligand Predicts Ischemic Stroke and Myocardial Infarction in Patients With Nonvalvular Atrial Fibrillation (2007) (82)
Platelet deposition at high shear rates is enhanced by high plasma cholesterol levels. In vivo study in the rabbit model. (1991) (82)
Diagnosing and managing unstable angina. Agency for Health Care Policy and Research. (1994) (81)
In Vivo PET Imaging of HDL in Multiple Atherosclerosis Models. (2016) (81)
The SI! Program for Cardiovascular Health Promotion in Early Childhood: A Cluster-Randomized Trial. (2015) (81)
Inhibition of tissue factor reduces thrombus formation and intimal hyperplasia after porcine coronary angioplasty. (2000) (81)
Machine Learning to Predict Mortality and Critical Events in a Cohort of Patients With COVID-19 in New York City: Model Development and Validation (2020) (81)
Aspirin and clopidogrel in acute coronary syndromes: therapeutic insights from the CURE study. (2003) (80)
Stroke risk assessment in atrial fibrillation: risk factors and markers of atrial myopathy (2016) (80)
Pathogenesis of thrombosis in unstable angina. (1991) (80)
Role of platelet activation and fibrin formation in thrombogenesis. (1986) (80)
Healed Culprit Plaques in Patients With Acute Coronary Syndromes. (2019) (80)
Recognizing global burden of cardiovascular disease and related chronic diseases. (2012) (80)
Treatment of congestive heart failure: guidelines for the primary care physician and the heart failure specialist. (2001) (80)
Non-invasive estimation of pulmonary vascular resistance with cardiac magnetic resonance. (2011) (80)
Optimal risk factor management in the patient after coronary revascularization. A statement for healthcare professionals from an American Heart Association Writing Group. (1994) (79)
Association of myocardial T1-mapping CMR with hemodynamics and RV performance in pulmonary hypertension. (2015) (79)
The Risk Continuum of Atherosclerosis and its Implications for Defining CHD by Coronary Angiography. (2016) (79)
A new approach for local intravascular drug delivery. Iontophoretic balloon. (1994) (78)
Aragon workers’ health study – design and cohort description (2012) (78)
The Unstable Atherosclerotic Plaque: Clinical Significance and Therapeutic Intervention (1997) (78)
Guidelines for the Management of Patients With Supraventricular Arrhythmias * — Executive Summary (2003) (78)
Inhibition of growth of thrombus on fresh mural thrombus. Targeting optimal therapy. (1994) (78)
Effect of Early Metoprolol on Infarct Size in ST-Segment Elevation Myocardial Infarction Patients Undergoing Primary PCI: The METOCARD-CNIC Trial (2013) (78)
Evolving Concepts (2005) (77)
Cardiovascular risk factors in patients with chronic kidney disease (2009) (77)
Electrical Aggregometry in Whole Blood from Human, Pig and Rabbit (1986) (77)
Elucidation of the role of plaque instability and rupture in acute coronary events. (1995) (77)
The MOGE(S) Classification for a Phenotype-Genotype Nomenclature of Cardiomyopathy: Endorsed by the World Heart Federation. (2013) (77)
Fibrin-targeted contrast agent for improvement of in vivo acute thrombus detection with magnetic resonance imaging. (2005) (76)
Molecular Imaging of the Cardiac Extracellular Matrix (2014) (76)
Impact of the Timing of Metoprolol Administration During STEMI on Infarct Size and Ventricular Function. (2016) (76)
In vivo quantitation of platelet deposition on human peripheral arterial bypass grafts using indium-111-labeled platelets. Effect of dipyridamole and aspirin. (1983) (76)
Gold nanocrystal labeling allows low-density lipoprotein imaging from the subcellular to macroscopic level. (2013) (75)
COCATS 4 Introduction. (2015) (75)
Risk factors associated with the incidence and progression of mitral annulus calcification: the multi-ethnic study of atherosclerosis. (2013) (75)
In vivo characterization of a new abdominal aortic aneurysm mouse model with conventional and molecular magnetic resonance imaging. (2011) (75)
Platelet function tests in clinical cardiology: unfulfilled expectations. (2013) (74)
Distribution of von Willebrand Factor in Porcine Intima Varies with Blood Vessel Type and Location (1987) (74)
Targeting preschool children to promote cardiovascular health: cluster randomized trial. (2013) (73)
Trial of platelet-inhibiting drug in scleroderma. Double-blind study with dipyridamole and aspirin. (1984) (73)
Corrigendum: Endothelial to mesenchymal transition is common in atherosclerotic lesions and is associated with plaque instability (2017) (73)
Coronary Atherosclerotic Phenotype and Plaque Healing in Patients With Recurrent Acute Coronary Syndromes Compared With Patients With Long-term Clinical Stability: An In Vivo Optical Coherence Tomography Study (2019) (73)
The Vulnerable Atherosclerotic Plaque: Understanding, Identification, and Modification (1999) (72)
A polypill strategy to improve global secondary cardiovascular prevention: from concept to reality. (2014) (71)
New Understanding of Atherosclerosis (Clinically and Experimentally) with Evolving MRI Technology in Vivo (2001) (71)
Reproductive history in women with coronary heart disease. A case-control study. (1984) (71)
Calcified Plaques in Patients With Acute Coronary Syndromes. (2019) (70)
Platelets in Thrombotic and Non‐Thrombotic Disorders: pathophysiology, pharmacology and therapeutics (2002) (70)
Spontaneous echo contrast videodensity is flow-related and is dependent on the relative concentrations of fibrinogen and red blood cells. (2003) (70)
Left ventricular function after myocardial infarction: clinical and angiographic correlations. (1985) (69)
Cost-effectiveness and public health benefit of secondary cardiovascular disease prevention from improved adherence using a polypill in the UK (2015) (69)
Quantification of platelet retention in aortocoronary femoral vein bypass graft in dogs treated with dipyridamole and aspirin. (1984) (69)
Persistent Thrombin Generation in Humans During Specific Thrombin Inhibition With Hirudin (1994) (69)
Regression of inflammation in atherosclerosis by the LXR agonist R211945: a noninvasive assessment and comparison with atorvastatin. (2012) (69)
The year in atherothrombosis. (2004) (69)
Spontaneous and Diet‐Induced Coronary Atherosclerosis in Normal Swine and Swine with von Wiiiebrand Disease (1985) (69)
Viewpoint Overcoming restenosis with sirolimus: from alphabet soup to clinical reality (2002) (69)
Anticoagulation in pregnant women with prosthetic heart valves. (2004) (69)
Diagnostic and therapeutic strategies for small abdominal aortic aneurysms (2011) (68)
Relationship of serum inflammatory biomarkers with plaque inflammation assessed by FDG PET/CT: the dal-PLAQUE study. (2013) (68)
Local delivery of r-hirudin by a double-balloon perfusion catheter prevents mural thrombosis and minimizes platelet deposition after angioplasty. (1994) (68)
Availability, Use, and Barriers to Cardiac Rehabilitation in LMIC. (2017) (68)
A Medical Perspective (1994) (68)
In Vivo 16-Slice, Multidetector-Row Computed Tomography for the Assessment of Experimental Atherosclerosis: Comparison With Magnetic Resonance Imaging and Histopathology (2004) (68)
Antithrombotic Therapy for Deep Arterial Injury by Angioplasty: Efficacy of Common Platelet Inhibition Compared With Thrombin Inhibition in Pigs (1991) (68)
Metabolic syndrome and diabetic atherothrombosis: implications in vascular complications. (2006) (67)
Pharmacology of platelet inhibitors. (1986) (67)
Radiotracers for low density lipoprotein biodistribution studies in vivo: technetium-99m low density lipoprotein versus radioiodinated low density lipoprotein preparations. (1988) (67)
Effect of p27 Deficiency and Rapamycin on Intimal Hyperplasia: In Vivo and In Vitro Studies Using a p27 Knockout Mouse Model (2001) (67)
Dynamic Edematous Response of the Human Heart to Myocardial Infarction (2017) (67)
Effect of aspirin on prevention of coronary and cerebrovascular disease in patients with rheumatoid arthritis. A long-term follow-up study. (1978) (66)
The relationships between cardiovascular disease and diabetes: focus on pathogenesis. (2014) (66)
Marfan syndrome. Part 2: treatment and management of patients (2010) (66)
ACC 2015 Core Cardiovascular Training Statement (COCATS 4) (Revision of COCATS 3) (2015) (66)
Global cardiovascular health: urgent need for an intersectoral approach. (2011) (66)
Changing Demographics: A New Approach to Global Health Care Due to the Aging Population. (2017) (66)
Serial in vivo positive contrast MRI of iron oxide‐labeled embryonic stem cell‐derived cardiac precursor cells in a mouse model of myocardial infarction (2008) (66)
Atherosclerotic lesions in genetically modified mice quantified in vivo by non-invasive high-resolution magnetic resonance microscopy. (2002) (65)
Hirudin reduces tissue factor expression in neointima after balloon injury in rabbit femoral and porcine coronary arteries. (1998) (65)
Cardiovascular magnetic resonance parameters of atherosclerotic plaque burden improve discrimination of prior major adverse cardiovascular events (2009) (65)
Increased Neovascularization in Advanced Lipid-Rich Atherosclerotic Lesions Detected by Gadofluorine-M–Enhanced MRI: Implications for Plaque Vulnerability (2009) (65)
Stem Cell Factor Gene Transfer Promotes Cardiac Repair After Myocardial Infarction via In Situ Recruitment and Expansion of c-kit+ Cells (2012) (65)
The year in atherothrombosis. (2013) (65)
Atherothrombosis: mechanisms and clinical therapeutic approaches (1998) (64)
Links between inflammation and thrombogenicity in atherosclerosis. (2006) (64)
Fast T2 gradient-spin-echo (T2-GraSE) mapping for myocardial edema quantification: first in vivo validation in a porcine model of ischemia/reperfusion (2015) (64)
β3 adrenergic receptor selective stimulation during ischemia/reperfusion improves cardiac function in translational models through inhibition of mPTP opening in cardiomyocytes (2014) (64)
Tissue characteristics of restenosis after percutaneous transluminal coronary angioplasty in diabetic patients. (1999) (63)
Prevalence and risk factors of carotid vessel wall inflammation in coronary artery disease patients: FDG-PET and CT imaging study. (2011) (62)
Inflammation, neovascularization and intra-plaque hemorrhage are associated with increased reparative collagen content: Implication for plaque progression in diabetic atherosclerosis (2011) (62)
Transition of Macrophages to Fibroblast-Like Cells in Healing Myocardial Infarction. (2019) (62)
von Willebrand Factor and Cardiovascular Disease (1993) (62)
Impact of noninsulin-dependent type 2 diabetes on carotid wall 18F-fluorodeoxyglucose positron emission tomography uptake. (2012) (62)
Obesity as a risk factor in coronary artery disease (2001) (61)
Haptoglobin genotype is a major determinant of the amount of iron in the human atherosclerotic plaque. (2008) (61)
Restrictive cardiomyopathy. (1997) (61)
How Low to Go With Glucose, Cholesterol, and Blood Pressure in Primary Prevention of CVD. (2017) (61)
The CVD paradox: mortality vs prevalence (2009) (61)
Household Fuel Use and Cardiovascular Disease Mortality: Golestan Cohort Study (2016) (61)
The cardioprotection granted by metoprolol is restricted to its administration prior to coronary reperfusion. (2011) (61)
A Novel Circulating MicroRNA for the Detection of Acute Myocarditis. (2021) (60)
Intraoperative contrast echocardiography to evaluate mitral valve operations. (1984) (60)
Do cardiologists do it better? (1997) (60)
Recombinant apolipoprotein A-I Milano rapidly reverses aortic valve stenosis and decreases leaflet inflammation in an experimental rabbit model. (2010) (60)
Rationale and design of dal-PLAQUE: a study assessing efficacy and safety of dalcetrapib on progression or regression of atherosclerosis using magnetic resonance imaging and 18F-fluorodeoxyglucose positron emission tomography/computed tomography. (2011) (60)
Family-Based Approaches to Cardiovascular Health Promotion. (2016) (60)
Short Telomere Load, Telomere Length, and Subclinical Atherosclerosis: The PESA Study. (2016) (59)
The complementary roles of dynamic contrast-enhanced MRI and 18F-fluorodeoxyglucose PET/CT for imaging of carotid atherosclerosis (2013) (59)
GLOMERULAR COAGULATION IN ACUTE ISCHAEMIC RENAL FAILURE1 (1970) (59)
Negative impact of depression on outcomes in patients with coronary artery disease: mechanisms, treatment considerations, and future directions (2005) (59)
Predicting Subclinical Atherosclerosis in Low-Risk Individuals: Ideal Cardiovascular Health Score and Fuster-BEWAT Score. (2017) (58)
Negative Risk Markers for Cardiovascular Events in the Elderly. (2019) (58)
Modulation of apoptosis, proliferation, and p27 expression in a porcine coronary angioplasty model. (2000) (58)
Effects of Percutaneous Transluminal Angioplasty and Endovascular Brachytherapy on Vascular Remodeling of Human Femoropopliteal Artery by Noninvasive Magnetic Resonance Imaging (2004) (58)
Committee on Preventing the Global Epidemic of Cardiovascular Disease: Meeting the Challenges in Developing Countries (2010) (58)
Cardiac magnetic resonance imaging: a “one-stop-shop” evaluation of myocardial dysfunction (2002) (58)
Machine Learning to Predict Mortality and Critical Events in COVID-19 Positive New York City Patients: A Cohort Study. (2020) (58)
ACCF 2008 Training Statement on Multimodality Noninvasive Cardiovascular Imaging A Report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and Training Developed in Collaboration With the American Society of (2009) (58)
Characterization of Patients Who Return to Hospital Following Discharge from Hospitalization For COVID-19 (2020) (57)
Platelet function normalization after a prasugrel loading‐dose: time‐dependent effect of platelet supplementation (2013) (57)
Total correction of tetralogy of Fallot at age 40 years and older: long-term follow-up. (1985) (57)
Aortic Atherosclerosis in Pigs with Heterozygous von Willebrand Disease: Comparison with Homozygous von Willebrand and Normal Pigs (1985) (57)
Monitoring of arterial wall remodelling in atherosclerotic rabbits with a magnetic resonance imaging contrast agent binding to matrix metalloproteinases. (2011) (57)
Dissolution of mural thrombus by specific thrombin inhibition with r-hirudin: comparison with heparin and aspirin. (1998) (57)
The necessity for tricuspid valve repair can be determined intraoperatively by two-dimensional echocardiography. (1987) (57)
Guide to Anticoagulant Therapy: Heparin (2001) (56)
Antiplatelet drug 'resistance'. Part 2: laboratory resistance to antiplatelet drugs—fact or artifact? (2009) (56)
Different response to balloon angioplasty of carotid and coronary arteries: effects on acute platelet deposition and intimal thickening. (1998) (56)
The human high-risk plaque and its detection by magnetic resonance imaging. (2001) (56)
Macrophages Transmit Potent Proangiogenic Effects of oxLDL In Vitro and In Vivo Involving HIF-1α Activation: a Novel Aspect of Angiogenesis in Atherosclerosis (2013) (56)
Comparative efficacy of coronary artery bypass surgery vs. percutaneous coronary intervention in patients with diabetes and multivessel coronary artery disease with or without chronic kidney disease. (2016) (56)
Decreased Reendothelialization and Increased Neointima Formation With Endostatin Overexpression in a Mouse Model of Arterial Injury (2003) (55)
The porcine model for the understanding of thrombogenesis and atherogenesis. (1991) (55)
13C-NMR spectroscopy of human atherosclerotic lesions. Relation between fatty acid saturation, cholesteryl ester content, and luminal obstruction. (1994) (55)
Hurst's The Heart: Manual of Cardiology (2001) (55)
Aspirin in the prevention of coronary disease. (1989) (55)
Coronary thrombolysis--a perspective for the practicing physician. (1993) (55)
Long-Term Dabigatran Treatment Delays Alzheimer's Disease Pathogenesis in the TgCRND8 Mouse Model. (2019) (54)
Fenofibrate induces plaque regression in hypercholesterolemic atherosclerotic rabbits: in vivo demonstration by high-resolution MRI. (2007) (54)
Effect of Ischemia Duration and Protective Interventions on the Temporal Dynamics of Tissue Composition After Myocardial Infarction (2017) (54)
Imaging platelet deposition with 111In-labeled platelets in coronary artery bypass grafts in dogs. (1978) (54)
Antithrombotic therapy for acute myocardial infarction: mechanisms and prevention of deep venous, left ventricular, and coronary artery thromboembolism. (1986) (54)
Technology Insight: targeting of biological molecules for evaluation of high-risk atherosclerotic plaques with magnetic resonance imaging (2004) (54)
Acute Coronary Syndromes: Pathophysiology and Preventive Priorities (1999) (54)
18F-Sodium Fluoride PET/MR for the Assessment of Cardiac Amyloidosis. (2016) (54)
Morphologic and dynamic changes of atherosclerotic plaque at the carotid artery bifurcation: sequential imaging by real time B-mode ultrasonography. (1988) (54)
Prolonged Thrombin Inhibition Reduces Restenosis After Balloon Angioplasty in Porcine Coronary Arteries (1996) (53)
A Novel Nonobstructive Intravascular MRI Coil: In Vivo Imaging of Experimental Atherosclerosis (2003) (53)
Usability and feasibility of a tablet-based Decision-Support and Integrated Record-keeping (DESIRE) tool in the nurse management of hypertension in rural western Kenya (2015) (53)
Up-regulation of reverse cholesterol transport key players and rescue from global inflammation by ApoA-IMilano (2008) (53)
Platelet deposition on von Willebrand factor-deficient vessels. Extracorporeal perfusion studies in swine with von Willebrand's disease using native and heparinized blood. (1987) (53)
Redevelopment and validation of the SYNTAX score II to individualise decision making between percutaneous and surgical revascularisation in patients with complex coronary artery disease: secondary analysis of the multicentre randomised controlled SYNTAXES trial with external cohort validation (2020) (53)
Atherothrombosis and coronary artery disease (2005) (53)
Aortic and mitral valve incompetence: long-term follow-up (10 to 19 years) of patients treated with the Starr-Edwards prosthesis. (1984) (53)
Endothelium and atherosclerosis. (1992) (53)
Ticagrelor With or Without Aspirin After PCI: The TWILIGHT Platelet Substudy. (2020) (53)
Air pollution and cardiovascular disease: a window of opportunity (2018) (52)
Prolonged thrombin inhibition reduces restenosis after balloon angioplasty in porcine coronary arteries. (1998) (52)
Testing Platelet Activation With a Shear-Dependent Platelet Function Test Versus Aggregation-Based Tests: Relevance for Monitoring Long-Term Glycoprotein IIb/IIIa Inhibition (2001) (52)
Innovative Approaches to Hypertension Control in Low- and Middle-Income Countries. (2017) (52)
Children Present a Window of Opportunity for Promoting Health: JACC Review Topic of the Week. (2018) (52)
Synergistic action of severe wall injury and shear forces on thrombus formation in arterial stenosis: definition of a thrombotic shear rate threshold. (1994) (52)
Oral platelet glycoprotein IIb/IIIa receptor antagonists: the present challenge is safety. (1998) (52)
Medical Treatment and Revascularization Options in Patients With Type 2 Diabetes and Coronary Disease. (2016) (52)
Clinical and Laboratory Predictors for Plaque Erosion in Patients With Acute Coronary Syndromes (2019) (52)
Angina pectoris and disease progression. (1995) (52)
Antithrombotic therapy after myocardial reperfusion in acute myocardial infarction. (1988) (51)
Diagnostic value of coronary artery calcium scoring in low-intermediate risk patients evaluated in the emergency department for acute coronary syndrome. (2011) (51)
Inverse relationship between body mass index and coronary artery calcification in patients with clinically significant coronary lesions. (2012) (51)
Epidemiology of Cardiovascular Disease (2010) (51)
Myocardial infarction and coronary artery occlusion: a prospective 5-year angiographic study (1990) (51)
Rationale and Design of the EMPA-TROPISM Trial (ATRU-4): Are the “Cardiac Benefits” of Empagliflozin Independent of its Hypoglycemic Activity? (2019) (51)
Clinical Utility of Combined FDG-PET/MR to Assess Myocardial Disease. (2017) (50)
Usefulness of cardiac computed tomographic delayed contrast enhancement of the left atrial appendage before pulmonary vein ablation. (2012) (50)
Importance of antithrombin therapy during coronary angioplasty. (1991) (50)
Promotion of cardiovascular health in preschool children: 36-month cohort follow-up. (2013) (50)
Inflammatory markers in coronary artery disease: let prevention douse the flames. (2001) (50)
Angiographic patterns of balloon inflation during percutaneous transluminal coronary angioplasty: role of pressure-diameter curves in studying distensibility and elasticity of the stenotic lesion and the mechanism of dilation. (1990) (50)
Are both aspirin and heparin justified as adjuncts to thrombolytic therapy for acute myocardial infarction? (1993) (50)
Antithrombotic effects of S 18886, a novel orally active thromboxane A2 receptor antagonist (2004) (50)
Aortocoronary artery vein-graft disease: experimental and clinical approach for the understanding of the role of platelets and platelet inhibitors. (1985) (49)
Principles for national and regional guidelines on cardiovascular disease prevention (2006) (49)
Intratracheal Gene Delivery of SERCA2a Ameliorates Chronic Post-Capillary Pulmonary Hypertension: A Large Animal Model. (2016) (49)
Challenges in the classification of atrial fibrillation (2010) (49)
Increased thrombus formation relates to ambient blood glucose and leukocyte count in diabetes mellitus type 2. (2000) (49)
Role of Thrombin in Arterial Thrombosis: Implications for Therapy (1991) (49)
Atrial Fibrillation in Patients Hospitalized With COVID-19 (2021) (49)
Decreased salivary lactoferrin levels are specific to Alzheimer's disease (2020) (48)
Design of a multicenter randomized trial for the Stroke Prevention in Atrial Fibrillation Study. The Stroke Prevention in Atrial Fibrillation Investigators. (1990) (48)
Characterization of Patients Who Return to Hospital Following Discharge from Hospitalization for COVID-19 (2020) (48)
Contrast-enhanced ultrasound imaging detects intraplaque neovascularization in an experimental model of atherosclerosis. (2010) (48)
Redefining medical treatment in the management of unstable angina. (2011) (48)
AHA Scientific Statement: Guide to anticoagulant therapy: heparin: a statement for healthcare professionals from the American Heart Association. (2001) (48)
Comparison of MR-based attenuation correction and CT-based attenuation correction of whole-body PET/MR imaging (2014) (47)
The risk of coronary occlusion is not proportional to the prior severity of coronary stenoses (1998) (47)
Cardiovascular Health Promotion: An Issue That Can No Longer Wait. (2018) (47)
Next Steps in Primary Prevention of Coronary Heart Disease: Rationale for and Design of the ECAD Trial. (2015) (46)
Daily and seasonal variation in sudden cardiac death, Rochester, Minnesota, 1950-1975. (1982) (46)
The pathogenesis and prevention of aortocoronary vein bypass graft occlusion and restenosis after arterial angioplasty: role of vascular injury and platelet thrombus deposition. (1986) (46)
Triglycerides and Residual Atherosclerotic Risk (2021) (46)
Should patients with atrial fibrillation be anticoagulated prior to and chronically following cardioversion? (1990) (46)
Preoperative M-mode echocardiography as a predictor of surgical results in chronic aortic insufficiency. (1980) (46)
Arterial and fat tissue inflammation are highly correlated : a prospective 18F-FDG PET/CT study (2014) (46)
Dual Antiplatelet Therapy Versus Aspirin Monotherapy in Diabetics With Multivessel Disease Undergoing CABG: FREEDOM Insights. (2017) (46)
Patent foramen ovale and recurrent stroke: another paradoxical twist. (2002) (45)
Pathogenesis of thrombosis in coronary artery disease. (1997) (45)
Smoking water-pipe, chewing nass and prevalence of heart disease: a cross-sectional analysis of baseline data from the Golestan Cohort Study, Iran (2012) (45)
Anticoagulation clinics and the monitoring of anticoagulant therapy. (1988) (45)
Crushed clopidogrel administered via nasogastric tube has faster and greater absorption than oral whole tablets. (2009) (45)
The development of endotension is associated with increased transmission of pressure and serous components in porous expanded polytetrafluoroethylene stent-grafts: characterization using a canine model. (2006) (45)
Detection of healed myocardial infarction with multidetector-row computed tomography and comparison with cardiac magnetic resonance delayed hyperenhancement. (2006) (45)
In vivo non-invasive serial monitoring of FDG-PET progression and regression in a rabbit model of atherosclerosis (2009) (45)
Top 10 cardiovascular therapies and interventions for the next decade (2014) (45)
Platelet-inhibitor drugs' role in coronary artery disease. (1987) (44)
Anticoagulation during pregnancy in patients with a prosthetic heart valve (2012) (44)
Promoting global cardiovascular health ensuring access to essential cardiovascular medicines in low- and middle-income countries. (2011) (44)
Projected impact of polypill use among US adults: Medication use, cardiovascular risk reduction, and side effects. (2011) (44)
Barriers Influencing Linkage to Hypertension Care in Kenya: Qualitative Analysis from the LARK Hypertension Study (2016) (43)
The High-Risk Plaque Initiative: Primary Prevention of Atherothrombotic Events in the Asymptomatic Population (2011) (43)
Study design for the "effect of METOprolol in CARDioproteCtioN during an acute myocardial InfarCtion" (METOCARD-CNIC): a randomized, controlled parallel-group, observer-blinded clinical trial of early pre-reperfusion metoprolol administration in ST-segment elevation myocardial infarction. (2012) (43)
Malignant Arrhythmias in Patients With COVID-19 (2020) (43)
Cardiac magnetic resonance evaluation of left ventricular remodelling distribution in cardiac amyloidosis (2014) (43)
The Importance of End-Systole for Optimal Reconstruction Protocol of Coronary Angiography With 16-Slice Multidetector Computed Tomography (2005) (42)
Preoperative M-mode echocardiography as a predictor of surgical results in chronic aortic insufficiency (1980) (42)
Cross-sectional, prospective study of MRI reproducibility in the assessment of plaque burden of the carotid arteries and aorta. (2009) (42)
Lipidomic profiling identifies signatures of metabolic risk (2019) (42)
Learning from the transgenic mouse: endothelium, adhesive molecules, and neointimal formation. (1998) (42)
Association of APOC3 Loss-of-Function Mutations With Plasma Lipids and Subclinical Atherosclerosis: The Multi-Ethnic BioImage Study. (2015) (42)
Metoprolol exerts a non-class effect against ischaemia–reperfusion injury by abrogating exacerbated inflammation (2020) (42)
The Program SI! intervention for enhancing a healthy lifestyle in preschoolers: first results from a cluster randomized trial (2013) (42)
Human Lesion Studies (1997) (42)
Synergistic effect of liver X receptor activation and simvastatin on plaque regression and stabilization: an magnetic resonance imaging study in a model of advanced atherosclerosis. (2012) (42)
Does antithrombotic therapy influence residual thrombus after thrombolysis of platelet-rich thrombus? Effects of recombinant hirudin, heparin, or aspirin. (1996) (42)
Comparison of the antithrombotic action of calcium antagonist drugs with dipyridamole in dogs. (1983) (41)
10. Antithrombotic therapy: role of platelet-inhibitor drugs. II. Pharmacologic effects of platelet-inhibitor drugs (second of three parts). (1981) (41)
Update in atherothrombotic disease. (2004) (41)
SYNTAX Score in Patients With Diabetes Undergoing Coronary Revascularization in the FREEDOM Trial. (2018) (41)
Noninvasive monitoring of serial changes in pulmonary vascular resistance and acute vasodilator testing using cardiac magnetic resonance. (2013) (41)
Drug Insight: cyclo-oxygenase 2 inhibitors and cardiovascular risk—where are we now? (2005) (41)
COVID-19: Staging of a New Disease (2020) (41)
Antithrombotic Effects of DX-9065a, a Direct Factor Xa Inhibitor (2002) (41)
The Future REvascularization Evaluation in patients with Diabetes mellitus: optimal management of Multivessel disease (FREEDOM) trial: clinical and angiographic profile at study entry. (2012) (41)
Medical aspects of acute aortic dissection. (1991) (40)
Can we dramatically reduce the incidence of coronary heart disease? (2011) (40)
Dynamic thrombosis and thrombolysis. Role of antithrombins. (1991) (40)
Clopidogrel and the reduced-function CYP2C19 genetic variant: a limited piece of the overall therapeutic puzzle. (2010) (40)
Myocardial cell therapy at the crossroads (2007) (40)
A cluster randomized trial to evaluate the efficacy of a school-based behavioral intervention for health promotion among children aged 3 to 5 (2013) (40)
Multiethnic Exome-Wide Association Study of Subclinical Atherosclerosis (2016) (39)
Increased macrophage infiltration and neovascularization in congenital bicuspid aortic valve stenosis. (2011) (39)
Actions and clinical status of platelet-suppressive agents. (1978) (39)
Intracardiac thrombi and systemic thromboembolism: detection, incidence, and treatment. (1985) (39)
Distinct effects of recombinant desulfatohirudin (Revasc) and heparin on plasma levels of fibrinopeptide A and prothrombin fragment F1.2 in unstable angina. A multicenter trial. (1996) (39)
Early identification of atherosclerotic disease by noninvasive imaging (2010) (39)
The broad spectrum of unstable angina pectoris and its implications for future controlled trials. (1986) (38)
A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina) (2002) (38)
Systemic thromboembolism in valvular heart disease and prosthetic heart valves. (1982) (38)
The Relationships Among Dose, Effectiveness, and Side Effects (1998) (38)
Arterial Thrombus Stability: Does It Matter and Can We Detect It? (2017) (38)
Thrombosis and embolism from cardiac chambers and infected valves. (1986) (38)
Vascular inflammation. (2007) (37)
Platelet/vessel wall interactions, rheologic factors and thrombogenic substrate in acute coronary syndromes: preventive strategies. (1987) (37)
Antithrombotic therapy in acute myocardial infarction: prevention of venous, left ventricular and coronary artery thromboembolism. (1989) (37)
AHA consensus panel statement. Preventing heart attack and death in patients with coronary disease. The Secondary Prevention Panel. (1995) (37)
Optimizing linkage and retention to hypertension care in rural Kenya (LARK hypertension study): study protocol for a randomized controlled trial (2014) (37)
The fixed-dose combination drug for secondary cardiovascular prevention project: improving equitable access and adherence to secondary cardiovascular prevention with a fixed-dose combination drug. Study design and objectives. (2011) (37)
Cardiovascular thrombosis : thrombocardiology and thromboneurology (1998) (37)
C-reactive protein and coronary heart disease. (2004) (37)
Oxidized LDL Is Associated With Metabolic Syndrome Traits Independently of Central Obesity and Insulin Resistance (2016) (37)
Investing in Global Health for Our Future (2017) (36)
Importance of experimental models for the development of clinical trials on thromboatherosclerosis. (1991) (36)
Community Health Workers Improve Linkage to Hypertension Care in Western Kenya. (2019) (36)
Atherosclerosis neovascularization and imaging. (2006) (36)
Evaluation and management of the adult patient with transposition of the great arteries following atrial-level (Senning or Mustard) repair (2008) (36)
Alternatively Spliced Tissue Factor Promotes Plaque Angiogenesis Through the Activation of Hypoxia-Inducible Factor-1&agr; and Vascular Endothelial Growth Factor Signaling (2014) (35)
Glycated Hemoglobin and Subclinical Atherosclerosis in People Without Diabetes. (2021) (35)
Variations in atherosclerosis and remodeling patterns in aorta and carotids (2010) (35)
A polypill for secondary prevention: time to move from intellectual debate to action (2007) (35)
Diagnosis of Isolated Noncompaction of the Myocardium by Magnetic Resonance Imaging (2002) (35)
Acute coronary syndromes: pathology, diagnosis, genetics, prevention, and treatment. (2014) (35)
Thrombosis: Studies under Flow Conditions (1987) (35)
From Treating Complex Coronary Artery Disease to Promoting Cardiovascular Health: Therapeutic Transitions and Challenges, 2010–2020 (2011) (35)
Distribution and dosimetry of 111In-labeled platelets. (1981) (35)
Short-Term Progression of Multiterritorial Subclinical Atherosclerosis. (2020) (35)
Dendritic cells in neointima formation after rat carotid balloon injury: coordinated expression withanti-apoptotic Bcl-2 and HSP47 in arterial repair. (2003) (34)
Metabolomics reveals metabolite changes in acute pulmonary embolism. (2014) (34)
Role of platelets in atherogenesis: relevance to coronary arterial restenosis after angioplasty. (1987) (34)
Guided antithrombotic therapy: current status and future research direction: report on a National Heart, Lung and Blood Institute working group. (2012) (34)
The links between complex coronary disease, cerebrovascular disease, and degenerative brain disease (2012) (34)
Regression or stabilization of atherosclerosis means regression or stabilization of what we don't see in the arteriogram. (1995) (34)
Preclinical Evaluation of MR Attenuation Correction Versus CT Attenuation Correction on a Sequential Whole-Body MR/PET Scanner (2013) (34)
Machine Learning to Predict Mortality and Critical Events in COVID-19 Positive New York City Patients (2020) (34)
Drug Insight: statins for nonischemic heart failure—evidence and potential mechanisms (2007) (34)
Resistance to atherosclerosis in pigs with von Willebrand's disease. (2009) (34)
Aiming at strategies for a complex problem of medical nonadherence. (2013) (34)
Integration of vascular biology and magnetic resonance imaging in the understanding of atherothrombosis and acute coronary syndromes (2003) (34)
New “Ex Vivo” Radioisotopic Method of Quantitation of Platelet Deposition – Studies in Four Animal Species (1983) (34)
Serum Inflammatory Biomarkers and Plaque Inflammation Assessed by 18 F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the dal-PLAQUE Study (2013) (34)
Metoprolol in Critically Ill Patients With COVID-19 (2021) (33)
Improved intraoperative evaluation of mitral valve operations utilizing two-dimensional contrast echocardiography. (1985) (33)
Promoting cardiovascular health worldwide: strategies, challenges, and opportunities. (2014) (33)
Magnetic resonance imaging and computed tomography in assessment of atherosclerotic plaque (2004) (33)
Combined detection of coronary artery disease and lung cancer. (2014) (33)
Real time magnetic resonance guided endomyocardial local delivery (2005) (33)
Child Health Promotion in Underserved Communities: The FAMILIA Trial. (2019) (33)
Association Between a Social-Business Eating Pattern and Early Asymptomatic Atherosclerosis. (2016) (33)
Identifying needs and opportunities for advancing translational research in cardiovascular disease. (2009) (33)
ACC / AHA / NASPE 2002 Guideline Update for Implantation of Pacemakers and Antiarrhythmia Devices (2002) (32)
Mechanisms of arterial thrombosis: foundation for therapy. (1998) (32)
Beta-3 adrenergic agonists reduce pulmonary vascular resistance and improve right ventricular performance in a porcine model of chronic pulmonary hypertension (2016) (32)
Role of antithrombotic therapy in unstable angina, myocardial infarction and sudden death. (1986) (32)
Swine Model of Chronic Postcapillary Pulmonary Hypertension with Right Ventricular Remodeling: Long-Term Characterization by Cardiac Catheterization, Magnetic Resonance, and Pathology (2014) (32)
Carotid Artery Remodeling Is Segment Specific: An In Vivo Study by Vessel Wall Magnetic Resonance Imaging (2018) (32)
The Future Role of the United States in Global Health: Emphasis on Cardiovascular Disease. (2017) (32)
Regression in thromboembolic type of primary pulmonary hypertension during 2 1/2 years of antithrombotic therapy. (1986) (32)
Increased expression of oxidation-specific epitopes and apoptosis are associated with haptoglobin genotype: possible implications for plaque progression in human atherosclerosis. (2012) (32)
Modernizing the World Health Organization List of Essential Medicines for Preventing and Controlling Cardiovascular Diseases. (2018) (32)
Primary prophylaxis with the implantable cardioverter-defibrillator: The need for improved risk stratification (2005) (32)
Evaluation and Management of Patients With Stable Angina: Beyond the Ischemia Paradigm: JACC State-of-the-Art Review. (2020) (32)
Working group 8: Defining the different types of cardiovascular specialists and developing a new model for training general clinical cardiologists. (2004) (32)
Lethal myocardial reperfusion injury: a necessary evil? (2011) (31)
Role of von Willebrand factor in mediating platelet-vessel wall interaction at low shear rate; the importance of perfusion conditions. (1989) (31)
The von Willebrand Pig as a Model for Atherosclerosis Research (1977) (31)
The Fuster-CNIC-Ferrer Cardiovascular Polypill: a polypill for secondary cardiovascular prevention. (2015) (31)
Management of stable coronary artery disease. (1997) (31)
Acute aortic dissection: the need for rapid, accurate, and readily available diagnostic strategies. (2003) (31)
Aortic dissection: a medical perspective. (1994) (31)
Thrombin/inflammation paradigms: a closer look at arterial and venous thrombosis. (2005) (31)
Polypill Strategy in Secondary Cardiovascular Prevention. (2022) (31)
The utility of magnetic resonance imaging in cardiac tissue regeneration trials (2006) (31)
Strong family history and cigarette smoking as risk factors of coronary artery disease in young adults. (1982) (30)
Role of platelets in the development of atherosclerotic disease and possible interference with platelet inhibitor drugs. (2009) (30)
New index α improves detection of pulmonary hypertension in comparison with other cardiac magnetic resonance indices. (2012) (30)
Parental and self-reported dietary and physical activity habits in pre-school children and their socio-economic determinants (2014) (30)
Antithrombotic effects of abciximab. (2000) (30)
Transient thrombotic state after abrupt discontinuation of heparin in percutaneous coronary angioplasty. (1996) (30)
Association of HIV viral load with monocyte chemoattractant protein-1 and atherosclerosis burden measured by magnetic resonance imaging (2009) (30)
Antithrombotic therapy in cardiac disease: an approach based on pathogenesis and risk stratification. (1990) (30)
Atrial Infarction and Ischemic Mitral Regurgitation Contribute to Post-MI Remodeling of the Left Atrium. (2017) (30)
Metoprolol blunts the time-dependent progression of infarct size (2020) (29)
Platelet-inhibitor drugs before and after coronary artery bypass surgery and coronary angioplasty: the basis of their use, data from animal studies, clinical trial data, and current recommendations. (1986) (29)
Drug trials in prevention of occlusion of aorta--coronary artery vein grafts. (1982) (29)
Medical treatment of the aorta. I. (1999) (29)
Oxidized Low-Density Lipoprotein Receptor in Lymphocytes Prevents Atherosclerosis and Predicts Subclinical Disease (2019) (29)
Atherosclerotic risk factors, vascular cognitive impairment, and Alzheimer disease. (2012) (29)
Emerging importance of HDL cholesterol in developing high‐risk coronary plaques in acute coronary syndromes (2003) (29)
Impact of Timing on the Functional Recovery Achieved With Platelet Supplementation After Treatment With Ticagrelor (2017) (29)
Evaluation of right ventricular function and post-operative findings using cardiac computed tomography in patients with left ventricular assist devices. (2011) (29)
ACCF 2006 Update for Training in Adult Cardiovascular Medicine (Focused Update of the 2002 COCATS 2 Training Statement): A Report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and Training. Introduction. (2006) (29)
Machine Learning Improves Cardiovascular Risk Definition for Young, Asymptomatic Individuals. (2020) (29)
Role of von Willebrand factor in mediating platelet-vessel wall interaction at low shear rate; the importance of perfusion conditions (1989) (29)
Perspectives on Directions and Priorities for Future Preclinical Studies in Regenerative Medicine (2019) (29)
Clinical protocol. A phase IIb, randomized, multicenter, double-blind study of the efficacy and safety of Trinam (EG004) in stenosis prevention at the graft-vein anastomosis site in dialysis patients. (2001) (29)
Ovariectomy increases vascular calcification via the OPG/RANKL cytokine signalling pathway (2008) (29)
Bloodless reperfusion with the oxygen carrier HBOC-201 in acute myocardial infarction: a novel platform for cardioprotective probes delivery (2017) (28)
Impact of Chronic Kidney Disease on Outcomes of Myocardial Revascularization in Patients With Diabetes. (2019) (28)
Optimization of dual-saturation single bolus acquisition for quantitative cardiac perfusion and myocardial blood flow maps (2015) (28)
Behavior of atherosclerotic plaque components after in vitro angioplasty and atherectomy studied by high field MR imaging. (1998) (28)
Glomerular coagulation in acute ischaemic renal failure. (1970) (28)
CANTOS: A Gigantic Proof-of-Concept Trial. (2017) (28)
New understanding, diagnosis, and prognosis of atherothrombosis and the role of imaging. (2003) (27)
Treatment of type II endoleaks with a novel polyurethane thrombogenic foam: induction of endoleak thrombosis and elimination of intra-aneurysmal pressure in the canine model. (2005) (27)
Apical right ventricular dysfunction in patients with pulmonary hypertension demonstrated with magnetic resonance (2011) (27)
[Metabolic syndrome in children and adolescents]. (2005) (27)
Evaluation of the Pooled Cohort Equations for Prediction of Cardiovascular Risk in a Contemporary Prospective Cohort. (2017) (27)
Syndromes of atherosclerosis : correlations of clinical imaging and pathology (1996) (27)
Porcine von Willebrand disease: implications for the pathophysiology of atherosclerosis and thrombosis. (1986) (27)
Can we predict future acute coronary events in patients with stable coronary artery disease? (1997) (27)
Results of Expert Meetings: Obesity and Cardiovascular Disease. Obesity as a risk factor in coronary artery disease. (2001) (27)
Selective estrogen receptor modulation influences atherosclerotic plaque composition in a rabbit menopause model. (2008) (27)
Apoptosis, proliferation, and p27 expression during vessel wall healing: time course study in a mouse model of transluminal femoral artery injury. (2000) (27)
Tissue Factor Coagulation Pathway: A New Therapeutic Target in Atherothrombosis (2004) (27)
Response to 'Laurberg JM, Olsen AK, Hansen SB, et al. Imaging of vulnerable atherosclerotic plaques with FDG-microPET: no FDG accumulation' [Atherosclerosis 2006]. (2007) (27)
Associations of LV hypertrophy with prevalent and incident valve calcification: Multi-Ethnic Study of Atherosclerosis. (2012) (27)
The Mikamo Lecture 2002. Therapeutic targets for the treatment of atherothrombosis in the new millennium--clinical frontiers in atherosclerosis research. (2002) (26)
Response to letter regarding article, "effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) trial". (2014) (26)
Lipids, nutrition, and coronary heart disease. (1996) (26)
Prospective comparision of unstable angina versus non-Q wave myocardial infarction during antithrombotic therapy (1993) (26)
Surgery for asymptomatic degenerative aortic and mitral valve disease (2011) (26)
Asymptomatic Atherosclerosis. Pathophysiology, Detection and Treatment (2010) (26)
Limitations of the exercise test as a screen for acute cardiac events in asymptomatic patients. (1990) (26)
Association Between Left Ventricular Noncompaction and Vigorous Physical Activity. (2020) (26)
Usefulness of ST-segment changes in greater than or equal to 2 leads on the emergency room electrocardiogram in either unstable angina pectoris or non-Q-wave myocardial infarction in predicting outcome. (1991) (26)
Risk stratification of sudden cardiac death in hypertrophic cardiomyopathy (2007) (26)
Cod liver oil alters platelet-arterial wall response to injury in pigs. (1992) (26)
Carvedilol administration in acute myocardial infarction results in stronger inhibition of early markers of left ventricular remodeling than metoprolol. (2011) (26)
Summary of the institute of medicine report promoting cardiovascular health in the developing world. (2011) (26)
Cardiovascular Diseases on the Global Agenda: The United Nations High Level Meeting, Sustainable Development Goals, and the Way Forward. (2016) (26)
Intraoperative echocardiography for the evaluation of valvular regurgitation: experience in 263 patients. (1986) (26)
Thrombosis, antithrombotic agents, and the antithrombotic approach in cardiac disease. (1997) (25)
Polypill and global cardiovascular health strategies. (2011) (25)
Remote ischaemic preconditioning ameliorates anthracycline-induced cardiotoxicity and preserves mitochondrial integrity (2020) (25)
Proteomic footprint of myocardial ischemia/reperfusion injury: Longitudinal study of the at-risk and remote regions in the pig model (2017) (25)
Indium-111 platelet kinetics in normal human subjects: tropolone versus oxine methods. (1986) (25)
Clinical approach and management of congenital heart disease in the adolescent and adult. (1980) (25)
Characteristics of non-culprit plaques in acute coronary syndrome patients with layered culprit plaque. (2019) (25)
Catheter ablation for atrial fibrillation (2008) (25)
Response of the right ventricle to exercise in isolated mitral stenosis. (1985) (25)
Plaque imaging and characterization using magnetic resonance imaging: towards molecular assessment. (2006) (25)
A 30‐month worksite‐based lifestyle program to promote cardiovascular health in middle‐aged bank employees: Design of the TANSNIP‐PESA randomized controlled trial (2017) (25)
CD90 Identifies Adventitial Mesenchymal Progenitor Cells in Adult Human Medium- and Large-Sized Arteries (2018) (25)
Plaque disruption and thrombosis in unstable angina pectoris. (1991) (25)
Coronavirus and Cardiometabolic Syndrome (2020) (25)
Trends and contexts in European cardiology practice for the next 15 years: the Madrid Declaration: a report from the European Conference on the Future of Cardiology, Madrid, 2-3 June 2006. (2006) (25)
Therapeutic Anticoagulation Is Associated with Decreased Mortality in Mechanically Ventilated COVID-19 Patients (2020) (25)
Exome sequencing of extreme clopidogrel response phenotypes identifies B4GALT2 as a determinant of on‐treatment platelet reactivity (2016) (24)
The Stethoscope's Prognosis: Very Much Alive and Very Necessary. (2016) (24)
COCATS 4 Task Force 1: Training in Ambulatory, Consultative, and Longitudinal Cardiovascular Care. (2015) (24)
Complement C5 Protein as a Marker of Subclinical Atherosclerosis. (2020) (24)
Long-term antiarrhythmic therapy. Problem of low drug levels and patient noncompliance. (1984) (24)
Contemporary medical management of systolic heart failure. (2012) (24)
Usefulness of a Cardiovascular Polypill in the Treatment of Secondary Prevention Patients in Spain: A Cost-effectiveness Study. (2017) (24)
Coronary excimer laser angioplasty: reduced complications and indium-111 platelet accumulation compared with thermal laser angioplasty. (1990) (24)
Predicting plaque rupture: enhancing diagnosis and clinical decision-making in coronary artery disease (2000) (24)
Noninvasive radioisotopic technique for detection of platelet deposition in mitral valve prostheses and quantitation of visceral microembolism in dogs. (1983) (24)
Coronavirus Historical Perspective, Disease Mechanisms, and Clinical Outcomes (2020) (23)
Implications of Coronary Artery Calcium Testing Among Statin Candidates According to American College of Cardiology / American Heart Association Cholesterol Management Guidelines : MESA ( Multi-Ethnic Study of Atherosclerosis ) (2016) (23)
Retrospective cohort study of clinical characteristics of 2199 hospitalised patients with COVID-19 in New York City (2020) (23)
Academic Careers in Cardiovascular Medicine (2009) (23)
Rationale and design of the school-based SI! Program to face obesity and promote health among Spanish adolescents: A cluster-randomized controlled trial. (2019) (23)
EMPAGLIFLOZIN INDUCES A MYOCARDIAL METABOLIC SHIFT FROM GLUCOSE CONSUMPTION TO KETONE METABOLISM THAT MITIGATES ADVERSE CARDIAC REMODELING AND IMPROVES MYOCARDIAL CONTRACTILITY (2018) (23)
Antithrombotic therapy in the coronary vein graft patient (1991) (23)
Imaging Subclinical Atherosclerosis: Is It Ready for Prime Time? A Review (2014) (23)
Progression of Early Subclinical Atherosclerosis (PESA) Study: JACC Focus Seminar 7/8. (2021) (23)
Quantification of serial changes in plaque burden using multi-detector computed tomography in experimental atherosclerosis. (2009) (23)
Comparison of two aspirin doses on ischemic stroke in post-myocardial infarction patients in the warfarin (Coumadin) Aspirin Reinfarction Study (CARS). (2001) (23)
The (R)Evolution of the CICU: Better for the Patient, Better for Education. (2018) (23)
Framework for Action (2010) (23)
Bridging Income Generation with Group Integrated Care for cardiovascular risk reduction: Rationale and design of the BIGPIC study. (2017) (22)
Takotsubo Cardiomyopathy (2008) (22)
Genotype-Dependent Impairment of Hemoglobin Clearance Increases Oxidative and Inflammatory Response in Human Diabetic Atherosclerosis (2012) (22)
Symposium presentations. How to become a cardiovascular investigator. (2005) (22)
New Anticoagulants for Prevention of Stroke in Patients with Atrial Fibrillation (2011) (22)
Images in cardiovascular medicine. Diagnosis of isolated noncompaction of the myocardium by magnetic resonance imaging. (2002) (22)
Partial atrioventricular canal defect in adults. (1982) (22)
New approaches to treatment of myocardial infarction. (1990) (22)
Novel Small Leucine-Rich Repeat Protein Podocan Is a Negative Regulator of Migration and Proliferation of Smooth Muscle Cells, Modulates Neointima Formation, and Is Expressed in Human Atheroma (2013) (22)
Acute biologic response to excimer versus thermal laser angioplasty in experimental atherosclerosis. (1991) (22)
Antiplatelet therapy: Personalized medicine for clopidogrel resistance? (2009) (22)
Anticoagulation in Patients With COVID-19 (2022) (22)
Correlation between coronary artery disease and aortic arch plaque thickness measured by non-invasive B-mode ultrasonography. (2006) (22)
The cardiovascular polypill: clinical data and ongoing studies. (2015) (22)
Cardiovascular Magnetic Resonance: Established and Emerging Applications (2004) (22)
Cardiovascular defense challenges at the basic, clinical, and population levels (2012) (22)
Healed Plaques in Patients With Stable Angina Pectoris (2020) (22)
Potent arterial antithrombotic effect of direct factor-Xa inhibition with ZK-807834 administered to coronary artery disease patients (2007) (22)
National policies and strategies for noncommunicable diseases (2009) (22)
QRS distortion in pre-reperfusion electrocardiogram is a bedside predictor of large myocardium at risk and infarct size (a METOCARD-CNIC trial substudy). (2016) (22)
The concept of the polypill in the prevention of cardiovascular disease. (2014) (22)
An acute surge of epinephrine stimulates platelet deposition to severely damaged vascular wall (1990) (22)
Comparison of echocardiographic measurements of left ventricular volumes to full volume magnetic resonance imaging in normal and diseased rats. (2013) (21)
Heart repair: from natural mechanisms of cardiomyocyte production to the design of new cardiac therapies (2012) (21)
Rate or rhythm control for atrial fibrillation: update and controversies. (2012) (21)
Antithrombotic therapy in prosthetic heart valve replacement. (1994) (21)
Primary prophylaxis with the implantable cardioverter-defibrillator: the need for improved risk stratification. (2005) (21)
Clinical features and long-term natural history of the postpericardiotomy syndrome. (1983) (21)
Efficacy and safety of out-of-hospital intravenous metoprolol administration in anterior ST-segment elevation acute myocardial infarction: insights from the METOCARD-CNIC trial. (2015) (21)
In vivo coronary plaque histology in patients with stable and acute coronary syndromes: relationships with hyperlipidemic status and statin treatment. (2007) (21)
A cross-sectional study of cardiovascular disease and associated factors. (2011) (21)
Endothelial injury and coronary vasomotion. (1989) (21)
Artery dissection and arterial thrombus aging: the role of noninvasive magnetic resonance imaging. (2001) (20)
Double‐Blind Crossover Trial of Diltiazem versus Propranolol in the Management of Thyrotoxic Symptoms (1990) (20)
Task force #5--the role of cardiovascular specialists as leaders in prevention: from training to champion. 33rd Bethesda Conference. (2002) (20)
CHAPTER 5 NORMAL PHYSIOLOGY OF THE CARDIOVASCULAR SYSTEM (2016) (20)
Effects of Poisoning on Serum Enzyme Activities, Coagulation, and Fibrinolysis (1971) (20)
Effect of balloon inflation on smooth muscle cell proliferation in the porcine carotid artery (1990) (20)
Percutaneous Coronary Intervention) (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Cardiology/American Heart Association Task Force on Practice Guidelines Intervention—Summary Article: A Report of the American College of ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary (2006) (19)
Cells and Aggregates at Surfaces a (1987) (19)
50th anniversary historical article. Myocardial infarction and coronary care units. (1999) (19)
Pacemaker Guidelines) Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 American College of Cardiology/American Heart Association Task Force on Pacemakers and Antiarrhythmia Devices: Summary Article : A Report of the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac (2006) (19)
Metabolite Signatures of Metabolic Risk Factors and their Longitudinal Changes. (2016) (19)
A canine model to study the significance and hemodynamics of type II endoleaks. (2005) (19)
Thrombosis and coagulation abnormalities in the acute coronary syndromes. (1999) (19)
Predictors of stroke associated with coronary artery bypass grafting in patients with diabetes mellitus and multivessel coronary artery disease. (2015) (19)
An overview of antiplatelet and antithrombotic drugs. (1985) (19)
Evolution of the polypill concept and ongoing clinical trials. (2014) (19)
The AHA Guidelines and Scientific Statements Handbook (2008) (19)
Platelet Inhibition in the Management of Thrombosis (1974) (19)
Coronary microcirculation damage in anthracycline cardiotoxicity (2021) (19)
Cell therapy for patients with acute myocardial infarction: ACCRUEd evidence to date. (2015) (18)
Prevention of atherosclerosis in coronary-artery bypass grafts. (1997) (18)
Does Medical Therapy for Thoracic Aortic Aneurysms Really Work? Are β-Blockers Truly Indicated? PRO (2010) (18)
Atrial fibrillation, stroke, and quality of life (2012) (18)
Antithrombotic effect of FK506 vs cyclosporine in cardiac transplant recipients: potential implications in transplant arteriopathy. (1999) (18)
Hirudin and other thrombin inhibitors experimental results and potential clinical applications. (1991) (18)
Clinical Effectiveness of the Cardiovascular Polypill in a Real-Life Setting in Patients with Cardiovascular Risk: The SORS Study. (2019) (18)
Types of myocardial injury and mid-term outcomes in patients with COVID-19. (2021) (18)
Tumors of the Great Vessels (2003) (18)
Urgent need for human resources to promote global cardiovascular health (2011) (18)
Cardiomyopathy associated with cancer therapy. (2014) (18)
Prevention: Polypills for cardiovascular prevention: a step forward? (2013) (18)
Histone deacetylase 9 promotes endothelial-mesenchymal transition and an unfavorable atherosclerotic plaque phenotype (2021) (18)
Diabetes and aspirin: beware of underpowered negative trials (2009) (18)
A Personalized Approach to Chronic Kidney Disease and Cardiovascular Disease: JACC Review Topic of the Week. (2021) (18)
Hypertension Treatment Rates and Health Care Worker Density: An Analysis of Worldwide Data (2019) (18)
Troponin release overestimates infarct size in presence of left ventricular hypertrophy. (2012) (18)
Meeting the challenge of peripheral arterial disease. (2003) (17)
Does Socioeconomic Status Influence the Risk of Subclinical Atherosclerosis?: A Mediation Model. (2019) (17)
Omnipresent atherosclerotic disease: time to depart from analysis of individual vascular beds. (2012) (17)
Accurate quantification of atherosclerotic plaque volume by 3D vascular ultrasound using the volumetric linear array method. (2016) (17)
Impact of Left Ventricular Hypertrophy on Troponin Release During Acute Myocardial Infarction: New Insights From a Comprehensive Translational Study (2015) (17)
Promotion of cardiovascular health at three stages of life: never too soon, never too late. (2014) (17)
Comparison of three platelet markers for measurement of platelet survival time in healthy volunteers. (1986) (17)
Atherosclerosis and the vulnerable plaque--pathogenesis: Part I. (2000) (17)
Acute ApoA-I Milano administration induces plaque regression and stabilisation in the long term (2012) (17)
Characterization of retrograde collateral (type II) endoleak using a new canine model. (2004) (17)
Platelet Deposition Induced by Severely Damaged Vessel Wall Is Inhibited by a Boroarginine Synthetic Peptide with Antithrombin Activity (1994) (17)
Effects of Colchicine on Atherosclerotic Plaque Stabilization: a Multimodality Imaging Study in an Animal Model (2020) (17)
Prevention of thromboembolism induced by prosthetic heart valves. (1988) (17)
Evaluation of platelet-inhibitor drugs in a canine bilateral femoral graft implant model. (1982) (17)
Coronary artery disease in aging women: a menopause of endothelial progenitor cells? (2012) (17)
Preventive stenting in acute myocardial infarction. (2015) (17)
Chronic endothelial dysfunction after oversized coronary balloon angioplasty in pigs: a 12-week follow-up of coronary vasoreactivity in vivo and in vitro. (2001) (17)
Cardiovascular disease and the UN Millennium Development Goals: a serious concern (2006) (17)
[Role of coronary risk factors in blood thrombogenicity and acute coronary syndromes]. (2003) (16)
50th anniversary historical article. Acute coronary syndromes: the degree and morphology of coronary stenoses. (2000) (16)
Translational large animal model of hibernating myocardium: characterization by serial multimodal imaging (2020) (16)
Early identification of patients with native valve infectious endocarditis at risk for major complications by initial clinical presentation and baseline echocardiography. (1995) (16)
Noninvasive Molecular Imaging of Cell Death in Myocardial Infarction using 111In-GSAO (2014) (16)
Atherothrombosis as a systemic, often silent, disease (2005) (16)
Individualizing Revascularization Strategy for Diabetic Patients With Multivessel Coronary Disease. (2019) (16)
Anticoagulation in patients with heart failure: who, when, and why? (2006) (16)
Developed in partnership with the European Society of Cardiology and in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society (2011) (16)
Antibiotics for myocardial infarction? A possible role of infection in atherogenesis and acute coronary syndromes. (1999) (16)
Influence of LDL-Cholesterol Lowering on Cardiovascular Outcomes in Patients With Diabetes Mellitus Undergoing Coronary Revascularization. (2020) (16)
The Generalist/Cardiovascular Specialist: A Proposal for a New Training Track (1997) (16)
Platelet consumption in chronically induced plasma platelet factor 4-like activity reflecting rate of intravascular coagulation in dogs. (1974) (16)
Antithrombins as conjunctive therapy in arterial thrombolysis (1992) (16)
Assay of platelet factor 4 in plasma. (1973) (16)
Are we ignoring the dilated thoracic aorta? (2012) (16)
World Heart Day: a World Heart Federation enterprise promoting the prevention of heart disease and stroke across the world. (2003) (16)
Series on pharmacology in practice. 10. Antithrombotic therapy: role of platelet-inhibitor drugs. III. Management of arterial thromboembolic and atherosclerotic disease (third of three parts). (1981) (16)
Effect of Nurse-Based Management of Hypertension in Rural Western Kenya (2016) (16)
Barriers and Facilitators to Nurse Management of Hypertension: A Qualitative Analysis from Western Kenya. (2016) (16)
Antithrombotic potency of ticagrelor versus clopidogrel in type-2 diabetic patients with cardiovascular disease (2017) (15)
Developing a Mobile Application for Global Cardiovascular Education. (2018) (15)
Rationale and Design of Family‐Based Approach in a Minority Community Integrating Systems–Biology for Promotion of Health (FAMILIA) (2017) (15)
Microwave-driven synthesis of bisphosphonate nanoparticles allows in vivo visualisation of atherosclerotic plaque (2015) (15)
Combination Proximal Pulmonary Artery Coiling and Distal Embolization Induces Chronic Elevations in Pulmonary Artery Pressure in Swine (2015) (15)
The natural history of idiopathic pulmonary hypertension (1981) (15)
Impact Factor: A Curious and Capricious Metric. (2017) (15)
Cell biology of restenosis post-angioplasty. (1995) (15)
Sudden cardiac death in low- and middle-income countries. (2012) (15)
A new in vivo model of arterial thrombosis: the effect of administration of ticlopidine and verapamil in dogs. (1982) (15)
Stratified Approach to Health: Integration of Science and Education at the Right Time for Each Individual. (2015) (15)
Influence of left ventricular remodeling on atrial fibrillation recurrence and cardiovascular hospitalizations in patients undergoing rhythm-control therapy. (2014) (15)
Neovascularization is the most powerful independent predictor for progression to disruption in high-risk atherosclerotic plaques (2003) (15)
Coronary artery calcification is inversely related to body morphology in patients with significant coronary artery disease: a three-dimensional intravascular ultrasound study. (2014) (15)
Atherothrombotic plaques and the need for imaging. (2002) (15)
The role of noninvasive imaging in promoting cardiovascular health (2010) (15)
Cardiac gated breath-hold black blood MRI of the coronary artery wall: An in vivo and ex vivo comparison (2001) (15)
Dipyridamole levels in plasma of man and other species. (1979) (15)
Acute coronary syndromes and diabetes mellitus: a winning ticket for prasugrel. (2008) (15)
The power of resilience. (2014) (15)
Clinical and Experimental Experience with Factor Xa Inhibitors (2004) (15)
Early intravenous beta-blockers in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: A patient-pooled meta-analysis of randomized clinical trials (2019) (14)
Rationale and design of a double-blind, multicenter, randomized, placebo-controlled clinical trial of early administration of intravenous β-blockers in patients with ST-elevation myocardial infarction before primary percutaneous coronary intervention: EARLY β-blocker administration before primary PC (2014) (14)
Aspirin for primary prevention of coronary disease. (1995) (14)
Vascular calcification, diabetes, and cardiovascular disease: connecting the dots. (2012) (14)
Gene therapy and stem cell therapy for cardiovascular diseases today: a model for translational research (2007) (14)
Evolving role of molecular imaging for new understanding: targeting myofibroblasts to predict remodeling (2012) (14)
Effects of percutaneous transluminal angioplasty and endovascular brachytherapy on vascular remodeling of human femoropopliteal artery: 2 years follow-up by noninvasive magnetic resonance imaging. (2007) (14)
Antithrombotic efficacy of low-molecular-weight heparin in deep arterial injury. (1992) (14)
Imaging of platelets in right-sided extracardiac conduits in humans. (1982) (14)
Sudden cardiac death: mechanisms, therapies and challenges (2005) (14)
Accuracy of Area at Risk Quantification by Cardiac Magnetic Resonance According to the Myocardial Infarction Territory. (2017) (14)
Ten-year all-cause death after percutaneous or surgical revascularization in diabetic patients with complex coronary artery disease (2021) (14)
In vivo dynamic real-time monitoring and quantification of platelet-thrombus formation: use of a local isotope detector. (2000) (14)
Effect of Early Metoprolol During ST-Segment Elevation Myocardial Infarction on Left Ventricular Strain: Feature-Tracking Cardiovascular Magnetic Resonance Substudy From the METOCARD-CNIC trial. (2019) (14)
Application of Echocardiography) (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Cardiology/American Heart Association Task Force on Practice Guidelines Echocardiography: Summary Article: A Report of the American College of ACC/AHA/ASE 2003 Guideline Update for the Clinical App (2006) (14)
Rapid Screening for Subclinical Atherosclerosis by Carotid Ultrasound Examination: The HAPPY (Heart Attack Prevention Program for You) Substudy. (2013) (14)
Images in cardiovascular medicine. Double-chambered left ventricle: complete characterization by cardiac magnetic resonance and multidetector-row computed tomography. (2004) (14)
Dose antiplatelet agents; the relationship among side effects, and antithrombotic effectiveness. (1986) (14)
Rationale and design of the SI! Program for health promotion in elementary students aged 6 to 11 years: A cluster randomized trial. (2019) (14)
Role of the polypill for secondary prevention in ischaemic heart disease (2017) (14)
Promoting Cardiovascular and Cerebrovascular Health (2010) (14)
Training cardiovascular fellows in cardiovascular magnetic resonance and vascular imaging; Current status following the core cardiovascular training symposium (COCATS-2) guidelines. (2004) (13)
Mechanisms of Stroke in Atrial Fibrillation. (2014) (13)
Controversies regarding the new oral anticoagulants for stroke prevention in patients with atrial fibrillation (2014) (13)
Atrial fibrillation: an epidemiologic, scientific and clinical challenge (2005) (13)
Subclinical Atherosclerosis and Brain Metabolism in Middle-Aged Individuals: The PESA Study. (2021) (13)
Low‐Dose Aspirin for Primary Prevention of Cardiovascular Disease: Use Patterns and Impact Across Race and Ethnicity in the Southern Community Cohort Study (2019) (13)
Expression of angiotensin-converting enzyme 2 and its end product angiotensin 1-7 is increased in diabetic atheroma: implications for inflammation and neovascularization. (2013) (13)
Optical Coherence Tomography of Plaque Vulnerability and Rupture: JACC Focus Seminar Part 1/3. (2021) (13)
Dietary Patterns and Cardiovascular Risk Factors in Spanish Adolescents: A Cross-Sectional Analysis of the SI! Program for Health Promotion in Secondary Schools (2019) (13)
Disease Prevention: The moving target of global cardiovascular health (2009) (13)
Exercise performance in patients with pulmonary hypertension linked to cardiac magnetic resonance measures. (2009) (13)
Update on advances in atherothrombosis (2007) (13)
Evolving concepts in the pathogenesis and treatment of arterial thrombosis. (1995) (13)
Left ventricular functional recovery of infarcted and remote myocardium after ST-segment elevation myocardial infarction (METOCARD-CNIC randomized clinical trial substudy) (2020) (13)
Molecular Imaging of Apoptosis in Atherosclerosis by Targeting Cell Membrane Phospholipid Asymmetry. (2020) (13)
Thrombosis triggered by severe arterial lesions is inhibited by oral administration of a glycoprotein IIb/IIIa antagonist (1997) (13)
AMERICAN COLLEGE OF CARDIOLOGY, AMERICAN HEART ASSOCIATION AND EUROPEAN SOCIETY OF CARDIOLOGY GUIDELINES (2006) FOR THE MANAGEMENT OF PATIENTS WITH ATRIAL FIBRILLATION (ENDING) (2007) (13)
Promoting global cardiovascular and cerebrovascular health. (2012) (13)
Rhythm Control for Management of Patients With Atrial Fibrillation: Balancing the Use of Antiarrhythmic Drugs and Catheter Ablation (2011) (13)
Lipid-rich obstructive coronary lesions is plaque characterization any important? (2010) (13)
Comprar Hurst's the Heart. 2Volume SET 13th Edition | Robert A. Harrington | 9780071636469 | Mcgraw-Hill Education (2011) (13)
Images in cardiovascular medicine. Right and left ventricular outflow tract obstruction in hypertrophic cardiomyopathy. (2002) (13)
Strategy for ensuring a better future for the vessel wall (2002) (13)
Platelet-vessel wall interactions in the development of restenosis after coronary angioplasty. (1987) (13)
Optical Coherence Tomography of Plaque Erosion: JACC Focus Seminar Part 2/3. (2021) (12)
Association Between Body Size Phenotypes and Subclinical Atherosclerosis (2020) (12)
Diagnostic accuracy of coronary ct for the quantification of the syntax score in patients with left main and/or 3-vessel coronary disease. Comparison with invasive angiography. (2015) (12)
Task force 3: Disclosure of relationships with commercial interests: policy for educational activities and publications. (2004) (12)
Detection of subclinical atherosclerosis in peripheral arterial beds with B-mode ultrasound: a proposal for guiding the decision for medical intervention and an artifact-corrected volumetric scoring index. (2014) (12)
Anticoagulation for Mechanical Heart Valves in Patients with and without Atrial Fibrillation (2010) (12)
Diagnosing and managing unstable angina (1994) (12)
Myocardial Amyloid Quantification with Look-Locker Magnetic Resonance Sequence in Cardiac Amyloidosis. Diagnostic Accuracy in Clinical Practice and Histological Validation. (2017) (12)
Quantitative assessment of right ventricular function in pectus excavatum. (2012) (12)
Nurse management of hypertension in rural western Kenya: implementation research to optimize delivery. (2014) (12)
Interactions of Platelets and Vessel Wall in the Development of Restenosis after Coronary Angioplasty a (1987) (12)
A second dilemma in cardiovascular medicine: personalized medicine versus personal interaction with the patient. (2014) (12)
Perspectives and opportunities for nanomedicine in the management of atherosclerosis (2011) (12)
The time has come for clinical cardiovascular trials with plaque characterization as an endpoint. (2012) (12)
Coronary thrombosis (1996) (12)
(Committee on the Management of Patients With Chronic Stable Angina) Cardiology/American Heart Association Task Force on Practice Guidelines Stable Angina—Summary Article: A Report of the American College of ACC/AHA 2002 Guideline Update for the Management of Patients With Chronic (2008) (12)
The therapeutic challenge of plaque rupture: Value of biochemical markers* (1987) (12)
Serial phase-contrast MRI for prediction of pulmonary hemodynamic changes in patients with pulmonary arterial hypertension. (2012) (12)
Comparative study of antithrombotic effect of a low molecular weight heparin and unfractionated heparin in an ex vivo model of deep arterial injury. (2000) (12)
Revascularization in advanced stable coronary artery disease. (1998) (12)
Inactivation of Nuclear Factor-Y Inhibits Vascular Smooth Muscle Cell Proliferation and Neointima Formation (2013) (12)
Effect of Percutaneous Transluminal Angioplasty on Severely Stenotic Femoral Lesions In Vivo Demonstration by Noninvasive Magnetic Resonance Imaging (2002) (12)
Usefulness of aspirin for coronary artery disease. (1988) (11)
Validation study of a semi-automated program for quantification of atherosclerotic burden. (2007) (11)
Platelets and platelet-inhibitor drugs in aortocoronary vein bypass operations. (1983) (11)
Fine-tuning therapy for acute coronary syndromes. (2010) (11)
EVOLVING CHALLENGES IN PROMOTING CARDIOVASCULAR HEALTH (2012) (11)
Therapy for patients with acute coronary syndromes--new opportunities. (2006) (11)
The obstetrical patient with a prosthetic heart valve. (2006) (11)
Management of Antithrombotic Therapy in Atrial Fibrillation Patients UndergoingPCI (2019) (11)
Emergency thrombolysis in acute myocardial infarction. (1988) (11)
Thrombosis/platelets and other blood factors in acute coronary syndromes. (1989) (11)
Arti ﬁ cial Intelligence in Cardiovascular Imaging (2019) (11)
A new perspective on nonprescription statins: an opportunity for patient education and involvement. (2007) (11)
Myocardial infarction and coronary care units (2000) (11)
The Proliferation of Scoring Systems: Trying to Keep Our Heads Out of The Clouds. (2017) (11)
Meta-analysis of small trials: proceed with caution. (2008) (11)
Muramidase: A useful monocyte/macrophage immunocytochemical marker in swine, of special interest in experimental cardiovascular disease. (1994) (11)
Improvement Of Shortened Platelet Survival Half-Life From The Early To The Late Phase Of Myocardial Infarction (1981) (11)
Conjunctive antithrombotic therapy for thrombolysis in myocardial infarction. (1993) (11)
Does medical therapy for thoracic aortic aneurysms really work? Are beta-blockers truly indicated? CON. (2010) (11)
Cardiovascular disease in Sub-Saharan Africa: a complex picture demanding a multifaceted response (2008) (11)
Thrombolysis in acute myocardial infarction. (1988) (11)
Acute coronary syndromes in the united states and united kingdom: A comparison of approaches (1998) (11)
Catheter based intracoronary brachytherapy leads to increased platelet activation (2004) (11)
Pathophysiologic bases for adjunctive therapies in the treatment and secondary prevention of acute myocardial infarction (1998) (11)
The polypill approach – An innovative strategy to improve cardiovascular health in Europe (2017) (11)
Safe and Sustained Overexpression of Functional Apolipoprotein A-I/High-density Lipoprotein in Apolipoprotein A-I–null Mice by Muscular Adeno-associated Viral Serotype 8 Vector Gene Transfer (2009) (11)
Bioimaging and Subclinical Cardiovascular Disease in Low- and Middle-Income Countries (2014) (10)
Impact factor versus impact to readers: not necessarily at odds. (2014) (10)
Lessons Learned From 10 Years of Preschool Intervention for Health Promotion: JACC State-of-the-Art Review. (2022) (10)
Atrial fibrillation through the years: contemporary evaluation and management. (2013) (10)
Prospective comparison of unstable angina versus non-Q wave myocardial infarction during antithrombotic therapy. Antithrombotic Therapy in Acute Coronary Syndromes Research Group. (1993) (10)
Cardiovascular Risk Factor Control for All. (2017) (10)
Exogenous prostacyclin decreases vasoconstriction but not platelet thrombus deposition after arterial injury. (1993) (10)
A stratified approach to the treatment of a symptomatic myocardial bridge (2002) (10)
An ounce of prevention with a calcium score scan? (2009) (10)
Clinical and angiographic characteristics and outcome of patients with rest-unstable angina occurring during regular aspirin use. (1991) (10)
Lessons from the youth: simplicity and insightfulness. (2014) (10)
Guidelines for Management of Left-Sided Prosthetic Valve Thrombosis: A Role for Thrombolytic Therapy 11These guidelines are the results of a Consensus Conference held during the Symposium on Prosthetic Valve Thrombosis on September 16, 1994, in Budapest, Hungary. (1997) (10)
Antithrombotic therapy for patients with cardiac disease. (1988) (10)
Special Report Guide to Anticoagulant Therapy Part 1: Heparin (2005) (10)
Group Medical Visit and Microfinance Intervention for Patients With Diabetes or Hypertension in Kenya. (2021) (10)
Childhood: a critical focus for 'primordial prevention' research (2005) (10)
A case of symptomatic coronary artery fistula (2006) (10)
Refractory Prinzmetal Angina Treated with Cyproheptadine (1994) (10)
Cardiovascular Complications of Interatrial Conduction Block: JACC State-of-the-Art Review. (2022) (10)
Magnetic Resonance Characterization of Cardiac Adaptation and Myocardial Fibrosis in Pulmonary Hypertension Secondary to Systemic-To-Pulmonary Shunt (2016) (10)
The role of Willebrand factor in platelet - blood vessel interaction, including a discussion of resistance to atherosclerosis in pigs with von Willebrand's disease. (1981) (10)
Pathophysiology of coronary artery disease. (1996) (10)
Optimal antithrombotic therapy for mechanical prosthetic heart valves. (1996) (10)
Cardiovascular risk surveillance to develop a nationwide health promotion strategy: the grenada heart project. (2012) (10)
[An alarming threat to secondary prevention: low compliance (lifestyle) and poor adherence (drugs)]. (2012) (10)
Role of von Willebrand factor in platelet interaction with an expanded PTFE surface. (1987) (10)
Association between anthropometry and high blood pressure in a representative sample of preschoolers in madrid. (2015) (10)
Adeno-associated Virus Serotype 8 ApoA-I Gene Transfer Reduces Progression of Atherosclerosis in ApoE-KO Mice: Comparison of Intramuscular and Intravenous Administration (2011) (9)
Effect of pulmonary artery denervation in postcapillary pulmonary hypertension: results of a randomized controlled translational study (2019) (9)
Current Strategies in the Evaluation and Management of Cocaine-Induced Chest Pain (2015) (9)
Exploration of the atherosclerotic plaque. (1990) (9)
Surgical repair of Ebstein's anomaly. (1982) (9)
Dilemmas of NIH funding for cardiovascular research. (1998) (9)
Noninvasive radioisotopic technique for detection of platelet deposition in mitral valve prosthesis and renal microembolism in dogs. (1980) (9)
Different Lifestyle Interventions in Adults from Underserved Communities: The FAMILIA Trial. (2019) (9)
Grenada Heart Project-Community Health ActioN to EncouraGe healthy BEhaviors (GHP-CHANGE): A randomized control peer group-based lifestyle intervention. (2019) (9)
Human-centered design as a guide to intervention planning for non-communicable diseases: the BIGPIC study from Western Kenya (2020) (9)
Left ventricular thrombus and stroke after myocardial infarction: toward prevention or perplexity? (1989) (9)
[Control of coronary heart disease risk factors and evidence-based therapies: joint efforts for coronary heart disease prevention in Spain]. (2011) (9)
The CNIC-Polypill reduces recurrent major cardiovascular events in real-life secondary prevention patients in Spain: The NEPTUNO study. (2022) (9)
Alternatively Spliced Tissue Factor Promotes Plaque Angiogenesis Through the Activation of HIF-1α and VEGF Signaling (2014) (9)
Three-dimensional cardiac fibre disorganization as a novel parameter for ventricular arrhythmia stratification after myocardial infarction (2019) (9)
Can we image the "active" thrombus? (2002) (9)
Statin Therapy Alone and in Combination with an Acyl-CoA:Cholesterol O-Acyltransferase Inhibitor on Experimental Atherosclerosis (2008) (9)
Magnetic Resonance Imaging and Asymptomatic Aortic Dissection (2000) (9)
Peripheral pulmonary artery stenosis masquerading as pulmonary hypertension: A diagnostic and therapeutic challenge (2012) (9)
A null mutation in ANGPTL8 does not associate with either plasma glucose or type 2 diabetes in humans (2016) (9)
No Such Thing as Ideal Blood Pressure: A Case for Personalized Medicine. (2016) (9)
Prospective Comparison of Patient Characteristics and Outcome of Non-prior Aspirin Users versus Aspirin Users with Unstable Angina or Non-Q-Wave Myocardial Infarction Treated with Combination Antithrombotic Therapy (2004) (9)
Children are key to CVD prevention (2010) (9)
Antithrombotic Therapy in Cardiovascular Diseases (1991) (9)
Isolated aortic stenosis with severe pulmonary hypertension. (1985) (9)
Laboratory investigation of platelets (2001) (9)
Design of the β3-Adrenergic Agonist Treatment in Chronic Pulmonary Hypertension Secondary to Heart Failure Trial (2020) (9)
A sensitive new method of "ex vivo" platelet deposition. (1982) (9)
Faster publication isn't always better (2007) (9)
Functional Behavior of Vessels from Pigs with von Willebrand Disease: Values of Platelet Deposition Are Identical to Those Obtained on Normal Vessels (1989) (9)
Peroxisome proliferator-activated receptor ligands in atherosclerosis (2004) (9)
Incidence, predictors, and evolution of conduction disorders and atrial arrhythmias after contemporary mitral valve repair. (2014) (9)
MR-based attenuation correction in cardiovascular PET/MR imaging: challenges and practical solutions for cardiorespiratory motion and tissue class segmentation (2016) (9)
Comparison of single plane videodensitometry-based right ventricular ejection fraction in right and left anterior oblique views to biplane geometry-based right ventricular ejection fraction. (1987) (9)
Antithrombotic therapy and venous graft disease. (1998) (9)
Acute coronary syndromes in low- and middle-income countries: Moving forward. (2016) (9)
Five-Year Outcomes and Prognostic Value of Feature-Tracking Cardiovascular Magnetic Resonance in Patients Receiving Early Prereperfusion Metoprolol in Acute Myocardial Infarction. (2020) (9)
Maximizing therapeutic envelope for prevention of cardiovascular disease: role of polypill. (2012) (9)
Mitral valve prolapse morphofunctional features by cardiovascular magnetic resonance: more than just a valvular disease (2021) (9)
Indications for cardiac catheterization and coronary arteriography in the adult. (1980) (8)
Therapeutic targets for the treatment of athero-thrombosis in the new millennium: Clinical frontiers in atherosclerosis research (2002) (8)
Global Overview of the Transnational Alliance for Regenerative Therapies in Cardiovascular Syndromes (TACTICS) Recommendations: A Comprehensive Series of Challenges and Priorities of Cardiovascular Regenerative Medicine. (2018) (8)
Prevalence and severity of ventricular dysfunction in patients with HIV-related pulmonary arterial hypertension. (2014) (8)
A first dilemma in cardiovascular medicine: adherence versus personalized therapy. (2014) (8)
Incidence, determinants and impact of acute kidney injury in patients with diabetes mellitus and multivessel disease undergoing coronary revascularization: Results from the FREEDOM trial. (2019) (8)
Hemoglobin A1c and Cardiovascular Outcomes Following Percutaneous Coronary Intervention: Insights From a Large Single-Center Registry. (2021) (8)
Unraveling the Complexities of Statistical Presentation: Why it Is Important. (2015) (8)
Net clinical benefit of warfarin: extending the reach of antithrombotic therapy for atrial fibrillation. (2012) (8)
Soluble CD 40 Ligand Predicts Ischemic Stroke and Myocardial Infarction in Patients With Nonvalvular Atrial Fibrillation (2007) (8)
Thrombosis and accelerated atherosclerosis in coronary bypass surgery and restenosis after percutaneous transluminal coronary angioplasty: implications for therapy (1990) (8)
[Cardiovascular, renal and other chronic diseases. Early intervention is necessary in chronic kidney disease]. (2009) (8)
Sustainability of and Adherence to Preschool Health Promotion Among Children 9 to 13 Years Old. (2020) (8)
What do we gain from the analysis of right ventricular function? (1984) (8)
Respiratory ventricular area changes measured with real-time cardiac magnetic resonance: a new, accurate, and reproducible approach for the diagnosis of pericardial constriction. (2013) (8)
SCN5A--a mechanistic link between inherited cardiomyopathies and a predisposition to arrhythmias? (2005) (8)
Prospective evaluation of a prostacyclin-sparing aspiring formulation and heparin/warfarin in aspirin users with unstable angina or non-Q wave myocardial infarction at rest (1994) (8)
Evaluation of right ventriculoarterial coupling in pulmonary hypertension: a magnetic resonance study (2011) (8)
Sesame street: changing cardiovascular risks for a lifetime. (2012) (8)
Platelet inhibitor therapy. Agents and clinical implications. (1990) (8)
Erratum: Carotid plaque burden as a measure of subclinical atherosclerosis: Comparison with other tests for subclinical arterial disease in the high risk plaque bioimage study. (JACC: Cardiovascular Imaging (2012) 5 (681-9)) (2013) (8)
Intravenous metoprolol during ongoing STEMI ameliorates markers of ischemic injury: a METOCARD-CNIC trial electrocardiographic study (2021) (8)
Statins and Plaque Stability (2003) (8)
Higher rates of coronary angiography and revascularization following myocardial infarction may be associated with greater survival in the United States than in Canada. The CARS Investigators (Coumadin/Aspirin Reinfarction Study). (1999) (8)
Pathogenesis and prevention of aortocoronary bypass graft occlusion. (1986) (8)
Usability of Implementing a Tablet-Based Decision Support and Integrated Record-Keeping (DESIRE) Tool in the Nurse Management of Hypertension in Rural Kenya (2014) (8)
Role of platelet inhibitor therapy in myocardial infarction (1989) (8)
Antithrombotic Approaches in Acute Coronary Syndromes: Optimizing Benefit vs Bleeding Risks. (2016) (8)
TP53-mediated clonal hematopoiesis confers increased risk for incident peripheral artery disease (2021) (8)
The evolving role of CT and MRI in atherothrombotic evaluation and management (2005) (8)
Pathobiology of coronary ischemic events: clinical implications. (1998) (7)
Usefulness of onset of the pulmonary wedge V wave in predicting mitral regurgitation. (1988) (7)
Erratum: The MOGE(S) classification for a phenotype-genotype nomenclature of cardiomyopathy: Endorsed by the world heart federation (J Am Coll Cardiol (2013) 62 (2046-2072)) (2014) (7)
Insights into the pathogenetic mechanisms of unstable angina. (1990) (7)
Platelet deposition on severely damaged vessel wall at flow conditions typical of stenotic vessel is inhibited by LJ-CP3. (antiplatelet glycoprotein GPIIB/IIIA monoclonal antibody) (1990) (7)
Atherosclerosis and the vulnerable plaque--imaging: Part II. (2000) (7)
Economic Costs Associated with Atrial Fibrillation (2008) (7)
Diabetes and Cardiovascular Disease (2008) (7)
Understanding systemic inflammation, oral hygiene, and cardiovascular disease. (2011) (7)
Calcium scoring and contrast-enhanced CT angiography. (2006) (7)
Platelet factor 4-like activity in the initial stages of atherosclerosis in pigeons. (1977) (7)
Reply: myocardial edema should be stratified according to the state of cardiomyocytes within the ischemic region. (2015) (7)
Identification of a peripheral blood gene signature predicting aortic valve calcification. (2020) (7)
Development and validation of a questionnaire to evaluate lifestyle-related behaviors in elementary school children (2015) (7)
Cardiac drug-psychotropic drug update. (2002) (7)
R2 prime (R2') magnetic resonance imaging for post-myocardial infarction intramyocardial haemorrhage quantification. (2019) (7)
Necrobiosis lipoidica diabeticorum: platelet survival and response to platelet inhibitors. (1989) (7)
Prime time for a polypill after myocardial infarction? (2009) (7)
Predicting coronary heart disease: from Framingham Risk Score to ultrasound bioimaging. (2012) (7)
Effects of a comprehensive lifestyle intervention on cardiovascular health: the TANSNIP-PESA trial (2022) (7)
[Mechanisms of acute ischemic syndromes and coronary atherosclerosis progression]. (1997) (7)
Polypill strategy at the heart of cardiovascular secondary prevention (2018) (7)
General Cardiology Perspective: Decision Making Regarding Revascularization of Patients With Type 2 Diabetes Mellitus and Cardiovascular Disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial (2010) (7)
Cardiovascular disease and the UN Millennium Development Goals: time to move forward (2008) (7)
Mechanisms of Plaque Formation and Occlusion in Venous Coronary Bypass Grafts (1994) (7)
New 3-Dimensional Volumetric Ultrasound Method for Accurate Quantification of Atherosclerotic Plaque Volume. (2022) (7)
DETECTION AND IMPACT OF SUBCLINICAL CORONARY AND CAROTID ATHEROSCLEROSIS ON CARDIOVASCULAR RISK PREDICTION AND RECLASSIFICATION IN ASYMPTOMATIC US ADULTS: INSIGHTS FROM THE HIGH RISK PLAQUE BIOIMAGE STUDY (2014) (7)
Coronary vasospasm attributable to fibromuscular dysplasia: the long bridge to transplant. (2013) (6)
Reply: "Waves of Edema" Seem Implausible. (2016) (6)
The Hazards of Physician Advertising. (2015) (6)
Disrupted Atherosclerosis in the Aorta : Implications for Plaque Vulnerability Intimomedial Interface Damage and Adventitial Inflammation Is Increased Beneath (2002) (6)
Policomprimido: ¿quimera o realidad? (2014) (6)
Atherosclerosis and coronary artery disease: Volume 1 and Volume 2. (1996) (6)
[The Spanish National Cardiovascular Research Center: a new phase]. (2008) (6)
The CNIC: A Successful Vision in Cardiovascular Research. (2016) (6)
Late medical versus interventional therapy for stable ST-segment elevation myocardial infarction (2008) (6)
THE SGLT2 INHIBITOR EMPAGLIFLOZIN DOES NOT EXHIBIT PRO THROMBOTIC EFFECTS (2018) (6)
Hurst's the heart, ninth edition (2000) (6)
Evaluation for Noncardiac Surgery) (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Cardiology/American Heart Association Task Force on Practice Guidelines Noncardiac Surgery—Executive Summary A Report of the American College of ACC/AHA Guideline Update for Perioperative Card (2008) (6)
Rationale and design of the pragmatic clinical trial tREatment with Beta-blockers after myOcardial infarction withOut reduced ejection fracTion (REBOOT). (2021) (6)
Left ventricular thromboembolism after myocardial infarction. (1994) (6)
Von Willebrand's disease in pigs and atherosclerosis (1979) (6)
GUIDELINE 2011 ACCF / AHA / HRS Focused Update on the Management of Patients With Atrial Fibrillation ( Updating the 2006 Guideline ) (2010) (6)
Long-Term Survival Following Multivessel Revascularization in Patients With Diabetes The (2019) (6)
Optical Coherence Tomography of Coronary Plaque Progression and Destabilization: JACC Focus Seminar Part 3/3. (2021) (6)
Quantitation of platelet deposition in core-tex femoral artery implants in the canine model and its reduction with dipyridamole and prostacyclin (1980) (6)
[Trends and contexts in European cardiology practice for the next 15 years. The Madrid Declaration: a report from the European Conference on the Future of Cardiology, Madrid, 2-3 June 2006]. (2007) (6)
In vivo platelet survival in rheumatoid arthritis. (1982) (6)
Cardiac cell and gene therapies: two trajectories, one goal (2008) (6)
Predicting Subclinical Atherosclerosis in Low-RiskIndividuals (6)
Identification of interleukin-2 for imaging atherosclerotic inflammation (2006) (6)
Smoking gun theory: angiographically normal or mild coronary plaque as a cause of myocardial infarction. (2012) (6)
Present concepts of coronary atherosclerosis-thrombosis, therapeutic implications and perspectives. (1997) (6)
Mechanism of arterial thrombosis platelet thrombus deposition in areas of stenosis (1987) (6)
Clinical approach and management of acquired valvular heart disease. (1980) (6)
Platelet Interaction with Vessel Wall and Collagen in Pigs with Homozygous von Willebrand’s Disease Associated with Abnormal Collagen Aggregation (1989) (6)
COVID-19 (2020) (6)
The acute hemodynamic effect of IV nitroglycerin and dipyridamole in patients with pulmonary arterial hypertension: comparison with IV epoprostenol. (2005) (6)
Value of blood-pool subtraction in cardiac indium-111-labeled platelet imaging. (1989) (6)
MR imaging of human atherosclerosis using immunomicelles molecularly targeted to macrophages (2009) (6)
Heart Disease Is Associated With Anthropometric Indices and Change in Body Size Perception Over the Life Course: The Golestan Cohort Study. (2015) (6)
Global position paper on cardiovascular regenerative medicine Scientific statement of the transnational alliance for regenerative therapies in cardiovascular syndromes ( TACTICS ) international group for the comprehensive cardiovascular application of regenerative medicinal products (2017) (6)
JACC: Basic to Translational Science (2018) (6)
Nutritional preconditioning by marine omega-3 fatty acids in patients with ST-segment elevation myocardial infarction: A METOCARD-CNIC trial substudy. (2017) (6)
The Art and Challenge of Crafting a Central Illustration or Visual Abstract. (2019) (6)
Spontaneous endothelial cell injury in the intimal cushions of atherosclerotic pigeons. (1977) (5)
Spontaneous arterial lesions in normal pigs and pigs with Von Willebrand's disease. (1977) (5)
Lipid lowering therapy reduces blood thrombogenicity in hypercholesterolemic patients: effect of simvastatin (1998) (5)
Comprar Platelets in Hematologic and Cardiovascular Disorders. A Clinical Handbook | Jos Vermylen | 9780521881159 | Cambridge University Press (2007) (5)
The 3 pathways of translational medicine: an evolution to a call-and-response method. (2014) (5)
AHA's new strategic impact goal designed to curb epidemic of cardiovascular disease and stroke. (1999) (5)
Potential for global progress in control of chronic diseases a turning point in 2011. (2011) (5)
Sunday, 26 August 2012 (2012) (5)
Role Of Verapamil (Calcium Blocker) In The Reduction Of Platelet Deposition In Gore-Tex Grafts In Dogs (1981) (5)
50th anniversary historical article. Acute coronary syndromes: the degree and morphology of coronary stenoses. (2000) (5)
Time to welcome the elderly into clinical trials (2008) (5)
Good night, sleep tight. (2021) (5)
The year in atherothrombosis. (2007) (5)
A journey toward converging 3 passions: research, patient care, and education. (2014) (5)
Are predictive risk scores useful? (2009) (5)
Acute coronary syndromes in the United States and United Kingdom: a comparison of approaches. The Antithrombotic Therapy in Acute Coronary Syndromes Research Group. (1998) (5)
The diagnosis of intravascular coagulation. (1973) (5)
Images in cardiovascular medicine. Effect of percutaneous transluminal angioplasty on severely stenotic femoral lesions: in vivo demonstration by noninvasive magnetic resonance imaging. (2002) (5)
Relationship between high shear stress and OCT-verified thin-cap fibroatheroma in patients with coronary artery disease (2020) (5)
Acute biological response to laser balloon angioplasty in the atherosclerotic rabbit (1994) (5)
PET performance of the GEMINI TF PET — MR: The world's first whole body PET — MRI scanner (2010) (5)
Platelet-inhibitor therapy in cardiovascular disease. Effective defense against thromboembolism. (1985) (5)
Arterial injury in ApoE -/- and C57/BL6 wild type mice: evidence for macrophage apoptosis as a mechanism regulating tissue-factor expression and plaque growth (2002) (5)
Polypill: chimera or reality? (2014) (5)
Atherosclerosis in Homozygous and Heterozygous von Willebrand Pigs (1979) (5)
The Vulnerable Patient: Providing a Lens Into the Interconnected Diseases of the Heart and Brain. (2015) (5)
Hypertension management in rural western Kenya: a needs-based health workforce estimation model (2019) (5)
Unbiased plasma proteomics discovery of biomarkers for improved detection of subclinical atherosclerosis (2022) (5)
Hypercholesterolemia induces abnormal coronary vasomotion in vivo (1991) (5)
Coronary thrombosis. (1996) (5)
Aspirin and mortality from coronary bypass surgery. (2003) (5)
Impact of implantable-cardioverter-defibrillator trials on clinical management of patients with heart failure (2006) (5)
Labeling galectin-3 for the assessment of myocardial infarction in rats (2014) (5)
Clinical Validation of a 3-Dimensional Ultrafast Cardiac Magnetic Resonance Protocol Including Single Breath-Hold 3-Dimensional Sequences (2021) (5)
Pathogenesis of Coronary Occlusion (1988) (5)
PREVALENCE AND CLINICAL SIGNIFICANCE OF LIPID-RICH PLAQUE DETECTED BY OPTICAL COHERENCE TOMOGRAPHY: A FOUR-YEAR FOLLOW-UP STUDY (2017) (5)
The Changing Epidemiology of Sudden Cardiac Death. (2009) (5)
[Identification of unstable coronary atherosclerotic plaques]. (2001) (5)
Increased circulating tissue factor and blood thrombogenicity in Type-2 diabetes (2002) (5)
Novel Anticoagulants for Stroke Prevention in Patients with Atrial Fibrillation (2014) (5)
The three mechanisms for coronary artery disease progression: insights into future management. (1995) (5)
Antithrombotic therapy in coronary artery disease. (1994) (4)
The year in atherothrombosis. (2010) (4)
Resistance to Atherosclerosis in Pigs with Cenetic and Therapeutic Inhibition of Platelet Function (1979) (4)
The MOGE ( S ) Classi fi cation of Cardiomyopathy for Clinicians (2014) (4)
Reply: The MOGE(S) classification for a phenotype-genotype nomenclature of cardiomyopathy: more questions than answers? (2014) (4)
Aortic Coarctation in the Adult (2014) (4)
Partial Atrioventricular Canal Defect in Adults (1981) (4)
Coronary thrombolysis. (1989) (4)
From Heart to Head, Thrombi to Emboli, and Inferences to Extrapolation. (2019) (4)
JUPITER strikes earth (2009) (4)
Fibromuscular hyperplasia and thrombosis are the predominant mechanisms for late luminal narrowing after balloon angioplasty in porcine coronary arteries (1996) (4)
Coronary collateral vessels and myocardial protection. (1983) (4)
Editorial note Coronary collateral vessels and myocardial protection (1983) (4)
MOGE(S) nosology in low-to-middle-income countries (2014) (4)
Meta-analysis of small trials: proceed with caution (2007) (4)
Evolving Anatomic, Functional, and Molecular Imaging in the Early Detection and Prognosis of Hypertrophic Cardiomyopathy (2009) (4)
Coronary thrombolysis. (1992) (4)
Obesity: a challenge for science and society (2005) (4)
Mediterranean dietary patterns in 3-5 year old children and their parents: the Program SI! study (2013) (4)
Novel cardiovascular biomarkers and implications for clinical trials (2006) (4)
Single breath-hold saturation recovery 3D cardiac T1 mapping via compressed SENSE at 3T (2020) (4)
A teenager with mixed connective tissue disease presenting with an acute coronary syndrome (2004) (4)
Industry Disclosures: More Reflective of Moral Integrity Than Rules. (2015) (4)
Antithrombotic efficacy of low molecular weight heparin after arterial injury in the pig (1990) (4)
Current State of Basic and Translational Cardiovascular Research in Spain. (2017) (4)
3D-ECHOCARDIOGRAPHY DEMONSTRATES EXCELLENT CORRELATION WITH CARDIAC MAGNETIC RESONANCE FOR ASSESSMENT OF LEFT VENTRICULAR FUNCTION AND VOLUMES IN A MODEL OF MYOCARDIAL INFARCTION (2012) (4)
Diagnosis of pulmonary artery hypertension. (1992) (4)
Endothelial Permeability And C-14- And I-131-Cholesterol Uptake On Aortocoronary Femoral Vein Bypass Grafts In Dogs (1981) (4)
Prevalence and correlates of cardiovascular health among early adolescents enrolled in the SI! Program in Spain: a cross-sectional analysis. (2020) (4)
Unstable angina: Is it time for more aggressive therapy? (1986) (4)
Coronary thrombolysis. (1998) (4)
Expanding the cardiovascular mandate: from treatment to the protection of health (2007) (4)
The ischemic risk syndrome following thrombolysis: the problem of arterial re-occlusion (1988) (4)
Coexistence of transmural and lateral wavefront progression of myocardial infarction in the human heart. (2020) (4)
Vessel Wall-Related Risk Factors in Acute Vascular Events (2012) (4)
Effect Of TicloPidine On Platelet Deposition In Gore-Tex And Autologous Vein Grafts (1981) (4)
831-1 Ruptured diabetic atherosclerotic plaques have more inflammation and neovascularization than ruptured plaques from patients without diabetes (2004) (4)
In ﬂ ammation, Immunity, and Infection in Atherothrombosis (2018) (4)
Serial, non-invasive, high resolution magnetic resonance microscopy measures progression of atherosclerosis in apolipoprotein E deficient mice (2001) (4)
Atherosclerosis in Normal and Von Willebrand PIGS: Cross-Aortic Transplantation Studies (1979) (4)
The effect of tissue-segmented attenuation maps on PET quantification with a special focus on large arteries. (2018) (4)
Thrombocytes in atherosclerosis-resistant and atherosclerosis-susceptible breeds of pigeon: a comparative ultrastructural study. (1976) (4)
Coronary artery bypass grafting. A model for the understanding of the progression of atherosclerotic disease and the role of pharmacological intervention. (1985) (4)
Cardiovascular Health Promotion Early in Life (2010) (4)
, Jr Cause for Concern Low Priority of Cardiovascular and Chronic Diseases on the Global Health Agenda : A (2007) (4)
Thrombogenesis and inhibition of platelet aggregation. Experimental aspects and future approaches. (1990) (4)
Preventing heart attack and death in patients with coronary disease. Endorsed by the board of trustees of the American College of Cardiology. (1996) (4)
12 Antithrombotic therapy for coronary artery disease and valvular heart disease (1990) (4)
A White Matter Atlas and Common Connectivity Space Facilitate the Pig as a Translational Model in Neuroscience (2020) (4)
Mechanisms of Acute Myocardial Infarction (1994) (4)
β3 adrenergic agonist treatment in chronic pulmonary hypertension associated with heart failure (SPHERE‐HF): a double blind, placebo‐controlled, randomized clinical trial (2022) (4)
Task force III : perspectives on the allocation of limited resources in cardiovascular medicine (1990) (4)
Russell Ross, PhD Visionary Basic Scientist in Cardiovascular Medicine (2001) (4)
Prospective evaluation of a prostacyclin-sparing aspirin formulation and heparin/warfarin in aspirin users with unstable angina or non-Q wave myocardial infarction at rest. The Antithrombotic Therapy in Acute Coronary Syndromes Research Group. (1994) (4)
Reperfusion, specific thrombin inhibition and reocclusion after thrombolysis. (1990) (4)
Response by Fernández-Jiménez et al to Letters Regarding Article, "Dynamic Edematous Response of the Human Heart to Myocardial Infarction: Implications for Assessing Myocardial Area at Risk and Salvage". (2018) (4)
Platelet Survival and the Development of Coronary Disease in the Young : The Effect of Cigarette Smoking, Family History and Medical Therapy (1979) (4)
[Fixed-dose compounds and the secondary prevention of ischemic heart disease]. (2011) (4)
Magnetic resonance imaging of coronary atherosclerosis (2003) (4)
LOW VERSUS STANDARD DOSE CORONARY ARTERY CALCIUM SCANNING (2014) (4)
[Modulation of the beta-adrenergic system during acute myocardial infarction: rationale for a new clinical trial]. (2011) (4)
Second Anniversary as JACC's Editor-in-Chief: Maintaining Focus Through Simplicity and Insightfulness, With a Look Toward Advocacy. (2016) (3)
Systematic review of three decades of Spanish cardiovascular epidemiology: improving translation for a future of prevention (2013) (3)
A praise for reviewers: how do we reward them? (2015) (3)
831-6 Atherosclerotic plaque inflammation is associated with increased intima-medial neovascularization (2004) (3)
Interactions between blood and coronary arterial wall (1989) (3)
Aspirin and other platelet active drugs. Relationship among dose, effectiveness, and side effects. (1989) (3)
Recombinant Hirudin for Unstable Angina Pectoris (2005) (3)
Increased Myeloperoxidase Expression is Associated with Increase in Intra-Plaque Hemorrhage, Iron Content, Inflammation and Neovascularization in Diabetic Atherosclerosis: Implications for Plaque Progression (2013) (3)
Perioperative antithrombotic therapy for aortocoronary artery bypass graft operations (1986) (3)
Task force I: Training in clinical cardiology (1986) (3)
Health Literacy and Primordial Prevention in Childhood-An Opportunity to Reduce the Burden of Cardiovascular Disease. (2020) (3)
BISPHOSPHONATES PREVENT OXIDIZED LOW-DENSITY LIPOPROTEIN-INDUCED EXPRESSION OF OSTEOGENIC MARKERS IN AORTIC VALVE MYOFIBROBLASTS (2010) (3)
Valuing our oath more than our politics. (2014) (3)
Chronic disease stigma, skepticism of the health system, and socio-economic fragility: Qualitative assessment of factors impacting receptiveness to group medical visits and microfinance for non-communicable disease care in rural Kenya (2020) (3)
Myocardial Extracellular Volume Is Not Associated With Malignant Ventricular Arrhythmias in High-risk Hypertrophic Cardiomyopathy. (2017) (3)
Expanded use of thrombolytic therapy. (1992) (3)
Impact of Noninsulin-Dependent Type 2 Diabetes on Carotid Wall 18 F-Fluorodeoxyglucose (2012) (3)
Long-term survival, symptomatic status and thromboembolism after starr-edwards prosthesis for isolated aortic or mitral incompetence (1982) (3)
Task Force 2: Academic health centers. (1994) (3)
Antiplatelet and antithrombin therapy. (1994) (3)
Reducing the Burden of Cardiovascular Disease: Intervention Approaches (2010) (3)
Increase in platelet factor 4-like activity in the initial stages of atherosclerosis in pigeons. (1977) (3)
In vivo magnetic resonance imaging of post angioplasty coronary vessell wall lesions in pigs (1998) (3)
Apolipoprotein ai and coronary disease progression: A 5-year angiographic study (1990) (3)
Should standard medical therapy for angina include a statin? (2004) (3)
MRI PLAQUE BURDEN OF THE CAROTID ARTERIES AND AORTA: REPRODUCIBILITY, AGE, SEX AND SYSTEMIC DISTRIBUTION (2008) (3)
RESPONSE: Placing Value in Peer Mentorship. (2015) (3)
Global collaboration needed for AF (2010) (3)
Interaction of platelets with the endothelium in normal and von Willebrand pigs. (1978) (3)
Sex differences in health status, healthcare utilization, and costs among individuals with elevated blood pressure: the LARK study from Western Kenya (2021) (3)
Reply: Myocardial Salvage, Area at Risk by T2w CMR: The Resolution of the Retrospective Radio Wave Paradigm? (2015) (3)
The inoperable valvular heart disease patient:the pluses and minuses of percutaneous valvular replacement. (2006) (3)
Changing Our Dietary Habits: Empathizing With Sisyphus. (2017) (3)
Where am I going? The future of academic cardiovascular medicine. (2005) (3)
Optimal treatment of the diabetic patient with multivessel disease (2008) (3)
[Applied cardiological research. Challenges for the new millenium]. (2002) (3)
TP53-mediated clonal hematopoiesis confers increased risk for incident atherosclerotic disease (2023) (3)
Simplicity and Insightfulness: A Promise and its Results: JACC at 1 Year. (2015) (3)
SUBCLINICAL ATHEROSCLEROSIS IN THE ABSENCE OF CARDIOVASCULAR RISK FACTORS: PRE-RISK STATUS IN THE PESA (PROGRESSION OF EARLY SUBCLINICAL ATHEROSCLEROSIS) STUDY (2017) (3)
Histopathology of coronary lesions with early loss of minimal luminal diameter after successful percutaneous transluminal coronary angioplasty: is thrombus a significant contributor? (1998) (3)
Evaluation of cardiac murmurs. (1980) (3)
155 Quantification of pulse wave velocity in the pulmonary artery in patients with pulmonary hypertension (2008) (3)
A statin-loaded reconstituted high-density lipoprotein nanoparticle inhibits atherosclerotic plaque inflammation (2014) (3)
Relation of Post-Coronary Artery Bypass Graft Creatine Kinase-MB Elevations and New Q Waves With Long-Term Cardiovascular Death in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease. (2016) (3)
Procedural‐related coronary atrial branch occlusion during primary percutaneous coronary intervention for ST‐segment elevation myocardial infarction and atrial arrhythmias at follow‐up (2020) (3)
[Thrombus remodeling. Key factor in the progression of coronary atherosclerosis]. (2000) (3)
From molecular imaging to pathogenesis and vice versa…. (2014) (3)
NIH funding: a roller coaster Ride? Priorities if NIH funding increases. (1999) (3)
Monday, 27 August 2012 (2012) (3)
Serial Platelet Survival Half-Life (PS) In Peripheral Vascular Disease And Diabetes Mellitus (1981) (3)
Understanding the coronary disease process and the potential for prevention: a summary. (1999) (3)
Direct 4D Patlak 18F-FDG PET/MR for the Multi-Parametric Assessment of active cardiac sarcoidosis (2017) (3)
Platelets in Hematologic and Cardiovascular Disorders: Preface (2007) (3)
Looking for the culprit of coronary in‐stent restenosis: debatable role for the fibrinolytic system? (2005) (3)
Natural history of idiopathic dilated cardiomyopathy. Implications for future therapy. (1985) (3)
Coronary vasospastic angina: a rare case of ergonovine positivity and curative bilateral cardiac sympathectomy. (2018) (3)
Not only how much, but also how to, when measuring epicardial adipose tissue. (2021) (3)
Platelet function inhibitors: their clinical use. (1978) (3)
Fulminant Myocarditis Following SARS-CoV-2 Infection (2022) (3)
Increased incidence of internal elastic lamina rupture and intimal medial changes in complex atherosclerotic lesions: understanding the remodeling paradox and plaque disruption (2002) (3)
THROMBOLYTIC THERAPY FOR ACUTE MYOCARDIAL INFARCTION : GUSTO CRITICIZED. AUTHORS REPLY (1994) (3)
Bone marrow activation in response to metabolic syndrome and early atherosclerosis. (2022) (3)
Subclinical Atherosclerosis in Young, Socioeconomically Vulnerable Hispanic and Non-Hispanic Black Adults. (2022) (3)
Evaluation of 99mTc-LDL for studying lipoprotein metabolism and imaging atherosclerotic lesions in vivo (1985) (3)
The dual challenge of BP control (2009) (2)
Introduction: Cardiologists should target obesity (2001) (2)
Why do we need yet another journal? (2004) (2)
Why aspirin and heparin in unstable angina (1992) (2)
Coronary atherosclerosis: morphology and characteristics to identify by evolving imaging technology : Use of imaging techniques to detect atherosclerosis and other forms of vascular injury (1992) (2)
Platelets in Thrombotic and Non-thrombotic Disorders: Editors' preface (2002) (2)
Myocardial fibrosis with T1 mapping and right ventricular performance in pulmonary hypertension (2013) (2)
Neutrophil β1 adrenoceptor blockade blunts stroke‐associated neuroinflammation (2022) (2)
Dynamic Thrombosis and Thrombolysis (2005) (2)
Abstract 18618: Endothelial to Mesenchymal Transition Contributes to Atherosclerotic Plaque Formation and Correlates With Plaque Instability (2016) (2)
272Pre-reperfusion metoprolol administration reduces ischemia/reperfusion injury (IRI) through beta1-adrenergic receptor (b1AR) blockade in the circulating cells (2014) (2)
A Historical and Contemporary Therapeutic Overview (2011) (2)
Diagnostic value of cardiac magnetic resonance for the differential diagnosis of thrombus vs tumor (2013) (2)
PT452 Barriers and Facilitators to Nurse Management of Hypertension in Rural Western Kenya: A Qualitative Analysis (2014) (2)
Motivational interview and imaging of subclinical atherosclerosis for cardiovascular disease prevention: a winning combination? (2023) (2)
CORONARY 18F-FLUORIDE HYBRID POSITRON EMISSION TOMOGRAPHY MAGNETIC RESONANCE IMAGING: INITIAL EXPERIENCE (2016) (2)
Egocentric social network characteristics and cardiovascular risk among patients with hypertension or diabetes in western Kenya: a cross-sectional analysis from the BIGPIC trial (2021) (2)
Special Report Aspirin As a Therapeutic Agent in Cardiovascular Disease (1993) (2)
CNIC: Achieving Research Excellence Through Collaboration. (2012) (2)
The year in atherothrombosis. (2008) (2)
Images in cardiovascular medicine. Magnetic resonance imaging and asymptomatic aortic dissection. (2000) (2)
MRI of atherosclerotic plaques: Water T2S are similar in vivo and in vitro (1995) (2)
Editorial [ Special Issue on Atherosclerosis Executive Editors: Pedro R. Moreno, Javier Sanz and Valentin Fuster ] (2006) (2)
Cardiovascular disease in the elderly: a challenge for science and clinical care (2005) (2)
Antithrombotic therapy in cardiovascular diseases. Future directions based on pathogenesis and risk. (1991) (2)
Rene G. Favaloro, MD (2001) (2)
Correction to: oxLDL Receptor in Lymphocytes Prevents Atherosclerosis and Predicts Subclinical Disease. (2019) (2)
Thrombosis on Stenosis: Mechanisms of Thrombus Growth and Embolization on Carotid Atherosclerotic Plaques (1989) (2)
Impact of diastolic wall stress on the diagnostic value of visually interpreted dobutamine stress MR imaging. (2014) (2)
Pre-Publication in Medical Research: A Race to Open Pandora's Box? (2016) (2)
Magnetic Resonance Imaging of the Atherosclerotic Mouse Aorta. (2015) (2)
Fifty years of experience with antithrombotic therapy in cardiac disease. A 1996 approach based on pathogenesis and risk. (1996) (2)
Contemporary Reviews in Cardiovascular Medicine Cholesterol Efflux and Atheroprotection Advancing the Concept of Reverse Cholesterol Transport (2012) (2)
[Cardiovascular disease and chronic kidney disease: from treatment to promoting health]. (2009) (2)
Platelet Thrombus Formation (2005) (2)
Abstract 16764: A Human-Centered Design Approach to Develop a Microfinance and Group Medical Visit Model for Cardiovascular Risk Reduction in Western Kenya (BIGPIC Study) (2017) (2)
Abstract 9601: A Statin-Loaded Nanotherapy Increases Anti-Inflammatory Effects of Statin on Atherosclerosis (2011) (2)
Pathogenesis of Atherosclerosis (2006) (2)
Molecular imaging for the diagnosis of high-risk plaque. (2003) (2)
Unlikely Allies: Partnering With the Food Industry to Fight the Obesity Epidemic. (2016) (2)
THE SGLT2 INHIBITOR EMPAGLIFLOZIN CAUSES A GREATER REDUCTION IN SKIN SODIUM CONTENT AND INTERSTITIAL VOLUME THAN LOOP DIURETICS IN HEART FAILURE (2020) (2)
One-year clinical outcome of early administration of intravenous beta-blockers in patients with ST-segment elevation myocardial infarction before primary percutaneous coronary reperfusion. (2018) (2)
WITHDRAWN: Global burden of CVD: Focus on secondary prevention of cardiovascular disease (2016) (2)
TERMINAL QRS DISTORTION IS AN INDEPENDENT PREDICTOR OF LARGE AREA AT RISK AND INFARCT SIZE IN PATIENTS WITH ANTERIOR STEMI (2015) (2)
Remote Ischemic Preconditioning Ameliorates Anthracycline-induced Cardiotoxicity and Preserves Mitochondrial Integrity (2020) (2)
The challenge of sustainability: long-term results from the Fifty-Fifty peer group-based intervention in cardiovascular risk factors. (2021) (2)
Risk profiling patients for selective use of drug-eluting stents is warranted (2007) (2)
Antithrombotic therapy for coronary artery disease and valvular heart disease. (1990) (2)
Cultural Third World War: How Economic Disparity Adversely Affects Health. (2016) (2)
Urgent Need for an Intersectoral Approach (2011) (2)
Systemic Thromboemboli In Mitral Starr-Edwards Prosthesis: A Long-Term Followup (10-19 Years) (1981) (2)
Abstract 18200: Intracoronary Delivery of Bioabsorbable Alginate Matrix (IK-5001) Ameliorates Adverse Post-infarction Left Ventricular Remodeling and Improves Left Ventricular Function in a Porcine Model of Reperfused Myocardial Infarction (2015) (2)
[Oral antithrombins and the future of antithrombotic therapy]. (2004) (2)
Imaging is Everything: What The Clinician Needs To Know (2007) (2)
PO9-259 ATHEROSCLEROTIC NEOVASCULARIZATION IN DIABETES MELLITUS IS RELATED TO PLAQUE INFLAMMATION EXPRESSED AS INCREASED MACROPHAGE AND T-CELL LYMPHOCYTE INFILTRATION (2007) (2)
Preparing the university community to respond to 21st century global public health needs. (2011) (2)
Hurst's the Heart. 2Volume SET 13th Edition (2011) (2)
A framework for action to promote cardiovascular health in the developing world. (2011) (2)
Centres of excellence: a Spanish cardiovascular research initiative. Interview by Jennifer Taylor. (2007) (2)
INFECTIVE ENDOCARDITIS : NEW PERSPECTIVES ON AN OLD DISEASE (1998) (2)
A Devotion to Never Feeling Satisfied: New JACC Content Avenues. (2017) (2)
PS015 Hypertension Related Skills Retention Among Community Health Workers in Rural Western Kenya: Process Evaluation of the Lark Hypertension Study (2016) (2)
Fulminant Myocarditis Following SARS-CoV-2 Infection (2022) (2)
Does dipyridamole plus aspirin affect aortocoronary vein graft narrowing over the 1st postoperative year (1984) (2)
Abstract of papers to be Presented at the 29th Annual Scientific Session of the American College of Cardiology Houston, Texas, March 9 to 13, 1980Preoperative M-mode echocardiography as a predictor of surgical results in chronic mitral insufficiency (1980) (2)
JACC Moving On: Maintaining Vision While Implementing Change. (2018) (2)
Hypercoagulable states and cardiovascular disease (1996) (2)
Highlight dementia risk to reduce CVD (2010) (2)
PHYSIOLOGIC IMPACT OF CHRONIC KIDNEY DISEASE ON WHOLE BLOOD CLOT KINETICS AND STRENGTH (2012) (2)
What Makes General Cardiovascular Education Courses Successful? (2016) (2)
Anticoagulant and Antiplatelet Therapy in Acute Coronary Syndromes and Atrial Fibrillation (1993) (2)
Prologue: Relevance of molecular imaging in clinical medicine (2008) (2)
The year in atherothrombosis. (2012) (2)
INCREASED EXPRESSION OF OXIDATION-SPECIFIC EPITOPES AND APOPTOSIS ARE HAPTOGLOBIN GENOTYPE DEPENDENT: IMPLICATIONS FOR PLAQUE PROGRESSION IN HUMAN ATHEROSCLEROSIS (2011) (2)
[Pulmonary hypertension: new insights from techniques imaging]. (2007) (2)
Polyphenols in Urine and Cardiovascular Risk Factors: A Cross-Sectional Analysis Reveals Gender Differences in Spanish Adolescents from the SI! Program (2020) (2)
GLOBAL PLAQUE BURDEN BY CAROTID AND FEMORAL 3D VASCULAR ULTRASOUND: THE PESA (PROGRESSION AND EARLY DETECTION OF SUBCLINICAL ATHEROSCLEROSIS) STUDY (2017) (2)
1007-173 Tissue factor pathway inhibition, a new antithrombotic strategy: Phase-II study of a novel, oral factor Xa inhibitor (2004) (2)
Histopathology and pathogenesis of plaque instability and thrombus formation. (1999) (2)
Fluid Dynamics, The Factor VIII/vWF Complex, and Thrombosis on Vessel Walls (1987) (1)
Child Health Promotion in UnderservedCommunities (2019) (1)
Antibiotics for Myocardial Infarction? (1999) (1)
MITRAL VALVE CHORDAL RUPTURE IS ASSOCIATED WITH ALTERED ELASTIC FIBRIL ARCHITECTURE AND DIMINISHED ELASTIN DENSITY IN FIBRO ELASTIC DEFICIENCY: IMPLICATIONS IN LEAFLET STABILITY (2013) (1)
Abstract 11: Comparison of Patient Reported Angina with Provider Assigned Canadian Cardiovascular Society Angina Class Before and After Revascularization (2016) (1)
Reply: Relevance of Indications for CABG in Evaluating the Effect of Dual Antiplatelet Therapy. (2017) (1)
The role of platelet glycoprotein IIb/IIIa antagonists in percutaneous coronary revascularization procedures. (1999) (1)
Abstract 16977: Estimating the Health Workforce Requirements for Hypertension Management in Rural Western Kenya (2015) (1)
Effect of High-Density Lipoproteins on Experimental Atherosclerosis (1987) (1)
Calci ﬁ ed Plaques in Patients With Acute Coronary Syndromes (1)
Erratum: Dietary Patterns and Cardiovascular Risk Factors in Spanish Adolescents: A Cross-Sectional Analysis of the SI! Program for Health Promotion in Secondary Schools; Nutrients 2019, 11, 2297 (2019) (1)
Anticoagulants and platelet inhibitors (1990) (1)
Who Truly Benefits From Pre-Publishing and Rushing Publishing?: Not Patients, Nor Clinicians. (2017) (1)
PRE-REPERFUSION METOPROLOL ADMINISTRATION DIMINISHES CMR-QUANTIFIED MICROVASCULAR OBSTRUCTION IN STEMI PATIENTS UNDERGOING PCI. ROLE OF NEUTROPHIL-PLATELET COAGGREGATES INHIBITION (2014) (1)
Panel conference. Antithrombotic therapy of artificial organs. (1981) (1)
PPAR γ-agonist induces regression of atherosclerotic plaques: invivo study by high resolution magnetic resonance imaging (2002) (1)
A Pig White Matter Atlas and Common Connectivity Space Provide a Roadmap for the Introduction of a New Animal Model in Translational Neuroscience (2020) (1)
ACC/AHA PRACTICE GUIDELINES ACC/AHA Guidelines for Percutaneous Coronary Intervention (Revision of the 1993 PTCA Guidelines)—Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1993 Guidelines for Perc (2016) (1)
Current issues of heart failure (1999) (1)
38. Anticoagulation in the Treatment of Pulmonary Hypertension (1990) (1)
MODIFIED DUKE SCORE BY CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY IS ASSOCIATED WITH ABNORMAL CHOLESTEROL MORE THAN CORONARY CALCIUM SCORE ALONE (2012) (1)
Prevention: Saving lives: the importance of having Resolve (2018) (1)
CALCIFIED PLAQUES IN PATIENTS WITH ACUTE CORONARY SYNDROMES (2019) (1)
Leaders in Cardiovascular Research: Valentin Fuster. (2020) (1)
The year in atherothrombosis. (2011) (1)
Sophisticated technology is not a substitute for cognitive cardiology (2007) (1)
Lipoprotein metabolism and vascular biology. (2007) (1)
Idiopathic pulmonary hypertension: The importance of a thromboembolic etiology (1982) (1)
Platelet Survival Half-Life in Coronary Disease Patients under and over age 50 (1979) (1)
Abstract 18635: Development of a Swine Model of Chronic Postcapillary Pulmonary Hypertension: Long Term Characterization by Cardiac Catheterization, Magnetic Resonance and Pathology (2013) (1)
Richard Gorlin, MD (1998) (1)
Abstract 1477: In Vitro and In Vivo Evidence for Hypoxia Inducible Factor 1-alpha Expression In Macrophages as Link between Vascular Inflammation and Angiogenesis (2006) (1)
Cardiogenic Shock and Mitral Valve Chord Rupture (2020) (1)
Enhanced Diagnosis of Plaque Erosion by Deep Learning in Patients With Acute Coronary Syndromes. (2022) (1)
1018-150 16-slice multidetector-row computed tomography and magnetic resonance imaging for the in vivo and noninvasive assessment of vessel areas and diameters (2004) (1)
Restenosis after Coronary Angioplasty (1996) (1)
Opening the Pig to Comparative Neuroimaging: A Common Space Approach Contextualizes the Pig and Human Structural Connectome (2022) (1)
The role of pharmacotherapy in secondary prevention of myocardial infarction and death. (1984) (1)
Myocardial Infarction During Antithrombotic Therapy (1993) (1)
LEFT VENTRICULAR GLOBAL CIRCUMFERENTIAL AND LONGITUDINAL STRAIN WITH FEATURE TRACKING CARDIOVASCULAR MAGNETIC RESONANCE ASSESSMENT AFTER ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION: PROGNOSTIC IMPLICATIONS (2018) (1)
A tribute to Attilio Maseri. (2021) (1)
Coronary plaque composition, macrophage infiltration and tissue factor content in patients with diabetes mellitus (1998) (1)
Abstract 19308: Metoprolol Protects Against AMI Through the Inhibition of Psgl1-Dependent Neutrophil-platelet Interactions (2015) (1)
JACC: Cardiovascular Imaging 2.0: The Next Decade in Digital. (2018) (1)
/sup 111/In-platelet survival kinetics: Tropolone vs oxine method (1985) (1)
New understanding, diagnosis, and prognosis of atherothrombosis and the prognosis role of imaging and the (2003) (1)
IMPACT OF CARDIOPROTECTIVE THERAPIES ON MYOCARDIAL EDEMA AFTER ISCHEMIA/REPERFUSION (2016) (1)
Further Investigating JACC's Vision of Simplicity: Understanding the Meaning Behind the Central Illustration. (2015) (1)
The AHA guidelines and statements handbook (2009) (1)
Lessons learned from reduced acute cardiovascular events and STEMI during Covid‐19 (2020) (1)
Hematological and vascular concepts in relation to stroke. (1976) (1)
Cardiovascular Research Center at Icahn School of Medicine at Mount Sinai Translational Mission. (2017) (1)
Abstract P271: Sedentary Behavior and Cardiovascular Disease Risk in a Middle-income Country: The Grenada Heart Project (2012) (1)
Update in Cardiology (2010) (1)
Editor-in-Chief's Top Picks From 2015: Part Two. (2016) (1)
T1 MAPPING ASSESSES DIAGNOSIS, SEVERITY AND PROGNOSIS IN ACUTE MYOCARDITIS (2017) (1)
Abstract 17274: Increased Fibroblast Activation Protein and Matrix Metalloproteinase- 9 Expression are Associated With Altered Extra-Cellular Matrix Changes in Barlow’s Disease Compared to Fibro Elastic Deficiency in Mitral Valve Degenerative Disease - Implication in Disease Progression (2014) (1)
Correction to: Human-centered design as a guide to intervention planning for non-communicable diseases: the BIGPIC study from Western Kenya (2020) (1)
Thrombosis, antithrombotic therapy and sudden death (1991) (1)
Contemporary Reviews in Cardiovascular Medicine Aspirin A Historical and Contemporary Therapeutic Overview (2011) (1)
Abstract 16566: T1 Mapping Calculated from Look-Locker Sequences Reliably Assesses Interstitial Myocardial Fibrosis Compared with Histology, and Diastolic Dysfunction (2012) (1)
Diabetic multivessel disease: stenting vs. coronary artery bypass grafting. (2007) (1)
Truncus arteriosus with pulmonary vascular obstructive disease — Medical vs surgical management (1980) (1)
THE SGLT2 INHIBITOR EMPAGLIFLOZIN IMPROVES DIASTOLIC FUNCTION IN A HEART FAILURE MODEL MEDIATED VIA ENHANCED MYOCARDIAL KETONE METABOLISM (2019) (1)
Abstract 17367: Infusion of the Ketone Body β-Hydroxybutyrate Improves Left Ventricular Systolic Function in an Animal Model of Heart Failure With Reduced Ejection Fraction (2018) (1)
Abstract 19550: Incidence, Correlates and Impact of Acute Kidney Injury in Diabetic Patients With Multivessel Disease Undergoing Coronary Revascularization: Results From the FREEDOM Trial (2016) (1)
Early luminal deterioration after successful coronary balloon angioplasty: Insights into the mechanisms from coronary tissue analysis (1996) (1)
Spontaneous echo contrast videodensity is dependent on the relative concentrations of fibrinogen and red blood cells (1996) (1)
Rapamycin (sirolimus) reduces luminal narrowing after balloon angioplasty in porcine coronary arteries (1996) (1)
Thrombin inhibitors in acute coronary artery disease. (2002) (1)
Lipid lowering: education is key (2009) (1)
Antithrombotic therapy in acute myocardial infarction (1991) (1)
ASSESSING THE IMPACT OF MEDICATION ADHERENCE ON LONG-TERM OUTCOMES IN PATIENTS WITH DIABETES (2015) (1)
Research Diagnosing and managing unstable angina. Agency for Health Care Policy and (2011) (1)
CHARACTERIZATION BY MULTIMODALITY IMAGING OF A LARGE ANIMAL MODEL OF ISCHEMIC DILATED CARDIOMYOPATHY WITH TRANSLATIONAL IMPLICATIONS (2019) (1)
APICAL HYPOKINESIS IS A SENSITIVE MARKER OF EARLY RIGHT VENTRICULAR DYSFUNCTION IN PULMONARY HYPERTENSION. (2010) (1)
Assessment of cardiac amyloidosis by using 18f-sodium fluoride PET/MR imaging (2017) (1)
Little Beacons of Change: Targeting Preschool Children to Drive a Culture of Health. (2016) (1)
The Evolving Future of Cardiovascular Practice: Technology + Clinicians: A Means to a Better End. (2015) (1)
The critical need to share our successes. (2014) (1)
INCREASED ANGIOTENSIN CONVERTING ENZYME IS ASSOCIATED WITH INCREASED INFLAMMATION AND NEOVASCULARIZATION IN PERIPHERAL VASCULAR DISEASE: MECHANISTIC ROLE OF ANGIOTENSIN II TYPE I RECEPTOR, INTERLEUKIN-6, AND TUMOR NECROSIS FACTOR ALPHA IN DIABETIC ATHEROSCLEROSIS (2010) (1)
The role of fibrates in chronic kidney disease and diabetes mellitus (2013) (1)
Clinical problems relevant to sudden death: Discussion (1985) (1)
World Bank Income Classifications July 2009 (2010) (1)
Abstract 14043: A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis (2013) (1)
Cardiac Effects of Nerve Growth Factor in Dogs (1982) (1)
low shear rate; the importance of perfusion conditions Role of von Willebrand factor in mediating platelet-vessel wall interaction at (2011) (1)
ACUTE THROMBOSIS IN STENOTIC AREAS: IMPORTANCE OF THE VASCULAR MATRIX EXPOSED TO BLOOD (1987) (1)
Oral anticoagulants: A plausible new treatment for Alzheimer's disease? (2023) (1)
Membranous Septal Aneurysm Causing Right Ventricular Outflow Tract Obstruction (2009) (1)
The year in atherothrombosis. (2009) (1)
JACC: Basic to Translational Science: Adding the Arc of Discovery to the JACC Family. (2017) (1)
Thrombosis and antithrombotic therapy in cardiovascular disease (1991) (1)
[Therapeutic approach to the epidemic of atrial fibrillation]. (2002) (1)
Lifetime Risk of Pulmonary Hypertension for All Patients After Shunt Closure (1)
[Visualizing arterial macrophage warfare with nuclear magnetic resonance, positron-emission tomography and computerized tomography]. (2009) (1)
High-Risk Pulmonary Embolism During Labor: JACC Patient Care Pathways. (2023) (1)
New Cardiovascular Training Track: Reinventing the Wheel? (1998) (1)
[Inoperable valve disease: should percutaneous valve replacement be an option?]. (2006) (1)
5020Prognostic value of left ventricular global circumferential and longitudinal strain with feature tracking cardiovascular magnetic resonance after ST-segment elevation myocardial infarction (2018) (1)
Reply: early intravenous beta-blockade before primary percutaneous coronary intervention gives major benefits apparently without side effects. (2014) (1)
DUAL ANTI-PLATELET THERAPY IS NOT SUPERIOR TO ASPIRIN ALONE AFTER CORONARY ARTERY BYPASS IN DIABETIC PATIENTS WITH MULTI-VESSEL DISEASE: INSIGHTS FROM THE FREEDOM TRIAL (2016) (1)
MILD RHEUMATIC VALVULAR HEART DISEASE IS ASSOCIATED WITH INTERSTITIAL MYOCARDIAL FIBROSIS: A T1 MAPPING STUDY (2017) (1)
Confronting the Tower of Babel in guideline development: can we unify the process? (2014) (1)
[Chronic multivessel disease: past, present and future]. (2008) (1)
Coronary thrombolysis. (1995) (1)
Survival Time and Organ Distribution of 111In-Oxine-Labelled Human Platelets in Normal Subjects (1984) (1)
Fibrillation : ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial (2012) (1)
Revisiting morphological features of cardiac amyloid with cardiac magnetic resonance (2013) (1)
Dynamic sustainability, a look at the philosophy behind one of Spain's flagship cardiovascular institutes, the CNIC. (2021) (1)
EFFECT OF EARLY INTRAVENOUS METOPROLOL ADMINISTRATION ON ISCHEMIA SEVERITY DURING ONGOING MYOCARDIAL INFARCTION: INSIGHTS FROM AN ELECTROCARDIOGRAPHY ANALYSIS (2018) (1)
Doubts about ventricular reconstruction (2009) (1)
Abstract 18503: Barriers to Linkage to Hypertension Care in Rural Western Kenya: A Qualitative Analysis (2013) (1)
Can adults at high-risk of cardiovascular disease be identified by screening their children for risk factors? (2007) (1)
Have the Government's prescription algorithm and the 2013 American College of Cardiology/American Heart Association guidelines for managing dyslipidemia influenced the management of dyslipidemia? The MEJORALO-CV Project (2020) (1)
Abstract 16831: Identifying Barriers to Hypertension Care: Development and Validation of a Behavioral Assessment Tool for Optimizing Linkage and Retention to Hypertension Care in Kenya (LARK Hypertension Study) (2015) (1)
Making Choices to Reduce the Burden of Cardiovascular Disease (2010) (1)
The recent trials for aspirin in the prevention of cardiovascular mortality (1989) (1)
Passive smoking and coronary heart disease. (1999) (1)
Severely Damaged Vessel Wall in Arterial Thrombosis (2005) (1)
ArticlesAspirin and Other Platelet Active Drugs: Relationship Among Dose, Effectiveness, and Side Effects (1989) (1)
JACC: Case Reports (2019) (1)
GENETIC RISK, ADHERENCE TO A HEALTHY LIFESTYLE, AND RISK OF CORONARY ARTERY DISEASE (2017) (1)
Halperin and Fuster Patent Foramen Ovale and Recurrent Stroke 2581 (2002) (1)
P567Early diagnosis of anthracycline induced cardiotoxicity in a swine model by serial multiparametric cardiac magnetic resonance (2017) (1)
Unstable angina: aspirin and anticoagulant use (1989) (1)
Abstract 20356: Comparison of CABG versus PCI Outcomes in Diabetic, Mutivessel Coronary Artery Disease Patients With and Without Acute Coronary Syndromes (2014) (1)
Abstract 17034: The Novel Extracellular Matrix Protein Podocan Shows a Distinct Expression Pattern in Human Primary versus Restenotic Atherosclerotic Coronary Lesions and its Lack of Extra-Cellular Expression in Restenotic Tissue is Associated with Increased Wnt-Pathway Activation (2011) (1)
RISK FACTORS FOR PROGRESSION OF MITRAL ANNULUS CALCIFICATION: THE MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS (2012) (1)
Revascularization strategies in patients with diabetes. (2013) (1)
Warfarin Therapy American Heart Association/American College of Cardiology Foundation Guide to (2013) (1)
Usefulness of combined FDG-PET/MR to diagnose active cardiac sarcoidosis. (2016) (1)
Aortic valve disease--etiology and the role of vascular pathology: is the face of the disease changing? (2002) (1)
Among Patients Treated With Clopidogrel Predominantly for PCI : A Meta-analysis Genotype and Risk of Adverse Clinical OutcomesCYP 2 C 19 Reduced-Function (2010) (1)
Avoiding the Curse of the "Sorcerer's Apprentice": How to Attract and Develop Successful Academicians. (2015) (1)
Abstract 20242: Right Ventricular Mechanics in Pulmonary Hypertension Evaluated With Cardiac Magnetic Resonance Feature Tracking (2014) (1)
A meta-analysis of risks versus benefit of oral anticoagulation on top of aspirin following unstable angina or myocardial infarction (2002) (1)
Left Ventricular Function During Combined Isometric and Dynamic Exercise-Induced ST Depression in Coronary Artery Disease (2000) (1)
THE SI! PROGRAM FOR PROMOTING HEART-HEALTHY HABITS IN CHILDREN AGED 3 TO 5 YEARS: PEDAGOGICAL STRATEGIES (2020) (1)
797-4 Comparative Effects of Heparin, Aspirin, and Hirudin on Thrombus Growth on Fresh Mural Thrombus: Deaggregation of Mural Thrombus by Specific Thrombin Inhibition (1995) (1)
1082-186 Reduced inflammation and neovascularization and increased fibrous cap thickness in advanced aortic atherosclerotic plaques from cigarette smokers (2004) (1)
[Advances in the diagnosis of arterial disease by magnetic resonance imaging]. (2001) (1)
Invited letter concerning: anticoagulant plus platelet inhibitor therapy in patients with mechanical valve prostheses. (1991) (1)
Postoperative follow-up of the cardiac surgical patient. (1980) (1)
The need for coronary surgery in 1993 (1993) (1)
Current issues of lipid-lowering and antithrombotic therapy (1999) (1)
Abstract 20673: Evaluation of an Intervention to Promote Healthy Heart Habits in Preschool Children: A Cluster Randomized Trial (2010) (1)
Intra-scar perfusion heterogeneity by cardiac magnetic resonance in a porcine model of non-reperfused myocardial infarction. (2014) (1)
Studies on Platelet Factor 4 Like Activity in Atherosclerosis Susceptible and Resistant Pigeons (1975) (1)
Beta-3 adrenergic receptor overexpression reverses aortic stenosis–induced heart failure and restores balanced mitochondrial dynamics (2022) (1)
The complementary roles of dynamic contrast-enhanced MRI and [supersript 18]F-fluorodeoxyglucose PET/CT for imaging of carotid atherosclerosis (2013) (1)
An ounce of prevention (2009) (1)
Abstract 17984: Validating the Gold-standard: Steady-State Free Precession Sequence for Assessment of Left Ventricular and Right Ventricular Mass (2014) (1)
Are there any differences in histopathology of coronary artery disease in diabetics (1996) (1)
Platelet-Mediated Thrombosis (2005) (1)
Neovascularization and Intra-plaque Hemorrhage: Role of Haptoglobin, Macrophages, and Heme-Oxygenase-1 Pathway (2010) (1)
Proceedings: Resistance to the development of spontaneous atherosclerosis in pigs with von Willebrand's disease. (1975) (1)
One year follow up in aortic and carotid FDG-PET/CT imaging of atherosclerotic plaque inflammation (2008) (1)
Fenofibrate induces plaque regression in hypercholesterolemic atherosclerotic rabbits: In vivo demonstration by high-resolution magnetic resource imaging (2003) (0)
A PEER-GROUP-BASED INTERVENTION ON CARDIOVASCULAR RISK FACTORS AND THE IMPACT ON QUALITY OF LIFE: THE FIFTY-FIFTY TRIAL (2016) (0)
Abstract 1916: Atherosclerosis Inflammation Imaging With FDG-PET/CT is Highly Reproducibile in Carotid, Iliac and Femoral Arteries (2007) (0)
INFLAMMATION IN ARTERIAL VESSELS AND DIFFERENT FAT TISSUES AS PROSPECTIVELY ASSESSED BY 18F-FDG-PET/CT ARE HIGHLY CORRELATED (2013) (0)
Preliminary studies on the protamine sulphate precipitation of plasma and serum. (1971) (0)
2 Economic Costs Associated with Atrial Fibrillation (2008) (0)
High-Risk Vulnerable Plaques (2012) (0)
Abstract 19487: Simvastatin Loaded High-Density Lipoprotein Nanoparticles Reduce Inflammation in Atherosclerotic Plaques by Directly Acting on Plaque Macrophages and Inflammatory Monocytes (2012) (0)
Reply: Medication Adherence and Cardiovascular Outcomes. (2017) (0)
Myocardial Viability and Low Left Ventricular Ejection Fraction Assessed Via Cardiac MRI: Impact on Survival in Ischemic Dilated Cardiomyopathy (2013) (0)
Abstract 18577: Evaluation of Right Ventricular Function using Cardiac Computed Tomography in Patients with Left Ventricular Assist Devices (2010) (0)
Polypill in cardiovascular disease prevention: recent advances. (2023) (0)
GENOTYPE-DEPENDENT IMPAIRMENT OF HEMOGLOBIN CLEARANCE INCREASES OXIDATIVE STRESS AND INFLAMMATION LEADING TO ACCELERATED NEOVASCULARIZATION IN HUMAN DIABETIC ATHEROSCLEROSIS (2011) (0)
Determinants of the Global CVD Epidemic and Barriers to the Control of Global CVD (2011) (0)
Abstract 15914: Sex Differences in Poverty, Health Care Utilization, and Health Care Costs Among Hypertensive Individuals in Western Kenya: LARK Hypertension Study (2016) (0)
Reply: Asymptomatic cardiovascular risk assessment: the road less traveled. (2015) (0)
Platelets in Thrombotic and Non-thrombotic Disorders: Pathophysiology of arterial thrombosis (2002) (0)
Atherosclerotic plaque inflammation in one arterial territory is highly correlated with inflammation elsewhere - An FDG-PET atherosclerosis imaging study (2007) (0)
HISTOLOGICAL VALIDATION OF MYOCARDIAL AMYLOID QUANTIFICATION WITH CARDIAC MAGNETIC RESONANCE T1 MAPPING (2014) (0)
Abstract 701: New {alpha} Index Improves Detection of the Pulmonary Hypertension With Magnetic Resonance Imaging (2009) (0)
In Memoriam: James T. Willerson, 1939 to 2020. (2020) (0)
Significant benefit of perioperative dipyridamole plus aspirin therapy for early postoperative aortocoronary vein graft patency (1982) (0)
Abstract 4334: Coordinated Apoptosis and Tissue-Factor Expression in Human Coronary Atheroma After Percutaneous Coronary Intervention: Evidence for Role of Apoptosis in Determining Arterial Wall Thrombogenicity (2009) (0)
P5586Metoprolol administration after coronary occlusion increase myocardial tolerance to ischemia/reperfusion injury (2018) (0)
Beneficial effects of statin therapy in the atherosclerotic human aorta are related to plaque location (2003) (0)
Macrophage-Specific Lipid-Based Nanoparticles Improve MRI Detection and Characterization of Human Atherosclerosis (2009) (0)
TCT-726 Early intravenous beta-blockers in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction A patient-pooled meta-analysis of randomised clinical trials (2018) (0)
T1 MAPPING AFTER ACUTE MYOCARDIAL INFARCTION: MULTIPHASE PHASE-SENSITIVE INVERSION- RECOVERY (MPPSIR) METHOD AS VALUABLE ALTERNATIVE TO THE MODIFIED LOOK-LOCKER INVERSION RECOVERY (MOLLI) METHOD (2012) (0)
Inhibitory effects of rapamycin on intimal hyperplasia after PTCA in the porcine coronary model: a 3-month follow-up (1998) (0)
Podium Presentations 1 A REDUCTION IN EJECTION FRACTION DURING STRESS WITHIN THE NORMAL RANGE WITH GATED SPECT IMAGING IS NOT ASSOCIATED WITH INCREASED MORTALITY (2010) (0)
Cardioprotective Effect of Empagliflozin and Circulating Ketone Bodies During Acute Myocardial Infarction (2023) (0)
Editor-in-Chief's Top Picks From 2015: Part One. (2016) (0)
The contribution of amyloid deposition in the aortic valve to calcification and aortic stenosis (2023) (0)
A polypill strategy for global secondary cardiovascular prevention : a worldwide reality (2015) (0)
Community Health Workers Improve Linkage to Hypertension Care in WesternKenya (2019) (0)
Abstract 18634: Serial Changes in Right Ventricular Geometry and Function in Patients After Left Ventricular Assist Device Implantation (2010) (0)
Abstract 1190: The Complement Component C5a is Present in Human Unstable Coronary Lesions in Vivo and Induces the Expression of MMP-9 in Human Macrophages via Nf-kappaB Activation In Vitro (2007) (0)
O182 Availability, use, and barriers to cardiac rehabilitation in low- and middle-income countries: A systematic review (2014) (0)
Heart Failure and Cardiomyopathies (2014) (0)
HIGH AND VERY HIGH DENSITY LIPOPROTEINS ADMINISTRATION INHIBITS PROGRESSION OF EXPERIMENTAL ATHEROSCLEROSIS IN THE RABBIT (1987) (0)
VALIDATION OF FAST T2-GRASE MAPPING OF THE HEART: MAGNETIC RESONANCE AND HISTOLOGICAL STUDY IN A PIG MODEL OF ISCHEMIA/REPERFUSION (2015) (0)
Thrombi Growth Inhibition 2433 Baseline Fresh thrombus : labeled blood _ I ' pruin pg 8 Fresh thrombus : unlabeled blood (2005) (0)
Conjunctive therapy to reduce the occurrence of coronary reocclusion after thrombolytic treatment of AMI (2001) (0)
Rapid Change in Plaque Size, Composition, and Molecular Footprint After Recombinant Apolipoprotein A-IMilano (ETC-216) Administration (2008) (0)
Social determinants of lifestyle and cardiovascular health in a minority community study for promotion of health (2018) (0)
PROTEOMIC TIME COURSE IN EARLY REMODELING AFTER MYOCARDIAL ISCHEMIA/REPERFUSION (2016) (0)
Reprint of: Cardiovascular Health Promotion: An Issue That Can No Longer Wait. (2018) (0)
Abstract 297: Haptoglobin Genotype is a Determinant of Oxidation and Inflammation in the Atherosclerotic Plaque (2006) (0)
Understanding atherothrombosis: from vulnerable plaque to vulnerable patient (2004) (0)
COARCTATION OF THE AORTA IN INFANTS. COMMENT. AUTHORS' REPLY (1990) (0)
Policomprimido: ? o realidad? (2016) (0)
Aspirin Resistance and Atherothrombotic Disease (2006) (0)
Abstract 11314: Inverse Relationship Between Body Mass Index and Coronary Artery Calcification in Older Patients with Clinically Significant Coronary Lesions (2011) (0)
Platelet Deposition In Extracardiac Conduits In Humans: A Noninvasive Quantification (1981) (0)
THE ACTIVATION OF SPHINGOSINE-1-PHOSPHATE RECEPTOR BY FINGOLIMOD DURING MYOCARDIAL INFARCTION IMPROVES DIASTOLIC FUNCTION IN PIGS (2014) (0)
Inhibition ofGrowthofThrombus on FreshMuralThrombus Targeting Optimal Therapy (1994) (0)
Magnetic Resonance Imaging in Pulmonary Arterial Hypertension (2006) (0)
Elucidating the role of plaque rupture in acute coronary events (1994) (0)
Abstract 19025: A Novel 3D Approach to Screen for Subclinical Atherosclerosis Using Carotid Ultrasound - Results of the BioImage High Risk Plaque Study (2010) (0)
Ischaemic conditioning for myocardial salvage after AMI (2010) (0)
DIAGNOSTIC ACCURACY OF MYOCARDIAL T1 MAPPING IN CARDIAC AMYLOIDOSIS (2013) (0)
RELATIONSHIPS BETWEEN LEFT VENTRICULAR MASS AND AORTIC VALVE CALCIFICATION: THE MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS (2010) (0)
Acute Coronary Syndromes (2014) (0)
Abstract 19765: Barriers to Implementation of a Health Promotion Program in Harlem, New York: The FAMILIA Study, an AHA Strategically Focused Research Network Study (2015) (0)
Magnetic resonance imaging of a bioprosthetic mitral valve: a smiling heart. (2007) (0)
Valentin Fuster and Jason C Kovacic Acute Coronary Syndromes : Pathology , Diagnosis , Genetics , Prevention and Treatment (2014) (0)
Magnetic Resonance Angiography and Evaluation of Vulnerable Plaque (2007) (0)
Increased neovascularization of thrombus in aneurysm sacs of retrograde collateral (type II) endoleaks: Implications for management (2006) (0)
Abstract 572: Non-invasive Multimodality Assessment of Vascular Effects of the PPAR-gamma Agonist-Pioglitazone (2009) (0)
THE SPHINGOSINE-1-PHOSPHATE RECEPTOR AGONIST FINGOLIMOD REDUCES ISCHEMIA-REPERFUSION INJURY BY DECREASING CARDIOMYOCYTE APOPTOSIS MEDIATED BY ACTIVATION OF THE RISK PATHWAY (2015) (0)
[Coronary arteriosclerotic disease: pathogenesis and antithrombosis treatment]. (1987) (0)
Contemporary Reviews in Cardiovascular Medicine Acute Coronary Events (2012) (0)
Comprar Hurst's the Heart Manual of Cardiology | Robert ORourke | 9780071592987 | Mcgraw-Hill Education (2009) (0)
, Claudia and VEGF Signaling α HIF-1 Alternatively Spliced Tissue Factor Promotes Plaque Angiogenesis Through the Activation of (2014) (0)
pulmonary hypertension . transplantation as treatments for severe Prostacyclin ( epoprostenol ) and heart-lung (0)
Arterial t hrombosis: a b rief o verview (2013) (0)
Quantitation of left ventricular myocardial fiber hypertrophy and interstitial tissue following mitral valve replacement for mitral incompetence (1976) (0)
The symptomatic patient with Ebstein's anomaly of the tricuspid valve: Beneficial effect of plastic repair (1982) (0)
In Memoriam Tribute to Robert A. O'Rourke, MD (1936–2011) (2011) (0)
Heparin enhances thrombolysis with rt-PA (1991) (0)
Abstract of the 15th annual inter ASC-ASCTS meetingMR imaging of coronary artery atherosclerosis in a porcine model (2000) (0)
In Vivo Detection of Platelet Deposition in Coronary Artery Bypass Grafts in Dogs and Its Prevention with Platelet-Inhibitors (1979) (0)
Abstract 18354: Cardiac Magnetic Resonance Allows Noninvasive and Accurate Monitoring of Serial Changes in Pulmonary Vascular Resistance and the Acute Vasodilator Response in Chronic Pulmonary Hypertension (2012) (0)
Differences between MRI and external CT derived attenuation corrected PET images obtained on PET/MRI system in presence of metallic artifacts (2012) (0)
Risk factor update: old wine in a new bottle? (2012) (0)
Design of the b 3-Adrenergic Agonist Treatment in Chronic Pulmonary Hypertension Secondary to Heart Failure Trial (0)
Abstract 3035: Decrease Of Aortic Valve Area In A Hypercholesterolemic Rabbit Model Is Reversed By Short-term ApoAI-treatment (2007) (0)
At the funeral service for Dr. Simon Dack, the following remarks were delivered by William D. Nelligan, former Executive Vice President of the College, and by Dr. Valentin Fuster, of the Cardiovascular Institute at Mount Sinai Medical Center (1994) (0)
High Blood Pressure Guidelines: Welcomed Advice, But Let's Not Lose the Patient Amid the Numbers. (2018) (0)
PF664 46/1 HAPLOTYPE IS ASSOCIATED WITH A HIGHER MONOCYTE/LYMPHOCYTE RATIO IN HEALTHY INDIVIDUALS (2019) (0)
Measurement and Evaluation (2010) (0)
TCT-831 Identification of High-Risk Plaques by Coronary Angiography: Confirmation of Computational Fluid Dynamics by Optical Coherence Tomography (2019) (0)
T1 MAPPING BY CMR IN PATIENTS WITH NONISCHEMIC CARDIOMYOPATHY: RELATION TO LEFT VENTRICULAR PERFORMANCE (2013) (0)
In vivo vasoreactivity during neoendothelialization after coronary angioplasty in pigs (1999) (0)
ALTERED CALCIFICATION MEDIATORS OF BONE MORPHOGENETIC PROTEIN–2 AND FETUIN–A PROTEIN EXPRESSION AND MEDIAL ARTERY CALCIFICATION IN PATIENTS WITH PERIPHERAL VASCULAR DISEASE, WITH OR WITHOUT DIABETES MELLITUS AND CHRONIC KIDNEY DISEASE: IMPLICATIONS IN LESION PROGRESSION (2013) (0)
[Science, health and education: a priority and a model]. (2010) (0)
Protecting Peer Review: Revolutionaries in the Fight for Quality and Against Scientific Misconduct. (2020) (0)
Abstract 11903: The FREEDOM Trial: A Snapshot at Randomization (2011) (0)
Results of Expert Meetings: Obesity and Cardiovascular Disease. Introduction: Cardiologists should target obesity. (2001) (0)
Abstract 17184: CMR Derived Myocardial Mechanics in Patients With Systemic Sarcoidosis (2014) (0)
Editor-in-chief's picks from 2014: part two. (2015) (0)
Quantitation of left ventricular interstitial tissue in low cardiac output syndrome following valve replacement for mitral incompetence (1975) (0)
Is There a Role for Antiplatelet and Antithrombotics in Preventing Atherosclerosis (1995) (0)
Hirsh and Fuster Guide to Anticoagulant Therapy : Part 1 TABLE 1 . Antihemostatic Effects of Heparin Effect Comment Binds to (2005) (0)
Valentin Fuster, MD, PhD: a conversation with the editor. Interview by Roberts WC. (2000) (0)
Professor Desmond Julian: The Cardiovascular World Mourns a Giant, I Mourn My Personal Friend and Mentor. (2020) (0)
Managing Anticoagulation in Patients with Mechanical Valves (2014) (0)
855-4 Cardiac magnetic resonance imaging-derived parameters of right ventricular function correlate significantly with hemodynamic data in patients with pulmonary hypertension (2004) (0)
Abstract 19046: The Role of the SYNTAX Score in Predicting Clinical Outcome in Diabetic Patients After Percutaneous Coronary Intervention and Coronary Artery Bypass Graft: A FREEDOM Trial Sub-analysis (2017) (0)
Abstract 2309: Intra-Valve Hemorrhage is Associated with Increased Inflammation, Neovascularization and Calcification in Patients with Severe Aortic Stenosis (2008) (0)
Abstract 18987: Wavefront Progression of Necrosis During Myocardial Infarction Revisited: The Wave Expands From Endo to Epi as Well as From Center to Lateral Borders (2015) (0)
A promising start for Nature Clinical Practice Cardiovascular Medicine (2005) (0)
Ischemic heart disease: Editorial overview (1989) (0)
CD90 MARKS A POPULATION OF ADVENTITIAL MESENCHYMAL STEM CELLS IN THE HUMAN AORTA THAT EXHIBIT DIMINISHED ANGIOGENIC POTENTIAL IN PATIENTS WITH ASCENDING AORTIC ANEURYSMS (2017) (0)
Contents (2020) (0)
HEART DISEASE Procedural Results and Safety of Common Interventional Procedures in Congenital Heart Disease : Initial Report From the National Cardiovascular Data Registry (2015) (0)
22. PRELIMINARY STUDIES ON THE PROTAMINE SULPHATE PRECIPITATION OF PLASMA AND SERUM (2009) (0)
Is a chimera the answer? (2003) (0)
Diabetes: Making sense of the rosiglitazone controversy (2010) (0)
Musculoskeletal Pain and€Cancer Risk of Staff€Working With Fluoroscopically Guided Procedures (2015) (0)
Pandemics and Clinical Practice How History Can Inform Our Future (2020) (0)
Thrombosis on atherosclerotic lesions: Implications for therapy (1994) (0)
Abstract 15277: Caspase Inhibition Reduces Aortic Valve Stenosis in Apolipoprotein E Deficient Mice (2010) (0)
Reply What Happened to Electrocardiogram as a Screening Test to Recognize Cardiovascular Complications in COVID-19 Patients? (2020) (0)
Impact of a comprehensive lifestyle peer-group-based intervention on cardiovascular risk factors: a randomized controlled trial (2015) (0)
Abstract 277: Insights Into The Transcriptional Reprogramming Induced By Beta-3 Adrenergic Cardioprotection (2014) (0)
Can Atherosclerotic Progression and Its Complications Be Prevented After Revascularization ? Overview of the Pathogenesis of Bypass Graft Closure and Post-PTCA Restenosis Saphenous Vein Bypass Graft Disease (2005) (0)
Beta-3 adrenoreceptor stimulation reduces pulmonary vascular resistance in experimental models of acute and chronic pulmonary hypertension in pigs (2013) (0)
Abstract 10383: Comparative Assessment of Medical Therapy, PCI, or CABG on Clinical Outcomes in Diabetic Patients With Stable CAD According to Coronary Angiography and Left Ventricular Function: Patient-level Meta-analysis of the BARI-2D, COURAGE, and FREEDOM Trials (2015) (0)
Wednesday, 29 August 2012 (2012) (0)
DYNAMICS AND LOCALIZATION OF PLATELET DEPOSITION ON A SYNTHETIC VASCULAR GRAFT: CONTINUOUS IMAGING (1987) (0)
A NOVEL MOBILE APPLICATION TO DIAGNOSE AND TRANSFER PATIENTS WITH STEMI IN A LARGE HEALTHCARE SYSTEM: STEMICATHAID (2021) (0)
Marcadores de riesgo negativos para eventos cardiovasculares en ancianos (2020) (0)
50th anniversary historical article. Myocardial infarction and coronary care units. (2000) (0)
LOW DOSE ASPIRIN FOR PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE: USE PATTERNS AND IMPACT ACROSS RACE IN THE SOUTHERN COMMUNITY COHORT STUDY (2018) (0)
Growth of carotid plaques. Reply (1990) (0)
Cardiovascular Thrombosis: Second Edition; Thrombocardiology and Thromboneurology (1999) (0)
Pathophysiology of coronary thrombosis (2011) (0)
Accuracy of magnetic resonance for noninvasive cardiac output quantification in postcapillary pulmonary hypertension (2013) (0)
Glomerular lesions in acute pancreatitis. (1970) (0)
Coronary risk factors update (2012) (0)
A Comprehensive Lifestyle PeerGroup-Based Intervention onCardiovascular Risk Factors (0)
Editor-in-Chief's Top Picks From 2019. (2020) (0)
Contents (2020) (0)
Macrophage hemoglobin scavenger receptor CD163 is functionally linked to heme oxygenase‐1 and ferritin expression in human diabetic atherosclerotic plaques (2010) (0)
Abstract 952: Increased Expression of Oxidative Stress Protein Myeloperoxidase in Diabetes Mellitus Atherosclerosis: Implications in Plaque Vulnerability (2008) (0)
MYOCARDIAL OXYGENATION USING BLOOD LEVEL-OXYGEN DEPENDENT SEQUENCE IN MAGNETIC RESONANCE DETERMINES MYOCARDIAL ENERGETICS AND CAPILLARY DENSITY (2017) (0)
Potential applications of iontophoresis for local drug delivery of vascular diseases. (1995) (0)
[Rapamycin: from the laboratory to the treatment of patients' arteries]. (2003) (0)
Coronary artery bypass grafting (2021) (0)
EFFECT OF SELECTIVE INHIBITION OF PLATELET THROMBOXANE ON PLATELET-VESSEL WALL INTERACTION IN VIVO (2018) (0)
Cardioprotective effect of empagliflozin in acute myocardial infarction: the role of ketone bodies availability (2022) (0)
Blood Group (BG) Prevalence In End-Stage (ES) Renal Disease (RD): Relationship To Ristocetin Willebrand Factor (VIII: RWF) And Platelet Survival (PS) (1981) (0)
Reproducibility of Three-Dimensional Vascular Ultrasound for the Detection and Quantification of Early Atherosclerosis: A FAMILIA Substudy (2018) (0)
Editor-in-Chief's Top Picks From 2018. (2019) (0)
The von Willebrand Pig as a Model for Atherosclerosis Research (1978) (0)
Abstract 19212: Clinical Outcomes More Than 12 Months After PCI in Diabetic Patients With or Without DAPT: Results From the FREEDOM Trial (2016) (0)
Magnetic resonance imaging for the evaluation of coronary artery atherosclerosis (2001) (0)
EFFECT OF SGLT2 INHIBITORS ON LIPID PARAMETERS: A META-ANALYSIS OF 30 RANDOMIZED CLINICAL TRIALS AND 10,246 PATIENTS (2020) (0)
PLATELET INTERACTION WITH ARTIFICIAL SURFACES UNDER DEFINED FLOW CONDITIONS: ROLE OF VON WILLEBRAND FACTOR (1987) (0)
GLUCAGON-LIKE PEPTIDE-1 RECEPTOR ACTIVATION WITH LIRAGLUTIDE DURING MYOCARDIAL ISCHEMIA DECREASES INFARCT SIZE AND IMPROVES SYSTOLIC LEFT VENTRICULAR FUNCTION (2013) (0)
Coronary Atherothrombosis: Pathophysiology and Clinical Implications (1999) (0)
Evaluation of platelet thromboxane radioimmunoassay method to measure platelet life-span: Comparison with /sup 111/indium-platelet method (1985) (0)
Development and Cardiovascular Disease (2010) (0)
Abstract 16938: Serial Phase-Contrast MRI for Prediction of Pulmonary Haemodynamic Changes in Patients with Pulmonary Arterial Hypertension (2010) (0)
1074-158 Optimal reconstruction protocol for noninvasive coronary angiography with 16-slice multidetector-row computed tomography (2004) (0)
A high ratio of arachidonic acid to eicosapentaenoic acid in red blood cells is associated with worse long-term ventricular function after acute myocardial infarction (2015) (0)
SOCIAL NETWORK CHARACTERISTICS OF PATIENTS WITH HYPERTENSION AND DIABETES IN WESTERN KENYA (2018) (0)
FIGURE 2.2, Age-standardized deaths due to cardiovascular disease (rate per 100,000), 2004 (2010) (0)
Which Antithrombotic Therapy Has Proven Most Effective for the Treatment of Deep Arterial Injury, Ruptured Plaque, and Post-thrombolysis? (1989) (0)
Machine Learning to Predict Mortality and Critical Events in a Cohort of Patients With COVID-19 in New York City: Model Development and Validation (Preprint) (2020) (0)
The next step for our journal: original clinical research (2007) (0)
AIL 4 Medical / Scientific Statement Special Report ACC / AHA Guidelines for the Early Management of Patients With Acute Myocardial Infarction (2005) (0)
Optimal Utilization of Magnetic Resonance Imaging (2008) (0)
Abstract 14660: A Nanomedicine-Based Treatment Regimen to Induce Plaque Remodeling to a Favorable Phenotype in Mice With Advanced Atherosclerosis (2013) (0)
Cost of Non-Adherence to Medication in a Post-Mi Population (2015) (0)
Associations of Left Ventricular Hypertrophy with Prevalent and Incident Valve Calcification: The Multi-Ethnic Study of Atherosclerosis (2012) (0)
1140-168 In vivo caspase-inhibition prevents plaque progression by reducing apoptosis and tissue-factor expression in a mouse model of chronic atherosclerosis (2004) (0)
Eligibility and Disquali ﬁ cation Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Preamble, Principles, and General Considerations (2017) (0)
Abstract 15096: Electrocardiographic QRS Amplitude Predicts Mortality in Hospitalized Patients With CoViD-19 (2020) (0)
Clinical Frontiers in Atherosclerosis Research-Therapeutic Targets for the Treatment of Atherothrombosis in the New Millennium (2002) (0)
A First Dilemma in Cardiovascular Medicine (2014) (0)
gOPINION EDITORIAL for Global Progress in Control of Chronic Diseases (2011) (0)
Public Session Agendas (2010) (0)
Challenging inertia by taking risks: a motivating tool for editors, authors, and students. (2015) (0)
MYOCARDIAL INTERSTITIAL FIBROSIS IS INCREASED IN LEFT VENTRICULAR NON-COMPACTION AND PREDICTS DROP IN SYSTOLIC FUNCTION (2020) (0)
1 PATHOGENESIS OF ATHEROSCLEROSIS (1999) (0)
Evolving Understanding of Coronary Thrombosis and New Insights into Therapeutic Strategies (1998) (0)
Reply: therapeutic goals in patients with acute aortic dissection: management before surgery. (2015) (0)
In vivo quantification of atherosclerotic plaque components with MRI in a rabbit model of atherosclerosis (2000) (0)
Abstract 3625: Targeted Ultra-Small Iron Oxide Particles for In Vivo MR Detection of Atherosclerotic Lesions Using Antibodies against Oxidized Low Density Lipoprotein (2008) (0)
Abstract 12657: Perceptions of the Role of Community Health Workers in Hypertension Management: A Qualitative Analysis of the LARK Hypertension Study (2015) (0)
Abstract P109: Factoring Influencing Fruit and Vegetable Intake and Associations with Cardiovascular Disease Risk Factors: The Grenada Heart Project (2013) (0)
ESC COMMITTEE FOR PRACTICE GUIDELINES & POLICY CONFERENCES MEMBERS (2001) (0)
Congress announcements (2000) (0)
Abstract 19389: The Net Clinical Benefit of Left Atrial Appendage Closure in the Continued Access Protocol (CAP) Registry (2012) (0)
PREOPERATIVE CORONARY ANGIOGRAPHY WITH MULTIDETECTOR CT IS A SAFE ALTERNATIVE TO INVASIVE CATHETERIZATION IN PATIENTS UNDERGOING MITRAL VALVE REPAIR (2010) (0)
Circulating andTissue Endothelin Immunoreactivit inHypercholesterol (1993) (0)
Erratum: How to become a cardiovascular investigator (Journal of the American College of Cardiology (October 4, 2005) SUPPL. A)) (2005) (0)
Conference of the XXXVII National Congress of the Spanish Society of Cardiology (0)
Beneficial effect of colchicine in an animal model of atherosclerosis (2020) (0)
Cardiac Risk, Imaging, and the Cardiology Consultation (2018) (0)
Abstract 18925: Enhanced Cellular Proliferation and Altered Collagen Deposition May Accelerate Atherosclerosis in Human Peripheral Artery Disease: Implication of Morphological Predictors in Restenotic Plaque Progression (2014) (0)
Abstract 17275: The SGLT2 Inhibitor Empagliflozin Ameliorates Left Atrial Dilatation in Non-Diabetic Patients With Heart Failure With Reduced Ejection Fraction: A Secondary Analysis of the EMPATROPISM Trial (2020) (0)
VASOSPASTIC ANGINA: A RARE CASE OF ERGONAVINE POSITIVITY AND CURATIVE VAGOTOMY (2017) (0)
Screening, stem cells, biomarkers and hypercholesterolemia: our first original clinical research (2008) (0)
No 2 August 1994 Macrophage Infiltration in Coronary Tissue From Patients With Acute Coronary Syndromes Stable Angina Unstable Angina (2005) (0)
Abstract 16749: BioImage Study: Value of Novel Biomarker Panel (CardioSCORE) in Predicting Major Adverse Cardiovascular Events among those with Absence of Coronary Artery Calcification (2012) (0)
EANM’09 Barcelona–a congress to be remembered! (2009) (0)
Comprar ABC of Spinal Disorders | Marrick Kukin | 9781405170697 | Wiley (2009) (0)
Reproducibility of high resolution magnetic resonance imaging for in vivo monitoring of atherosclerotic lesions in humans (2002) (0)
Statement of Task (2010) (0)
Abstract 10684: Prognostic Value of Late Gadolinium Enhancement in Patients with Non-Ischemic Cardiomyopathy (2011) (0)
PREDICTORS OF OUTCOMES BY CARDIAC MAGNETIC RESONANCE IN PATIENTS WITH PULMONARY HYPERTENSION (2016) (0)
The importance of basic science in clinical cardiology (2014) (0)
17th Bethesda conference: Adult cardiology training. Task Force I: Training in clinical cardiology. (1986) (0)
INCREASED EXPRESSION OF ADIPOKINE–RESISTIN EXPRESSION IN LIPID–RICH ATHEROMATOUS PLAQUES WHEN COMPARED TO LIPID POOR–FIBROTIC PLAQUES IN HUMAN ATHEROSCLEROSIS–IMPLICATION IN ACCELERATED ATHEROSCLEROTIC LESION PROGRESSION (2013) (0)
Computed Tomography and Magnetic Resonance Imaging for Noninvasive Coronary Angiography and Plaque Imaging Current and Potential Future Concepts Current Perspective (2002) (0)
Abstract 15601: Increased Left Ventricular Mass Predicts Incident Aortic and Mitral Valve Calcification: The Multi-Ethnic Study of Atherosclerosis (2010) (0)
Reply: Atherosclerotic Burden: Complex Interplay of Anatomic, Physiologic, and Outcome Data. (2015) (0)
VALUE OF CLASSICAL CRITERIA FOR DIAGNOSIS OF CARDIAC AMYLOID IN THE CARDIAC MAGNETIC RESONANCE ERA (2014) (0)
Editor-in-Chief's Picks From 2014: Part One. (2015) (0)
Abstract P360: Hypertension Treatment Rates And Health Worker Density: An Analysis Of Worldwide Data (2014) (0)
Cardiac drug–psychotropic drug update (2003) (0)
The Clinical Course of Idiopathic Dilated Cardiomyopathy (2020) (0)
Long-Term Follow-up of Left-to-Right Shunts Complicated by Pulmonary Vascular Obstructive Disease (1986) (0)
Demographic and clinical predictors of excessive anticoagulation following initiation of warfarin therapy (2003) (0)
Characterization of a Mediastinal Thymic Seminoma Using Cardiac Magnetic Resonance (2012) (0)
BOX 3.1, Interpreting Economic Data (2010) (0)
Dual Antiplatelet Therapy Versus Aspirin Monotherapy in Diabetics With Multivessel Disease Undergoing CABG (2016) (0)
Ail4 Medical/scientific Statement Special Report Acc/aha Guidelines for the Early Management of Patients with Acute Myocardial Infarction a Report of the American College of Cardiology/american Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (subcom (0)
108Biologic significance of healed culprit plaques in stable angina versus acute coronary syndromes (2019) (0)
Looking at the Crystal Ball: What Will Change the Future of Cardiology? (2015) (0)
Abstract 699: Comparison of Diagnostic Criteria for Left Ventricular Non-compaction by Cardiac Magnetic Resonance (2008) (0)
Plaque disruption and thrombus formation in acute coronary syndromes (1988) (0)
Abstract 17819: Implications of the Post-myocardial Infarction Bimodal Edematous Reaction for Quantifying Area at Risk, Infarct Size And Salvaged Myocardium by Cardiac Magnetic Resonance Imaging (2015) (0)
PULMONARY ARTERY STIFFNESS IS INDEPENDENTLY ASSOCIATED WITH THE DEGREE OF RIGHT VENTRICULAR DYSFUNCTION IN PULMONARY HYPERTENSION (2010) (0)
High systemic expression of endostatin following adenovirus-mediated gene transfer: effects on microvessel density and neointimal response of the injured arterial wall (2000) (0)
Profile: The Centro Nacional de Investigaciones Cardiovasculares Carlos III. Interview by Emma Wilkinson. (2013) (0)
adults . coronary artery disease in young smoking as risk factors of Strong family history and cigarette (0)
Abstract 3409: Monitoring of Changes in Atheroma Volume by 64-Slice Computed Tomography. (2007) (0)
Abstract 18949: Socioeconomic Patterning of Hypertension in Grenada (2012) (0)
Abstract 295: Intra-Plaque Hemorrhage Is Associated With Decreased Content of Macrophage Scavenger Receptor CD-163 in Diabetic Atherosclerosis. (2006) (0)
Review Article Cardiomyopathy Associated With Cancer Therapy (2014) (0)
Valve interventions—a word of caution (2010) (0)
PREDICTIVE VALUES OF THE IDEAL CARDIOVASCULAR HEALTH AND THE FUSTER-BEWAT SCORES FOR DETECTING SUBCLINICAL ATHEROSCLEROSIS IN HEALTHY INDIVIDUALS (2017) (0)
Abstract 1647: Bisphosphonate Use and the Prevalence of Cardiovascular Calcification in Women: The Multi-Ethnic Study of Atherosclerosis (2009) (0)
Abstract 17897: Pharmacological Inhibition of PTEN Increases Myocardial Salvage, Reduces Infarct Size, and Decreases Adverse Post-infarction Left Ventricular Remodeling in a Porcine Model of Reperfused Myocardial Infarction (2014) (0)
P2784Anthracycline cardiotoxicity in the hypertrophic heart: testing a dual-hit hypothesis (2018) (0)
P2785Early microcirculation impairment in a pig model of anthracycline cardiotoxicity: evaluation by cardiac magnetic resonance and coronary physiology assessment (2018) (0)
Body mass index is the only independent predictor of different degrees of carotid wall inflammation as revealed by FDG-PET/CT imaging in patients with known or suspected cardiovascular disease (2010) (0)
Is the Best Disease-Guided (0)
Quantitative comparison of lesion FDG uptake on a whole body PET-MR system with PET-CT (2013) (0)
Beta3-adrenergic stimulation restores endothelial mitochondrial dynamics and prevents pulmonary arterial hypertension (2020) (0)
Use of primary care electronic medical records for research purposes: is it taking off? (2021) (0)
Pre-hospital metoprolol administration in Killip-class I–II anterior ST-segment elevation acute myocardial infarction is safe and reduces infarct size and adverse events. Insights from the METOCARD-CNIC trial (2014) (0)
P5999Heart failure rescue by high fat diet in a porcine model of hibernated myocardium (2019) (0)
Bone marrow activation in response to metabolic syndrome and early atherosclerosis (2022) (0)
Midlife subclinical atherosclerosis and cardiovascular risk factors linked to hypometabolism in Alzheimer’s disease relevant regions (2021) (0)
Abstract MP38: The Program SI! Intervention for Enhancing a Healthy Lifestyle among Children aged 3 to 5: A Cluster Randomized Trial (2014) (0)
Brain metabolism changes in middle‐aged asymptomatic APOE‐ε4 carriers. The PESA Study (2022) (0)
P245Effect of pulmonary artery denervation in a translational model of chronic postcapillary pulmonary hypertension (2018) (0)
THE SPHINGOSINE 1-PHOSPHATE RECEPTOR AGONIST FINGOLIMOD REDUCES MYOCARDIAL ISCHEMIA-REPERFUSION INJURY MEDIATED BY ACTIVATION OF AUTOPHAGY: AN IN VITRO AND IN VIVO STUDY (2015) (0)
A Conceptual Strategy to Address CVD and Related Chronic Diseases in the Developing World. (2011) (0)
The polypill approach – An innovative strategy to improve cardiovascular health in Europe (2017) (0)
Chronic Valvular Heart Disease: Timing of Surgery (1988) (0)
Imagingof Plateletsin Right-SidedExtracardiacConduitsin Humans (2006) (0)
Abstract 18097: PTEN Inhibition With VO-OHPIC Ameliorates Myocardial Ischemia-Reperfusion Injury Mediated by RISK Pathway Activation-Mediated Reduction of Apoptosis: An in vitro and in vivo Study (2016) (0)
Cholesterol-lowering studies for aortic stenosis. (2004) (0)
Platelet Inhibitor Drugs in Coronary Artery Disease and Coronary Intervention (1989) (0)
P596Early markers of right ventricular involvement in experimental chronic postcapillary pulmonary hypertension (2019) (0)
Hurst's the heart vol.2 (2013) (0)
Characterization of a mediastinal thymic seminoma using cardiac magnetic resonance. (2012) (0)
Molecular imaging of atherosclerosis using FDG PET/CT with a novel, macrophage-specific CT contrast agent (2007) (0)
Child Health Promotion in Underserved Communities: Primary Results From the Cluster Randomized FAMILIA Trial (2018) (0)
Correction: JUPITER strikes earth (2009) (0)
Long-term evaluation (11–24 years) of open heart surgery for pulmonary atresia with ventricular septal defect (1982) (0)
An Homage to Peer Reviewers: Strengthening Our "Bundle of Sticks". (2019) (0)
PM203 Hypertension Knowledge Retention Among Community Health Workers in Rural Western Kenya: Process Evaluation of the Lark Hypertension Study (2016) (0)
PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9 PROTEIN EXPRESSION IS INCREASED IN LIPID RICH HUMAN ATHEROSCLEROTIC PLAQUES COMPARED TO FIBROUS PLAQUES (2017) (0)
Factor VIII Products and Inhibitors in Severe Hemophilia A (2013) (0)
Abstract 16778: Atherosclerotic Plaque Distribution Pattern and Burden in the Carotid and Iliac-Femoral Territories Assessed by 2D/3D Ultrasound in Middle-Aged Population. The PESA (Progression and Early Detection of Subclinical Atherosclerosis) Study (2013) (0)
Author ' s response to reviews Title : The Program SI ! intervention for enhancing a healthy lifestyle in preschoolers : First results from a cluster randomized trial (2013) (0)
Abstract 2949: Atherosclerotic Plaque Inflammation is Highly Correlated with Serum Inflammatory Biomarker Levels - An FDG-PET/CT Imaging Study (2007) (0)
Author ' s response to reviews Title : The Program SI ! intervention for enhancing a healthy lifestyle in preschoolers : First results from a cluster randomized trial (2013) (0)
In defence of auscultation: a glorious future? (2017) (0)
on a National Heart, Lung and Blood Institute Working Group Guided Antithrombotic Therapy: Current Status and Future Research Direction: Report (2014) (0)
0.S.5 Plasma lipids, clotting factors and cardiovascular risk (1997) (0)
Clonal hematopoiesis is not prevalent in Hutchinson-Gilford progeria syndrome (2022) (0)
Abstract 3021: Cardiovascular Risk Factors Affect Age Distribution of Atherosclerotic Disease Burden as Assessed by Magnetic Resonance Imaging (2006) (0)
The role of thrombosis in acute coronary heart disease (1996) (0)
Platelet Survival Half-Life in Diabetes Mellitus with and without Peripheral Arterial Occlusive Disease (1979) (0)
Abstract 17479: Cardiac Amyloid Burden Estimated with Myocardial T1 Mapping is Associated with Severity of Cardiac Disease (2012) (0)
Abstract 871: Differences in Demographics Between Subjects in the Grenada Heart Project Survey and the Related Heart Health Fairs (2009) (0)
The contribution of risk factors to inflammation in carotid atherosclerotic plaques -- An FDG PET/CT study (2007) (0)
SIGNIFICANT DOWN-REGULATION OF THE ANTI-INFLAMMATORY CYTOKINE INTERLEUKIN-10 IS GENOTYPE DEPENDENT IN ATHEROSCLEROTIC PLAQUES WITH INTRA-PLAQUE HEMORRHAGE (2010) (0)
Cardiac Imaging Noninvasive Monitoring of Serial Changes in Pulmonary Vascular Resistance and Acute Vasodilator Testing Using Cardiac Magnetic Resonance (0)
P4684Differential right ventricular adaptation patterns to chronic pressure overload (2019) (0)
Abstract 18340: Alternatively Spliced Tissue Factor Promotes Atherosclerosis by Increasing Foam Cell Formation via LOX-1 and SR-A1 up-regulation (2015) (0)
Abstract 17157: The SGLT2 Inhibitor Empagliflozin Ameliorates Interstitial Myocardial Fibrosis and Aortic Stiffness in Non-Diabetic Patients With Heart Failure With Reduced Ejection Fraction: A Secondary Analysis of the EMPATROPISM Trial (2020) (0)
A new partnership between the World Heart Federation and Nature Clinical Practice Cardiovascular Medicine (2006) (0)
Burden : Writing Group III High-Risk Patient for Primary Prevention : Noninvasive Tests of Atherosclerotic Prevention Conference V : Beyond Secondary Prevention : Identifying the (2008) (0)
Coumadin aspirin reinfarction study: Rationale and design of the CARS study (2005) (0)
The FREEDOM Trial: CABG Superior to PCI in Diabetic Patients with CAD (2012) (0)
Reply: To PMID 22789936. (2013) (0)
Following Mild Carotid Endothelial Injury, Platelet-Arterial Wall Interaction Is Impaired In Pigs With Von Willebrand'S Disease (1981) (0)
[Antithrombotic therapy in cardiac disease: approach for the selection of pharmacologic agents]. (1988) (0)
Ventricular ectopy after myocardial infarction: issues and controversies (1986) (0)
O NE DAY U PDATE I N D IABETES A ND C ARDIOVASCULAR D ISEASES (2016) (0)
JACC: Case Reports (2020) (0)
Platelets and parasites (2002) (0)
Optimal treatment for atrial fibrillation (1997) (0)
[Psychological effects of heart surgery. Preliminary study]. (1993) (0)
Sleep duration and its association with adiposity markers in adolescence: a cross-sectional and longitudinal study. (2023) (0)
A 3-year worksite-based lifestyle intervention to reduce cardiovascular disease risk factors in office employees: Rationale, development and design of two parallel randomized controlled trials (2016) (0)
The Cardiostars Project : inspiring the next generation of cardiologists (2014) (0)
Noninvasive in vivo MRI documents arterial remodeling in a novel WHHL rabbit model (2000) (0)
Understanding the pathophysiology of the arterial wall: which method should we choose? Magnetic resonance imaging (2002) (0)
Failing to ENHANCE science (2008) (0)
Abstract 20214: Ethnic Disparities in Metabolic Syndrome Among Caregivers of Preschool Children in a Community-Based Trial (2017) (0)
Abstract 2542: Accuracy of Multislice Computed Tomography for the Quantification of Plaque Volume. Validation with Magnetic Resonance Imaging. (2007) (0)
Abstract 17738: Elastic Fibril Protein Fibulin-2 Expression is Increased in Fibro Elastic Deficiency Compared to Barlow's Disease- Implication in Disease Progression (2012) (0)
Building modern medical societies through watching and listening. (2015) (0)
Abstract 16942: Alternatively Spliced Tissue Factor promotes plaque progression, inflammation and angiogenesis in experimental atherosclerosis (2014) (0)
Abstract 16751: BioImage Study: Reclassification and Discrimination by Novel Biomarker Panel (CardioSCORE), Coronary Calcium Score, Carotid Intima-Media Thickness&Plaque Burden in Asymptomatic Individuals (2012) (0)
Current issues of novel risk factors for coronary disease and interventions for arrhythmias (1999) (0)
Myocardial native T1 relaxation times are highly dependent on the blood T1 values (2015) (0)
Supplemental Table Legend (2016) (0)
Atherosclerosis / Coronary Heart Disease Short-term Cholesterol Lowering Decreases Size and Severity of Perfusion Abnormalities by Positron Emission Tomography After Dipyridamole in Patients With Coronary Artery Disease : A Potential Noninvasive Marker of Healing Coronary Endothelium (2005) (0)
Response to Letter Regarding Article, “Aspirin: A Historical and Contemporary Therapeutic Overview” (2011) (0)
Abstract 15813: Perioperative CK-MB Elevation is a Better Predictor of Survival Than New Q Waves Among Diabetic Patients With Multivessel Coronary Artery Disease Undergoing CABG (2013) (0)
Abstract 15068: Expression of PW1 Identifies a New Candidate Cardiac Progenitor Population in the Adult Heart (2015) (0)
Inhibition With Hirudin (2005) (0)
Reply: Vulnerable Plaque: Absence of Evidence or Evidence of Absence. (2015) (0)
P437Beta3-adrenergic receptor stimulation reduces ischemia/reperfusion injury through inhibition of the mitochondrial transition pore opening (mPTP) and subsequent apoptotic inhibition (2014) (0)
Optimal RiskFactor Management inthePatient After Coronary Revascularizatio n A Statement forHealthcare Professionals FromanAmerican HeartAssociation Writing Group (1994) (0)
Peripheral Vascular Disease - Fellows in Training Workshop (2014) (0)
Reply: Physical Activity-Related Left Ventricular Trabeculation: More Uncertainty Than Ever. (2021) (0)
Clinical comparison of a whole-body PET-MR system with PET-CT (2012) (0)
Antiarrhythmic drugs for ventricular tachycardia and evolving technology for coronary and valvular surgery (1999) (0)
Basic studies on thrombosis and fibrinolysis (1992) (0)
Genetics of Coronary Artery Disease (2014) (0)
Abstract 497: Ovariectomy Increases Vascular Calcification Via the Receptor Activator of Nuclear Factor-kB Ligand/Osteoprotegerin Cytokine Signaling Pathway (2006) (0)
1064-186 Magnetic resonance imaging detected relationship between atherosclerotic plaques and shear stress in human descending thoracic aorta in vivo (2004) (0)
Intrinsic thrombus modifications favouring embolization. (1994) (0)
A very unusual cause of mechanical left ventricular outflow tract obstruction. (2013) (0)
Abstract 15794: Glucagon-Like Peptide-1 Receptor Activation Improves Systolic LV Function and LV Mechanics in a Porcine Model of Ischemia and Reperfusion (2012) (0)
Mueller et al TIMI II Subgroup Analyses : Predictors of Early Events 1255 factors for early death in patients with AMI treated with thrombolytic therapy . The Thrombolysis in Myocardial Infarction ( TIMI ) phase (2005) (0)
Meeting highlights from the 67th scientific sessions of the American Heart Association (2005) (0)
Heparin and the haemolytic-uraemic syndrome. (1970) (0)
Cocaine As a Possible Emerging Cardiovascular Risk Factor: Response (2004) (0)
Acute Coronary Syndrome Long-Term Benefit of Early Pre-Reperfusion Metoprolol Administration in Patients With Acute Myocardial Infarction Results From the METOCARD-CNIC Trial ( Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction ) (2014) (0)
Contents (2020) (0)
RACIAL DIFFERENCES IN PREVALENCE OF CAROTID ATHEROSCLEROSIS: RESULTS FROM THE PLAQUE BIOIMAGE STUDY (2013) (0)
EFFECT OF LXR-623, ALONE OR IN COMBINATION WITH SIMVASTATIN, ON REGRESSION AND STABILIZATION OF ATHEROSCLEROTIC PLAQUES: AN MRI STUDY IN A MODEL OF ADVANCED ATHEROSCLEROSIS (2010) (0)
Platelets in Thrombotic and Non-thrombotic Disorders: Plate section (2002) (0)
Technology and the Pandemic: A Tool We Must Wield to Maintain Our Humanity. (2021) (0)
Sex Differences in Healthcare Utilization and Costs among Individuals with Elevated Blood Pressure: The LARK Study from Western Kenya (2020) (0)
JACC: Case Reports: New Era of Clinical Cases, Bridging Patients With Guidelines. (2019) (0)
Reply: "Zero": The New Superhero or Superhero in Training? (2019) (0)
PREDICTORS OF CARDIAC OUTCOMES BY CMRI IN PATIENTS WITH NONISCHEMIC CARDIOMYOPATHY (2013) (0)
Changing paradigms in atherothrombosis: inflammation and neovascularization in plaque progression, rupture and regression (2004) (0)
THE RELATIONSHIP BETWEEN PERICARDIAL ADIPOSE TISSUE VOLUME, ATHEROSCLEROTIC PLAQUE TYPE AND CARDIOVASCULAR RISK: A HIGH RISK PLAQUE BIOIMAGE SUB-STUDY (2017) (0)
Abstract 18876: Noninvasive Quantification of Pulmonary Vascular Resistance with Cardiac Magnetic Resonance Imaging (2010) (0)
ECHOCARDIOGRAPHICAL ASSESSMENT OF POST-REPERFUSION WALL THICKENING ACCURATELY QUANTIFIES THE AREA AT RISK: AN EXPERIMENTAL PORCINE STUDY VALIDATED WITH MAGNETIC RESONANCE AND HISTOLOGY (2014) (0)
Detecting Baseline Platelet Hyperreactivity ( Prothrombotic Status ) and Cardiac Risk (2013) (0)
LE-2. The pathogenesis of atherosclerotic lesions (1997) (0)
Transient Ischemic Attacks and Ischemic Strokes Clinical manifestations of atherosclerotic disease in the brain (2005) (0)
Barry A Love therapeutic challenge Peripheral pulmonary artery stenosis masquerading as pulmonary hypertension : A diagnostic and (2012) (0)
Abstract 14053: The Sphingosine 1-phosphate Receptor Agonist Fingolimod Increases Myocardial Salvage and Decreases Adverse Post-infarction Left Ventricular Remodeling in a Porcine Model of Reperfused Myocardial Infarction (2013) (0)
Diabetes and Cardiovascular Disease CARDIOVASCULAR DISEASE AND THE DIABETES MELLITUS EPIDEMIC Consequences of the modern lifestyle ? (2017) (0)
Quantitative dose-antithrombotic response of direct factor-Xa inhibitor ZK-807834 in stable coronary patients (2002) (0)
Abstract 16129: Low HDL is the only Major Risk Factor Independently Associated with Increased Inflammation in Diabetic Coronary Artery Disease Patients after Percutaneous Coronary Intervention as Measured by 18F-fluorodeoxyglucose Positron-Emission Tomography (2012) (0)
Digital technology in cardiac care (2010) (0)
Prostacyclin (epoprostenol) andheart-lung transplantation astreatments forsevere pulmonary hypertension (1993) (0)
Centres worldwide review percutaneous coronary intervention vs . CABG guidelines for diabetic patients following FREEDOM study Cardiologist Dr (2013) (0)
Intravascular Drug Delivery (2005) (0)
Beta-blocker effect on ST-segment: a prespecified analysis of the EARLY-BAMI randomised trial (2020) (0)
Prevention of left ventricular mural thrombosis and arterial embolism during and after acute myocardial infarction (1990) (0)
Ethics in cardiovascular medicine. Task Force III: Perspective on the allocation of limited resources in cardiovascular medicine. (1990) (0)
In vivo nanotracer for the detection of brain thrombi in an AD mouse model. (2022) (0)
Abstract 16635: Real Time 3d Echocardiography is Comparable to Cardiac Mri in Reducing Sample Size Required to Assess Changes in Lv Function (2012) (0)
RECOMBINANT APOLIPOPROTEIN A-I MILANO DECREASES LEAFLET INFLAMMATION AND CALCIFICATION IN EXPERIMENTAL MODELS OF AORTIC STENOSIS (2010) (0)
Abstract 15042: BioImage Study: Combined Use of Novel Biomarker Panel (CardioSCORE) and Computed Tomography Coronary Calcium Scores in Predicting Major Adverse Cardiovascular Events (2012) (0)
Platelets in Thrombotic and Non-Thrombotic Disorders: Platelet signalling: tyrosine kinases (2002) (0)
Abstract 18848: Carotid Artery Remodeling is Segment Specific: An in Vivo Study by Cardiovascular Magnetic Resonance Imaging (2015) (0)
P684Effects of colchicine on atherosclerotic plaque progression and composition: a multimodality imaging study in a rabbit model of atherosclerosis (2017) (0)
Editor-in-Chief's Top Picks From 2016: Part One. (2017) (0)
Abstract 19913: In vivo Characterization of a New Abdominal Aortic Aneurysm (AAA) Mouse Model with Conventional and Molecular MRI (2010) (0)
1038-152 Determination of left and right cardiac function with multislice computed tomography (2004) (0)
Abstract 14325: Smoking and Plaque Composition in Human Peripheral Arterial Disease: Implications for Disease Progression and Thrombogenicity (2013) (0)
Unstable angina: mechanisms and treatment (1990) (0)
Estimation of cardiac amyloid infiltration with myocardial T1 mapping correlates with severity of cardiac involvement (2013) (0)
Thrombolytic therapy in unstable angina (1989) (0)
Magnetic resonance imaging reference values for cardiac morphology, function and tissue composition in adolescents. (2023) (0)
XVth annual general meeting of the Association of European Paediatric Cardiologists, Madrid, Spain, May 8–11, 1979 (2005) (0)
Cardiovascular News Images in Cardiovascular Medicine Diagnosis of Isolated Noncompaction of the Myocardium by Magnetic Resonance Imaging (2002) (0)
P3108Microcirculation injury is involved in anthracycline-induced cardiac toxicity (2019) (0)
VARIABILITY OF ANTIPLATELET EFFECT WITH TICAGRELOR VERSUS CLOPIDOGREL IN DIABETIC PATIENTS (2016) (0)
Indium-111 PlateletKinetics in NormalHuman Subjects: TropoloneVersusOxine Methods (1986) (0)
Noninvasive Assessment of Atherosclerosis : From Structure to Function Series (2002) (0)
Abstract 11802: Coronary Artery Calcification is the Strongest Predictor of Abnormal Duke Prognostic Coronary Artery Disease Index (2014) (0)
Platelets and Atherogenesis in Normal and von Willebrand Disease Pigs (1983) (0)
RESPONSE: With Gratitude, and a Look to the Future. (2019) (0)
Cardiovascular Imaging Spontaneous Echo Contrast Videodensity Is Flow-Related and Is Dependent on the Relative Concentrations of Fibrinogen and Red Blood Cells (2016) (0)
Remote ischemic preconditioning ameliorates anthracycline-induced cardiotoxicity and preserves mitochondrial integrity: results from a randomized preclinical trial in pigs (2020) (0)
Coronary Artery Disease: Role of Antithrombotic Therapy * (2019) (0)
Committee and Staff Biographies (2010) (0)
A Multicenter, Randomized Angiographic Trial (2005) (0)
P260Quantification of systemic cardiac troponin overestimates infarct size in presence of left ventricular hypertrophy: insights into the underlying mechanisms (2014) (0)
Contents (2020) (0)
Reflections on 5 Years as JACC Editor-in-Chief: Proud of the Growing Family of Quality. (2019) (0)
Abstract 15984: Alternatively Spliced Tissue Factor Exerts Greater Angiogenic Potency than Full-Length Tissue Factor via HIF-1a Induction in Complicated Atherosclerotic Plaques (2013) (0)
The Right Diet for Heart Failure: Finding Morsels for Success. (2018) (0)
Kawasaki Disease (2021) (0)
(METOCARD-CNIC) Trial of Metoprolol in Cardioprotection During an Acute Myocardial Infarction Infarction Patients Undergoing Primary Percutaneous Coronary Intervention: The Effect Elevation Myocardial - Effect of Early Metoprolol on Infarct Size in ST-Segment (2013) (0)
Prinzmetal Angina and Cyproheptadine (1995) (0)
1007-177 Predictors of major hemorrhage following initiation of warfarin therapy (2004) (0)
ALTERNATIVELY SPLICED TISSUE FACTOR IS HIGHLY EXPRESSED IN COMPLEX HEMORRHAGIC CAROTID AND CLINICALLY UNSTABLE CORONARY PLAQUES (2013) (0)
JACC: Case Reports (2020) (0)
Tissue factor activity after angioplasty in atherosclerotic rabbits Inhibition by hirudin (1995) (0)
P4352Gut microbiota and its dependent metabolite Trimethylamine N-oxide (TMAO) exacerbate adverse post-infarction left ventricular remodeling (2017) (0)
Arterial Thrombosis: A Brief Overview (2012) (0)
Clinical Investigation andReports Recombinant Hirudin inPatients WithChronic, Stable Coronary Artery Disease Safety, Half-life, andEffect on Coagulation Parameters (2015) (0)
GLUCAGON-LIKE PEPTIDE-1 RECEPTOR ACTIVATION REDUCES COMPENSATORY HYPERTROPHY AND LEFT VENTRICULAR REMODELING IN A PORCINE MODEL OF ISCHEMIA AND REPERFUSION (2012) (0)
Abstract 14545: Glucagon-Like Peptide-1 Receptor Activation With Liraglutide During Acute Myocardial Infarction Improves Myocardial Salvage and Systolic Left Ventricular Function (2013) (0)
The several faces of clinical trials: from new therapies to failed preventive strategies (2006) (0)
PL02 The macrophage in atherogenesis: metalloproteinases and tissue factor as therapeutic targets? (1998) (0)
Quality of Life After PCI vs CABGAmong Patients With Diabetes andMultivessel Coronary Artery Disease A Randomized Clinical Trial (2013) (0)
Use of Noninvasive Combined MRI-PET/CT Imaging in dal-PLAQUE to Assess Dalcetrapib's Effects on Structural and Inflammatory Atherosclerotic Disease (2011) (0)
DIFFUSE INTERSTITIAL MYOCARDIAL FIBROSIS DETECTED BY T1 MAPPING IS INCREASED IN HYPERTROPHIC CARDIOMYOPATHY PATIENTS AND CORRELATES WITH LEFT VENTRICULAR SYSTOLIC AND DIASTOLIC DYSFUNCTION (2013) (0)
Primordial prevention: paramount in cardiovascular prevention. (2019) (0)
University of Groningen Noninvasive Molecular Imaging of Cell Death in Myocardial Infarction using 111 In-GSAO Tahara (2017) (0)
Inactivation of NF-Y inhibits vascular smooth muscle cell proliferation and neointima formation (2019) (0)
Recent Advances in Cardiology 1 Intr oducing the ANNALS OF GLOBAL HEALTH (2014) (0)
JACC: Basic to Translational Science: The Apple That Falls Closely to the JACC Family Tree. (2018) (0)
INCREASED SEPTAL EXTRACELLULAR VOLUME ESTIMATED BY T1-MAPPING PREDICTS RIGHT ventricular PERFORMANCE IN PULMONARY HYPERTENSION (2013) (0)
The Role of Macrophages and Tissue Factor (1998) (0)
Cost-effectiveness of newer antiplatelet drugs. Authors' reply (2003) (0)
Chronic Renal Insufficiency, Cardiovascular Disease and Mortality in Women: A Causal Relationship or Coincidence? (2009) (0)
In monocyte culture apoptosis and tissue-factor expression are induced by oxidized low-density lipoprotein and can be attenuated by caspase-inhibition (2003) (0)
Abstract 16618: Pre-Gadolinium Inversion-Recovery Sequence: A Novel and Reliable Magnetic Resonance Method for Assessing Area at Risk (2012) (0)
CorrespondenceLetters to the editorReply (2005) (0)
Response by Russo et al Regarding Article, "Healed Plaques in Patients With Stable Angina Pectoris". (2020) (0)
NEW FINDINGS IN THE PATHOPHYSIOLOGY OF ACUTE CORONARY SYNDROMES (1999) (0)
Racial Disparities in Early Subclinical Atherosclerosis: Insights from the FAMILIA Study (2018) (0)
Abstract 17855: Risk Factors For 30-Day Outcome Following Multivessel Bypass Surgery in Diabetic Patients With Stable CAD: Pre-Operative Glycemic Control and Blood Pressure Management Matter (2013) (0)
ATVB In Focus Noninvasive Assessment of Atherosclerosis: From Structure to Function (2002) (0)
Dynamic changes of T2-Weighted signal intensity magnetic resonance imaging in reperfused myocardial infarction: implications for retrospective area-at risk quantification (2014) (0)
CHORDAL RUPTURE CORRELATES WITH ELASTIC FIBRIL FRAGMENTATION AND DISORGANIZATION OF THE POSTERIOR LEAFLET IN MYXOMATOUS MITRAL VALVE PROLAPSE: IMPLICATIONS FOR LEAFLET STABILITY AND DISEASE PROGRESSION (2012) (0)
Abstract 1522: Anxiety with Depression is Associated with Increased Platelet Reactivity In Stable Acute Coronary Syndrome Patients (2007) (0)
Abstract 16702: BioImage Study: Elevated Uric Acid is Associated Increased Risk of Major Cardiovascular Events Independent of Burden of Subclinical Atherosclerosis and Inflammation (2012) (0)
Improved behavior in children aged 3 to 5 after one year of a school-based intervention for healthy living (2013) (0)
Authors' reply: Comorbidity in patients with asymptomatic AS (2011) (0)
Infective Endocarditis: New Perspectives on an Old Disease (1995) (0)
914-70 An Orally Active Synthetic IIb/IIIa Receptor Antagonist Inhibits Ex-vivo Platelet-Thrombus Formation (1995) (0)
Abstract 19124: Detection and Prevalence of Systemic Atherosclerosis: Results from the High-Risk Plaque (HRP) Initiative (2012) (0)
Editor-in-Chief's Top Picks From 2020. (2021) (0)
Abstract 6119: Ultrasound 2D Speckle Tracking Differentiates Stunned from Scarred Myocardium after Acute MI (2008) (0)
Proteomic footprint of myocardial ischemia/reperfusion injury: Longitudinal study of the at-risk and remote regions in the pig model (2017) (0)
Carotid 18FDG-PET uptake independently predicts non-obstructive coronary artery disease as evaluated by CT coronary angiography (2010) (0)
Editor-in-Chief's Top Picks From 2017. (2018) (0)
New three-dimensional volumetric ultrasound probe for accurate quantification of atherosclerotic plaque volume (2020) (0)
Arterial angioplasty. Thrombosis and restenosis (1993) (0)
Abstract 12379: Glucagon-Like Peptide-1 Receptor Activation During Myocardial Ischemia Causes Short- and Long-Term Improvements in Myocardial Infarction Size and Left Ventricular Function (2011) (0)
Reply (2020) (0)
COUNTERING THE ANTI-PLATELET EFFECTS OF TICAGRELOR WITH PLATELET CONCENTRATES WITHIN 48 HOURS OF A LOADING DOSE: EX VIVO TESTING OF TIME-EFFECT ON FUNCTIONAL RECOVERY IN PATIENTS WITH CARDIOVASCULAR DISEASE (2017) (0)
JACC Serving the Global Cardiovascular Community. (2018) (0)
Abstract 14911: Induction Of Regression Of Atherosclerosis By The LXR-agonist R211945-a Multimodality Non-invasive Assessment And Comparison With Atorvastatin (2011) (0)
Lp(a): Are Antithrombotic Therapies the Key to Event Reduction? (2022) (0)
Preventive cardiology abstractLipid lowering by simvastatin induces regression of human atherosclerotic lesions. Two years’ follow-up by high-resolution noninvasive magnetic resonance imaging☆ (2003) (0)
ISOLATED PULMONARY ARTERY STENOSIS IN VASCULITIS AND RIGHT HEART FAILURE (2019) (0)
Stroke Turns 40 Promoting Cardiovascular and Cerebrovascular Health (2010) (0)
T1 MAPPING IN PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION DETECTS INCREASED INTERSTITIAL MYOCARDIAL FIBROSIS AND ASSESSES THE SEVERITY OF HEART FAILURE (2017) (0)
5020Cardiac magnetic resonance characterization of maladaptive right ventricular hypertrophy in chronic pulmonary hypertension (2017) (0)
in the Developing World q (2011) (0)
Assessing Atherosclerotic Burden with CT (2007) (0)
1045-197 Evidence for hypoxia and hypoxia-inducible factor-1-alpha mediated vascular endothelial growth factor expression in lipid-rich plaque macrophages as link between inflammation and angiogenesis (2004) (0)
Ischemia and infarction III. Pathogenesis of coronary occlusion. (1988) (0)
TCT-109 Ten-Year All-Cause Death After Percutaneous or Surgical Revascularization in Diabetic Patients With Complex Coronary Artery Disease (2021) (0)
Current issues of gene therapy for cardiovascular disorders and antithrombotic therapy in chronic heart disease (2000) (0)
Century Epidemic Cardiovascular Disease : From Treatment to Promoting Health ; A Challenge for the Next Decade (2013) (0)
Fatty infiltration of the right ventricle assessed by computed tomography and magnetic resonance imaging. (2008) (0)
Sad news for Nat. Rev. Cardiol. in 2011 (2011) (0)
CORONARY COMPUTED TOMOGRAPHY FOR DETERMINATION OF THE SYNTAX SCORE IN PATIENTS WITH LEFT MAIN AND/OR 3-VESSEL CORONARY DISEASE: COMPARISON WITH INVASIVE ANGIOGRAPHY (2014) (0)
NORMALIZING PLATELET REACTIVITY OF CARDIOVASCULAR PATIENTS ON TICAGRELOR THERAPY USING FRESH PLATELETS: EX VIVO TESTING OF THE FUNCTIONAL RECOVERY ATTAINED WITHIN 48-HOURS OF STOPPING TREATMENT (2017) (0)
Abstract 19548: Detection, Correlation and Prediction of Systemic Vascular Disease using 3D volumetric Carotid Ultrasound: Results from the High Risk Plaque Initiative (2012) (0)
In Memoriam of Alfred Bove, MD, PhD: My Personal Encounters in 4 Phases. (2019) (0)
Optimal medical therapy for coronary artery disease (2021) (0)
Comprar Coronary Risk Factors Update, An Issue of Medical Clinics | Valentin Fuster | 9781455738892 | Saunders (2012) (0)
Rupture of the external elastic lamina increases plaque neovascularization after coronary angioplasty in the swine model (2003) (0)
Direct correlation between coronary artery disease and aortic arch plaque thickness measured by noninvasive B-mode ultrasonography (2002) (0)
Hurst's heart,arteries and venis (2013) (0)
Platelets in Hematologic and Cardiovascular Disorders: Glossary (2007) (0)
Erratum: The MOGE(S) classification of cardiomyopathy for clinicians (Journal of the American College of Cardiology (2014) 64 (304-18)) (2014) (0)
Journalists and researchers: equal responsibility in protecting the public. (2015) (0)
Neointima Formation Inactivation of Nuclear Factor-Y Inhibits Vascular Smooth Muscle Cell Proliferation and (2014) (0)
High-Sensitivity Cardiac Troponin, Statin Therapy, and Risk of Coronary Heart Disease (2016) (0)
Dots Vascular Calcification, Diabetes, and Cardiovascular Disease: Connecting the (2012) (0)
Atrial delayed enhancement is associated with the severity of diastolic dysfunction in cardiac amyloidosis (2013) (0)
194. Genomic Characterization of a Porcine Native Abdominal Aortic Aneurysm Model (2008) (0)
T1 MAPPING PREDICTS ADVERSE CLINICAL OUTCOME IN MYOCARDITIS (2018) (0)
Overview of Imaging Atherosclerosis (2007) (0)
INCREASED CORONARY VESSEL REMODELING AS MEASURED BY CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY IS ASSOCIATED WITH ABNORMAL SERUM BIOMARKERS (2012) (0)
Abstract 17376: Incremental Effects of Diabetes Mellitus and Chronic Kidney Disease in Medial Calcification: Synergistic Pathways for Peripheral Vascular Disease Progression (2012) (0)
1133-155 Phase velocity mapping by cardiac magnetic resonance is a valuable noninvasive tool in the assessment of patients with pulmonary hypertension (2004) (0)
NEW CARDIOVASCULAR TRAINING TRACK : REINVENTING THE WHEEL? AUTHORS' REPLY (1998) (0)
GLUCAGON-LIKE PEPTIDE-1 RECEPTOR ACTIVATION DURING MYOCARDIAL INFARCTION REDUCES DIASTOLIC DYSFUNCTION IN PIGS (2012) (0)
Abstract 15275: Altered Extracellular Matrix Proteoglycan- Decorin, Collagens and Elastin Deposition May Enhance Atherosclerosis in Human Peripheral Artery Disease: Implication of Morphological Predictors in Restenotic Plaque Progression (2015) (0)
Update: Drug-Psychotropic Drug Interactions Cardiac drug-psychotropic drug update (2002) (0)
Greater likelihood of right-sided over left-sided carotid wall inflammation as revealed by FDG-PET/CT imaging (2010) (0)
Interventional Management of Diabetic Coronaropathy and Diffuse Coronary Artery Disease (2015) (0)
gREVIEW REVIEW Cardiac Death in Low- and Middle-Income Countries (2012) (0)
Cost-effectiveness of Newer Antiplatelet Drugs [3] (multiple letters) (2003) (0)
Abstract 11971: Early Intravenous Beta Blockers Improve In-Hospital and Short-Term Mortality without Increasing the Risk of Cardiogenic Shock in Patients with Acute Coronary Syndrome-A Meta-Analysis (2011) (0)
Quantitative analysis of the admission electrocardiogram predicts extent of coronary disease and outcome in rest angina (1990) (0)
Current technological and non-techno- logical trends in cardiovascular fields (2013) (0)
Abstract 12754: Prevalence and Risk Factors of Carotid Vessel Wall Inflammation in Coronary Artery Disease Patients: An 18F-FDG PET / CT Imaging Study (2011) (0)
Coronary laser thermal angioplasty in the swine: reduced complications with shorter laser delivery time. (1991) (0)
Selecting antithrombic agents in cardiovascular disease (1988) (0)
S22 Atherogenesis, the role of new imaging modalities and therapeutic stabilization (1998) (0)
Editor-in-Chief's Top Picks From 2016: Part Two. (2017) (0)
In Memoriam of Alfred Bove, MD, PhD: My Personal Encounters in 4 Phases. (2019) (0)
P2466Association of actigraphy-measured sleep parameters and subclinical atherosclerotic burden: the PESA study (2018) (0)
[From complex multivessel disease to cardiovascular health]. (2010) (0)
RESTORING PLATELET FUNCTION EX VIVO BY ADDING FRESH PLATELETS WITHIN 24 HOURS OF A PRASUGREL 60 MG LOADING DOSE (2012) (0)
Abstract 16878: Troponin Release Overestimates Infarct Size in the Presence of Left Ventricular Hypertrophy (2011) (0)
ANTITHROMBOTIC EFFECTS OF TICAGRELOR VERSUS CLOPIDOGREL LOADING DOSE IN DIABETIC PATIENTS (2016) (0)
Abstract P108: Associations between Anthropometric Indices and the Prevalence of Heart Disease in Iran: The Golestan Cohort Study (2013) (0)
3070Caloric restriction increases lifespan in dilated cardiomyopathy mice by enhancing mitochondrial quality control (2019) (0)
CINE BALANCED STEADY-STATE FREE PRECESSION IS A RELIABLE ALTERNATIVE TO CONVENTIONAL T2-WEIGHTED IMAGING AND EVANS BLUE FOR THE CMR ASSESSMENT OF AREA AT RISK AFTER MYOCARDIAL INFARCTION (2013) (0)
23Quantification of post-reperfusion intramyocardial haemorrhage with cardiac magnetic resonance imaging in an ischemia/reperfusion pig model: T2* vs R2* vs R2" (2019) (0)
EPICARDIAL ADIPOSE TISSUE EVALUATED BY CARDIAC MAGNETIC RESONANCE PREDICTS ADVERSE OUTCOMES IN HEART FAILURE PATIENTS (2020) (0)

This paper list is powered by the following services:

Other Resources About Valentín Fuster

en.wikipedia.org

What Schools Are Affiliated With Valentín Fuster?

Valentín Fuster is affiliated with the following schools:

Image Attributions

Image Source for Valentín Fuster